<SEC-DOCUMENT>0001437749-22-023306.txt : 20220930
<SEC-HEADER>0001437749-22-023306.hdr.sgml : 20220930
<ACCEPTANCE-DATETIME>20220930161715
ACCESSION NUMBER:		0001437749-22-023306
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20221110
FILED AS OF DATE:		20220930
DATE AS OF CHANGE:		20220930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33678
		FILM NUMBER:		221284259

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>nby20220921_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<html><head>
	<title>nby20220921_def14a.htm</title>

	<!-- Generated by ThunderDome Portal - 9/28/2022 10:05:02 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 0pt auto 0pt auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SCHEDULE 14A INFORMATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proxy Statement Pursuant to Section 14(a) of</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>the Securities Exchange Act of 1934 </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Amendment No.&nbsp; &nbsp; )</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr class="hr-custom" style="text-align: center;height: 1px; color: #000000; background-color: #000000; width: 15%; border: none; margin: 0pt auto 0pt auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by the Registrant &#9746;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by a Party other than the Registrant&nbsp;&#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Preliminary Proxy Statement</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9746;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Definitive Proxy Statement</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Definitive Additional Materials</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Soliciting Material Pursuant to &#167; 240.14a-12</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOVABAY PHARMACEUTICALS, INC. </b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(Name of Registrant as Specified in Its Charter)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payment of Filing Fee (Check the appropriate box):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9746;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">No fee required</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Fee paid previously with preliminary materials</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div style="text-align: center;"><img alt="logo01.jpg" src="logo01.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOVABAY PHARMACEUTICALS, INC.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2000 Powell Street, Suite 1150</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Emeryville, California 94608</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><b><font style="text-transform:uppercase;">N<font style="font-size:10pt;">otice</font> o<font style="font-size:10pt;">f</font> S<font style="font-size:10pt;">pecial</font> M<font style="font-size:10pt;">eeting</font> o<font style="font-size:10pt;">f</font> S<font style="font-size:10pt;">tockholders</font></font></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(230, 230, 230);">
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>Date</u></b><b>:</b></p>
			</td>
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>Time</u></b><b>:</b></p>
			</td>
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><u>Place</u></b><b>:</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Thursday, November 10, 2022</b></p>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>11:00 a.m. Pacific Time</b></p>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Virtual meeting at: </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">www.virtualshareholdermeeting.com/NBY2022SM</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the Stockholders of NovaBay Pharmaceuticals, Inc.:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You are cordially invited to attend the 2022 Special Meeting of Stockholders (the &#8220;<b><i>Special Meeting</i></b>&#8221;) of NovaBay Pharmaceuticals, Inc., a Delaware corporation (&#8220;<b><i>NovaBay</i></b>,&#8221; the &#8220;<b><i>Company</i></b>,&#8221; &#8220;<b><i>we</i></b>,&#8221; &#8220;<b><i>our</i></b>&#8221; and &#8220;<b><i>us</i></b>&#8221;). The Special Meeting will be a virtual meeting of stockholders. Stockholders may attend the Special Meeting online, vote their shares electronically, and submit questions during the Special Meeting by visiting www.virtualshareholdermeeting.com/NBY2022SM and entering the 16-digit control number included in their proxy card, the Notice of Internet Availability of Proxy Materials, or the voting information form provided by their broker, bank, or other nominee. Prior to the Special Meeting, stockholders can vote at www.proxyvote.com using their 16-digit control number or by the other methods described in the accompanying proxy statement (the &#8220;<b><i>Proxy Statement</i></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Special Meeting will be held for the following purposes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 96%; margin-left: 36pt; margin-right: auto;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>Proposal One:</u></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>(The Company Guide Proposal)</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 74%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">To approve, as required by and in accordance with Sections 713(a) and 713(b) of the NYSE American Company Guide, the issuance of an aggregate of 96,468,114 shares of common stock, par value $0.01 per share (&#8220;<b><i>Common Stock</i></b>&#8221;) (i) upon exercise of the Amended Warrants and the New Reprice Warrants issued as part of our Warrant Reprice Transactions entered into on September 9, 2022 (each as discussed and defined in the Proxy Statement) and (ii) the conversion of the Series C Non-Voting Convertible Preferred Stock, par value $0.01 per share (&#8220;<b><i>Series C Preferred Stock</i></b>&#8221;) and the exercise of the Long-Term Warrants and the Short-Term Warrants to be issued upon the closing of the 2022 Private Placement (each as discussed and defined in the Proxy Statement), including any additional shares of Common Stock due to an increase as a result of applicable anti-dilution adjustments.</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 74%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>Proposal Two:</u></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>(The Reverse Stock Split Proposal)</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 74%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of all of our Common Stock issued and outstanding shares or held in treasury at a ratio of not less than 1-for-10 and not more than 1-for-35 (the &#8220;<b><i>Reverse Stock Split</i></b>&#8221;), and to grant authorization to our Board of Directors to determine, in its sole discretion, the specific ratio at any whole number within the above share range and the timing of the Reverse Stock Split becoming effective or to abandon the Reverse Stock Split.</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 74%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><u>Proposal Three:</u></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>(The Adjournment Proposal)</i></p>
			</td>
			<td style="vertical-align: top; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 74%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">To adjourn the Special Meeting to establish a quorum or to permit further solicitation of proxies if there are not sufficient votes cast at the time of the Special Meeting in favor of Proposal One or Proposal Two.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Proposal One (the Company Guide Proposal), Proposal Two (the Reverse Stock Split Proposal), and Proposal Three (the Adjournment Proposal) are collectively referred to as the &#8220;<b><i>Proposals</i></b>&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Proposals are described in the accompanying Proxy Statement, which we encourage you to read in its entirety before voting. <b>After careful consideration, the NovaBay Board of Directors has determined that the Proposals are advisable and in the best interests of NovaBay and its stockholders and recommends that the holders of Common Stock entitled to vote with respect to each of the Proposals vote or give instruction to vote </b>&#8220;<b>FOR</b>&#8221;<b> Proposal One, </b>&#8220;<b>FOR</b>&#8221;<b> Proposal Two, and </b>&#8220;<b>FOR</b>&#8221;<b> Proposal Three.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The record date for the Special Meeting is September 13, 2022. Only stockholders of record at the close of business on that date are entitled to notice of, and may vote at, the virtual Special Meeting or any adjournment or postponement thereof. A Notice of Internet Availability of Proxy Materials for the Special Meeting or this Notice of Special Meeting and the Proxy Statement are being distributed and being made available on or about September 30, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">A list of stockholders entitled to vote at the Special Meeting will be available at NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, California 94608, for a period of ten days prior to the Special Meeting. If you wish to inspect the stockholder list, please contact our Corporate Secretary at (510) 899-8800. The stockholder list will also be available during the virtual Special Meeting through the following secure link www.virtualshareholdermeeting.com/NBY2022SM.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 53%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">September 30, 2022</p>
			</td>
			<td style="vertical-align: top; width: 47%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board of Directors,</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 53%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 53%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">
			<div><img alt="sig01.jpg" src="sig01.jpg"></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 53%;">&nbsp;</td>
			<td style="vertical-align: top; width: 47%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Paul E. Freiman</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Chair of the Board </i></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0); vertical-align: top; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">You are cordially invited to attend, via live webcast, the virtual Special Meeting.&nbsp;&nbsp;<b>Your vote is important</b>. We encourage you to promptly vote your shares either by telephone, over the Internet or by completing, signing, dating and returning your proxy card, which contains instructions on how you would like your shares to be voted at the Special Meeting.&nbsp;<b>Please submit your vote by proxy through one of these methods regardless of whether you will attend the Special Meeting.</b>&nbsp;This will help us ensure that your shares are represented at the Special Meeting.&nbsp;&nbsp;A return envelope (which is postage prepaid if mailed in the United States) has been provided for your convenience if you plan to return your proxy card.&nbsp;&nbsp;Signing and submitting your proxy will not prevent you from voting electronically at the Special Meeting should you be able to attend the virtual Special Meeting, but will assure that your vote is counted, if for any reason you are unable to attend.&nbsp;&nbsp;Voting instructions are printed on your proxy card and are also included in the accompanying Proxy Statement.&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%; margin: 0pt;">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TABLE OF CONTENTS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b><u>Page</u></b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">SUMMARY OF THE PROXY STATEMENT</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">About NovaBay</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">1</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Proposal One (The Company Guide Proposal)</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">2</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Proposal Two (The Reverse Stock Split Proposal)</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">4</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Proposal Three (The Adjournment Proposal)</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">6</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">7</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">PROXY STATEMENT</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">8</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Purpose of Meeting</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">8</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Notice of Internet Availability</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">8</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Attendance at the Special Meeting</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">8</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Voting; Quorum</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">9</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Required Votes and Effects of Abstentions and Broker Non-Votes</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">9</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Effect of Not Voting</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">11</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Voting Methods</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">11</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Revoking Proxies</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">11</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Solicitation</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">12</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Results of Voting at the Special Meeting</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">12</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">MATTERS TO BE CONSIDERED&nbsp; AT THE SPECIAL MEETING</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">13</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">PROPOSAL ONE: THE COMPANY GUIDE PROPOSAL</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">13</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Overview and Description of the Financing Transactions</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">13</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Description of the Warrant Reprice Transactions</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">14</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">2022 Private Placement</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">15</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Reasons for Stockholder Approval&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">17</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Effect and Consequences of the Issuances of Underlying Common Stock</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">17</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Stockholder Approval</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">18</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Recommendation of the Board&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">18</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">PROPOSAL TWO: THE REVERSE STOCK SPLIT PROPOSAL</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">19</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Overview</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">19</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Effective Date&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">20</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Reasons for the Reverse Stock Split</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">20</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Risks Relating to the Reverse Stock Split</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">22</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Principal Effects of the Reverse Stock Split</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">23</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Board Discretion to Implement or Abandon Reverse Stock Split</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">25</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Fractional Shares</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">25</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">No Dissenters&#8217;&nbsp;Rights&#8217;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">25</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Certain United States Federal Income Tax Consequences</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">25</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Accounting Consequences</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">26</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Stock Certificates</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">26</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Book-Entry&nbsp;Shares</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">27</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Stockholder Approval</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">27</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Recommendation of the Board</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">27</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">PROPOSAL THREE: THE ADJOURNMENT PROPOSAL</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">28</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Overview</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">28</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Stockholder Approval</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">28</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Recommendation of the Board</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">28</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">29</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">DEADLINES FOR RECEIPT OF FUTURE STOCKHOLDER PROPOSALS AND NOMINATIONS FOR OUR 2023 ANNUAL MEETING</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">31</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">HOUSEHOLDING OF PROXY MATERIALS</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">31</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">METHOD OF PROXY SOLICITATION</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">32</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">WHERE YOU CAN FIND MORE INFORMATION</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: right;">32</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">ANNEX A &#8211; CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</p>
			</td>
			<td style="vertical-align: top; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">A-1</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div class="PGBRDR" style="border: Black solid 1px; width: 98%; padding: 11px;">
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SUMMARY OF THE PROXY STATEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>This summary highlights selected information from this proxy statement (</i>&#8220;<b><i>Proxy Statement</i></b>&#8221;<i>) for the 2022 Special Meeting of Stockholders (the </i>&#8220;<b><i>Special Meeting</i></b>&#8221;<i>) and may not contain all of the information that is important to you. To better understand the proposals being considered at the Special Meeting, you should read this entire Proxy Statement carefully, including the materials attached as annexes, as well as other documents referred to or referenced herein. Each item in this summary includes a page reference directing you to a more complete description of that item contained in later parts of this Proxy Statement. </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Except where specifically noted, the following information and all other information contained in this Proxy Statement does not give effect to the proposed Reverse Stock Split described in Proposal Two, which is summarized below and more fully described beginning on page 19 of this Proxy Statement.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>About NovaBay </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">NovaBay Pharmaceuticals, Inc. (&#8220;<b><i>NovaBay</i></b>&#8221;, the &#8220;<b><i>Company</i></b>&#8221;, &#8220;<b><i>we</i></b>&#8221;, &#8220;<b><i>our</i></b>&#8221;&nbsp;and &#8220;<b><i>us</i></b>&#8221;) develops and sells scientifically-created and clinically-proven eyecare and skincare products. Our leading product, Avenova&#174; Antimicrobial Lid and Lash Solution (&#8220;<b><i>Avenova Spray</i></b>&#8221;), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with our proprietary, stable and pure form of hypochlorous acid and is cleared by the U.S. Food and Drug Administration for sale in the United States. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress, and the i-Chek.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On November 5, 2021, we significantly expanded our business by acquiring DERMAdoctor, LLC (&#8220;<b><i>DERMAdoctor</i></b>&#8221;) as our wholly-owned subsidiary. DERMAdoctor offers over-the-counter dermatological products targeting common skin concerns.&nbsp;DERMAdoctor branded products are marketed and sold through the DERMAdoctor website, well-known traditional and digital beauty retailers, and a network of international distributors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In our Quarterly Report on Form 10-Q filed with the SEC on August 11, 2022 (the &#8220;<b><i>June Form 10-Q</i></b>&#8221;), we reported that based primarily on the funds available as of June 30, 2022, our existing cash and cash equivalents and cash flows generated from product sales will be sufficient to fund our existing operations and meet our planned operating expenses into at least the first quarter of 2023. However, we also reported that we expected that our 2022 expenses will continue to exceed our 2022 revenues, as the Company continues to invest in both its Avenova and DERMAdoctor commercialization efforts. Based on the amount of capital and liquidity that our Company had available at the time, we determined that our planned operations raised substantial doubt about our ability to continue as a going concern. In addition, we also noted that changing circumstances may cause us to expend cash significantly faster than currently anticipated or planned, and that we may need to spend more cash than expected because of circumstances beyond our control that impact the broader economy such as periods of inflation, supply chain issues, the continuation of the COVID-19 pandemic and international conflicts (e.g., the conflict between Russia and Ukraine).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">To address our need for liquidity and capital to fund our planned operations, we entered into financing transactions on September 9, 2022 to raise up to approximately $5.3 million in the aggregate of additional capital, as discussed in Proposal One and Proposal Two below. In the absence of our Company completing these financing transactions or substantial revenue growth from our commercialization efforts, there will be substantial doubt about our ability to continue as a going concern within one year after June 30, 2022, and we will be required to scale back or terminate operations and/or seek protection under applicable bankruptcy laws. For additional information regarding our capital and liquidity situation, please read our June 2022 Form 10-Q on file with the SEC. See &#8220;Where You Can Find More Information&#8221; on page 32.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 1 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div class="PGBRDR" style="border: Black solid 1px; width: 98%; padding: 11px;">
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposal One (The Company Guide Proposal) </b>(page 13)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Summary of Financing Transactions </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As more fully described in Proposal One in this Proxy Statement, on September 9, 2022, we entered into agreements relating to the following private financing transactions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i><u>Warrant Reprice Transactions</u></i>. Our warrant reprice transactions (the &#8220;<b><i>Warrant Reprice Transactions</i></b>&#8221;) with certain existing Company warrant holders provide for, pursuant to warrant reprice letter agreements, dated September 9, 2022, (i) amendments to previously issued Company common stock, par value $0.01 per share (&#8220;<b><i>Common Stock</i></b>&#8221;) purchase warrants (the &#8220;<b><i>Amended Warrants</i></b>&#8221;), which included a reduction of the exercise price to $0.18 per share and provided for exercise restrictions on such warrants (other than an initial cash exercise) until the later of (a) six months from September 9, 2022 and (b) or the date that Proposal One and Proposal Two as provided in this Proxy Statement are approved by stockholders and become effective (such date, the &#8220;<b><i>Stockholder Approval Date</i></b>&#8221;) and (ii) an initial cash exercise by certain of the participating warrant holders at the reduced exercise price and the issuance of a New Reprice Warrant (as defined below) to such exercising holders, which is described in additional detail in Proposal One. The Warrant Reprice Transactions became effective and resulted in us receiving approximately $2.1&nbsp;million in proceeds from the cash exercise of the Amended Warrants at the reduced exercise price.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i><u>2022 Private Placement</u></i>. A private placement transaction with institutional accredited investors (the &#8220;<b><i>2022 Private Placement</i></b>&#8221;) to sell, pursuant to the Securities Purchase Agreement, dated September 9, 2022 (the &#8220;<b><i>Securities Purchase Agreement</i></b>&#8221;), Company units (&#8220;<b><i>Units</i></b>&#8221;) that will consist of (i) a newly designated Series C Non-Voting Convertible Preferred Stock, par value $0.01 per share (&#8220;<b><i>Series C Preferred Stock</i></b>&#8221;), (ii) a new short-term Series A-1 warrant to purchase Common Stock (&#8220;<b><i>Short-Term Warrants</i></b>&#8221;), and (iii) a new long-term Series A-2 warrant to purchase common stock (&#8220;<b><i>Long-Term Warrants</i></b>&#8221;&nbsp;and, together with the Short-Term Warrants, the &#8220;<b><i>2022 Warrants</i></b>&#8221;). We expect to close the 2022 Private Placement in the fourth quarter of 2022, subject to receiving stockholder approval of Proposal One and Proposal Two and after satisfying other customary closing conditions as provided in the Securities Purchase Agreement. Upon the closing of the 2022 Private Placement, we expect to receive gross proceeds of $3.3 million from the sale of the Units.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">At the Special Meeting, we are asking stockholders to approve, in accordance with Sections 713(a) and 713(b) of the NYSE American Company Guide (the &#8220;<b><i>Company Guide</i></b>&#8221;), the issuance of an aggregate of 96,468,114 shares of Common Stock, subject to potential increase in the number of shares due to applicable anti-dilution adjustments, that will become issuable by the Company in connection with the Warrant Reprice Transactions and, if completed, the 2022 Private Placement as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">the future exercise of the Amended Warrants for 30,825,000 underlying shares of Common Stock and the New Reprice Warrants for 11,475,000 underlying shares of Common Stock that were both issued as part of the Warrant Reprice Transactions, such warrants not being exercisable until the later to occur of (i) six months from September 9, 2022 and (ii) the Stockholder Approval Date; and</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the conversion of 3,250 shares of Series C Preferred Stock for 18,057,000 shares of Common Stock (subject to potential increase in the number of shares due to applicable anti-dilution adjustments), the exercise of the Long-Term Warrants for&nbsp;18,055,557 underlying shares of Common Stock (subject to potential increase in the number of shares due to applicable anti-dilution adjustments), and the exercise of the Short Term Warrants for&nbsp;18,055,557 underlying shares of Common Stock (subject to potential increase in the number of shares due to applicable anti-dilution adjustments), all of which are contemplated to be issued and sold as provided in the Securities Purchase Agreement at the closing of the 2022 Private Placement. Upon the closing of the 2022 Private Placement, the shares of Series C Preferred Stock will be convertible into Common Stock and the 2022 Warrants will be exercisable into Common Stock, and such underlying shares of Common Stock will be registered by us for resale pursuant to a registration rights agreement that we will enter into at such closing.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">For additional information about the Warrant Reprice Transactions and the 2022 Private Placement, please see &#8220;Proposal One: The Company Guide Proposal&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Reasons for Approval of Proposal One</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>NYSE American Company Guide Requirements</i>. Since our Common Stock is currently listed on the NYSE American, we are required to comply with the continued listing rules of the Company Guide. Section 713(a) of the Company Guide requires stockholder approval in connection with any transaction, other than a public offering, involving the sale, issuance, or potential issuance, of common stock or securities convertible into common stock, equal to 20.0% or more of presently outstanding stock for less than the greater of book or market value (whichever is greater). Section 713(b) of the Company Guide requires stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) when the issuance or potential issuance of additional shares may result in a change of control of the issuer. Since the aggregate number of shares of Common Stock underlying the Series C Preferred Stock (18,057,000 shares of Common Stock) and the 2022 Warrants (36,111,114 shares of Common Stock) following the closing of the 2022 Private Placement, the issuance of Common Stock underlying the Amended Warrants (30,825,000 shares of Common Stock) and the New Reprice Warrants (11,475,000 shares of Common Stock), will collectively represent 148% of the total number of shares of Common Stock currently outstanding, we are seeking approval under both Sections 713(a) and 713(b) of the Company Guide. Stockholder approval of Proposal One will constitute stockholder approval for purposes of Sections 713(a) and 713(b) of the Company Guide.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 2 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div class="PGBRDR" style="border: Black solid 1px; width: 98%; padding: 11px;">
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Required Pursuant to Our Financing Transaction Agreements</i>. As a material condition of the Warrant Reprice Transactions and the 2022 Private Placement, we agreed to submit and recommend Proposal One and, as described below, Proposal Two to our stockholders. These contractual obligations address the Company&#8217;s obligation to satisfy the Company Guide requirement and for the Company to have a sufficient number of shares of Common Stock available for future issuance, as described under Proposal Two. Approval of Proposal One and Proposal Two will result in the restrictions on exercise under the Amended Warrants and the New Reprice Warrants no longer being effective. The Company&#8217;s Board of Directors (the &#8220;<b><i>Board</i></b>&#8221;) approved the Warrant Reprice Transactions and the 2022 Private Placement and believes that satisfying our contractual obligations in those transactions by submitting Proposal One to stockholders for their approval at this Special Meeting is in the best interests of our Company and our stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Consequences of the Warrant Reprice Transaction and the 2022 Private Placement</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Upon stockholder approval of Proposal One and Proposal Two, we will be able to close the 2022 Private Placement, which provides for the issuance of the Series C Preferred Stock and the 2022 Warrants and the Amended Warrants, and the New Reprice Warrants will become exercisable, resulting in a potential issuance of up to 96,468,114 shares of Common Stock or 148% of Common Stock currently outstanding as of the Record Date. If this occurs, it would result in significant dilution in ownership interests and voting rights to our stockholders. As a result of the consummation of the Warrant Reprice Transaction and the reduction of the exercise price of the Amended Warrant and the exercise price of the New Reprice Warrants, the anti-dilution protections of our existing Series B Non-Voting Convertible Preferred Stock, par value $0.01 per share (the &#8220;<b><i>Series B Preferred Stock</i></b>&#8221;), automatically adjusted the conversion price of the Series B Preferred Stock, which was $0.40 into 2,500 shares of Common Stock to be adjusted downward to now be $0.18 into 5,556 shares of Common Stock. Therefore, based on the 11,620 shares of Series B Preferred Stock currently outstanding there are an additional 35,510,720 shares of Common Stock issuable upon conversion, which resulted in significant dilution to our stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If either Proposal One or Proposal Two is not approved by stockholders at the Special Meeting, then we will not be able to close the 2022 Private Placement and raise additional capital for our Company, and the Amended Warrants and the New Reprice Warrants will not be exercisable and will remain subject to the exercise restrictions set forth in such warrants. In addition, the terms of the Securities Purchase Agreement and the Reprice Letter Agreements require us to continue to seek stockholder approval every four months until such proposals are approved.<b> </b>Also, if Proposal One and Proposal Two are not approved by stockholders, pursuant to the Securities Purchase Agreement, then NovaBay will be subject to restrictions on its ability to raise capital using Common Stock and Common Stock equivalents and incurring indebtedness, until such approvals are obtained, unless the Securities Purchase Agreement is terminated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Vote Required and Other Matters</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Stockholder approval of Proposal One requires a &#8220;FOR&#8221;&nbsp;vote from the holders of a majority of the shares of Common Stock present or represented and entitled to vote at the Special Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>It is important to understand that we are not seeking stockholder approval of, and you are not being asked to vote on, the Warrant Reprice Transactions (which have already been completed) or the issuance of the Amended Warrants and the New Reprice Warrants (which have already been issued).</b> In addition, although we committed, in connection with the Warrant Reprice Transactions, to seek stockholder approval of the Reverse Stock Split, as well as any approvals as may be required by the Company Guide, and such approvals are conditions to the closing of the 2022 Private Placement, you are not being asked to approve the closing of the 2022 Private Placement or the issuance of the Units (including the Series C Preferred Stock and the 2022 Warrants). Instead, we are seeking your approval of the issuance of shares of Common Stock underlying the Amended Warrants, the New Reprice Warrants, the Series C Preferred Stock and the 2022 Warrants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<p style="margin: 0pt;">&nbsp;</p>
</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 3 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div class="PGBRDR" style="border: Black solid 1px; width: 98%; padding: 11px;">
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposal Two (The Reverse Stock Split Proposal) </b>(page 19)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Reasons for Approval of Proposal Two</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Required Pursuant to Our Financing Transaction Agreements</i>. As a material condition of the Warrant Reprice Transactions and the 2022 Private Placement, we agreed to call the Special Meeting within 75 days to seek stockholder approval of an amendment to our Amended and Restated Certificate of Incorporation, as amended (&#8220;<b><i>Certificate of Incorporation</i></b>&#8221;), to effect a reverse stock split of all of our Common Stock issued and outstanding or held in treasury at a ratio of not less than 1-for-10 and not more than 1-for-35 (each 10 to 35 shares, as the case may be, of Common Stock will be combined to become one share of Common Stock without change to the number of authorized shares of Common Stock of the Company) (the &#8220;<b><i>Reverse</i></b>&nbsp;<b><i>Stock</i></b>&nbsp;<b><i>Split</i></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Maintain Compliance with NYSE American Continued Listing Requirements</i>. We are also seeking approval of Proposal Two so that the Company will continue to comply with the continued listing rules of the NYSE American under the Company Guide. Our Common Stock is listed on the NYSE American under the symbol &#8220;NBY.&#8221; In order to maintain continued listing on the NYSE American, among other requirements, our Common Stock must maintain an average minimum closing stock price of $0.20 over any 30-day consecutive trading period, with $0.20 being the current NYSE American internal precedent threshold of what the NYSE American considers to be a &#8220;low price per share&#8221; and constitute &#8220;low selling price issues&#8221; of the issuer pursuant to Section 1003(f)(v) of the Company Guide.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">As of September 16, 2022, our 30-day average closing stock price was $0.22 per share, which is above the $0.20 &#8220;low price per share&#8221; minimum threshold. However, our closing stock price has dropped below $0.20 per share on individual days in the month of September 2022, including a price of $0.14 as of September 16, 2022. Pursuant to the Warrant Reprice Transactions, the exercise price of the Amended Warrants was reduced to, and the exercise price of the New Reprice Warrants is, $0.18 per share. The Board expects that the Reverse Stock Split will increase the market price of Common Stock so that&nbsp;the Company&nbsp;will be able to&nbsp;satisfy the&nbsp;continued listing requirements&nbsp;of the NYSE American for the&nbsp;foreseeable future, although&nbsp;the Company&nbsp;cannot assure that it will be able to do so.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Additional Authorized Common Stock</i>. Due to the number of shares of Common Stock that we will be required to issue if all of the Amended Warrants and New Reprice Warrants in the Warrant Reprice Transactions are exercised and the Series C Preferred Stock and the 2022 Warrants to be issued in the 2022 Private Placement are converted or exercised, as the case may be, then we will not have a sufficient number of shares of Common Stock to issue upon exercise and/or conversion of these Company securities. If Proposal Two is approved by stockholders and the Board determines to effect the Reverse Stock Split, the number of authorized shares of Company capital stock, consisting of 150,000,000 authorized shares of Common Stock and 5,000,000 authorized shares of preferred stock, will remain unchanged. As a result of there being no change to the number of shares of our authorized capital stock in connection with the Reverse Stock Split, the number of authorized shares of Common Stock that will be available for future issuance will increase significantly. Therefore, the Reverse Stock Split will&nbsp; provide for a sufficient number of authorized shares under&nbsp;our Certificate of Incorporation in order to permit the issuance of shares of Common Stock upon the exercise of the Amended Warrants and the New Reprice Warrants and upon conversion of the Series C Preferred Stock and the exercise of the 2022 Warrants if the 2022 Private Placement closes. In addition, it will provide for additional shares of Common Stock that may be issued in any future offerings or potential strategic transactions that we may pursue.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Improve the Marketability and Liquidity of the Common Stock and Appeal to a Broader Range of Investors and Generate Greater Investor Interest. </i>We also believe that the expected increased market price of our Common Stock resulting from the Reverse Stock Split will improve the marketability and liquidity of our Common Stock and will encourage interest and trading in our Common Stock. A Reverse Stock Split could allow a broader range of institutions to invest in our Common Stock, potentially increasing the liquidity of our Common Stock, and may also help increase analyst and broker interest in our Common Stock as their policies can discourage them from following or recommending companies with low stock prices. However, the market price of our Common Stock will also be based on performance of the Company and other factors, some of which are unrelated to the number of shares outstanding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">For additional information, see &#8220;Reasons for the Reverse Stock Split&#8221; under Proposal Two&nbsp;below for&nbsp;addition reasons and information.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 4 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div class="PGBRDR" style="border: Black solid 1px; width: 98%; padding: 11px;">
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Background, Process and Effects of a Reverse Stock Split </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">The Board has unanimously approved resolutions to (i) effect a reverse split of all of our outstanding shares of Common Stock or held in treasury by a ratio of not less than 1-for-10 and not more than 1-for-35 (each 10 to 35 shares of Common Stock, as the case may be, shall be combined to become 1 share of Common Stock) that will be effected by amending our Certificate of Incorporation and (ii) directing that a proposal be submitted to our stockholders at the Special Meeting for the prior approval of the Reverse Stock Split, which proposal has been submitted at the Special Meeting as Proposal Two. The proposed Reverse Stock Split is a contractual commitment the Company made as part of the Warrant Reprice Transactions and as a condition to close the 2022 Private Placement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If Proposal Two is approved by our stockholders, the Board will have sole discretion pursuant to Section&nbsp;242(c) of the Delaware General Corporation Law to elect, as it determines to be in the Company&#8217;s best interests and without further action by our stockholders, whether or not and when to effect the Reverse Stock Split, or to abandon it. The Company reserves the right to abandon a reverse stock split without further action by our stockholders at any time before the effectiveness of the filing with the Secretary of the State of Delaware of a Certificate of Amendment (the &#8220;<b><i>Certificate of</i></b> <b><i>Amendment</i></b>&#8221;), even if the authority to effect a reverse stock split has been approved by our stockholders at the Special Meeting. By voting in favor of Proposal Two, you are expressly also authorizing the Board to delay, not to proceed with, and/or abandon, the Reverse Stock Split if it should so decide, in its sole discretion, that such action is in the best interests of the Company and its stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Should the Board proceed with the Reverse Stock Split, the exact ratio shall be set at a whole number within the above range as determined by the Board in its sole discretion without further action by our stockholders. Proportional adjustments (i.e., in proportion to the reverse stock split ratio) will be made to the maximum number of shares issuable under, outstanding awards under, and other terms of our 2002 Stock Option Plan, 2005 Stock Option Plan, 2007 Omnibus Incentive Plan, and 2017 Omnibus Incentive Plan (collectively, the &#8220;<b><i>Plans</i></b>&#8221;), and the terms of the Company&#8217;s outstanding warrants to purchase Common Stock, including the Amended Warrants and the New Reprice Warrants, will also be proportionally adjusted. The Reverse Stock Split, if effected, would affect all of our holders of Common Stock, as well as all of our holders of Series B Preferred Stock, which are convertible into shares of Common Stock, uniformly. The Board believes that the availability of alternative Reverse Stock Split ratios will provide it with the flexibility to implement the Reverse Stock Split in a manner designed to maximize the anticipated benefits for the Company and its stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">By approving Proposal Two and if the Reverse Stock Split is made effective, then 150,000,000 authorized shares of Common Stock and 5,000,000 authorized shares of preferred stock under our Certificate of Incorporation will remain unchanged, which will result in the number of authorized shares of Common Stock that will be available for future issuance to increase significantly. If Proposal Two is approved by our stockholders and the Reverse Stock Split is effective, then these additional authorized shares of Common Stock will be available for issuance for any proper corporate purpose as determined by the Board, without further approval by the stockholders, except as required by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Certain Risks Associated with a Reverse Stock Split</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">There are certain risks associated with a reverse stock split, and we cannot accurately predict or assure that the Reverse Stock Split will produce or maintain the desired results, which include the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The proposed Reverse Stock Split, if effected, may not increase our stock price, and could lead to a decrease in our overall market capitalization.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The proposed Reverse Stock Split, if effected, may decrease the liquidity of our Common Stock.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">If we do not obtain stockholder approval of the Reverse Stock Split at the Special Meeting, we may not be able to satisfy our obligations in connection with the Warrant Reprice Transactions and the 2022 Private Placement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The proposed Reverse Stock Split, if effected, may result in some stockholders owning &#8220;odd lots&#8221;&nbsp;that may be more difficult to sell or require greater transaction costs per share to sell.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The proposed Reverse Stock Split, if effected, will result in a significant increase in our authorized Common Stock and may result in future dilution to our stockholders.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 5 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div class="PGBRDR" style="border: Black solid 1px; width: 98%; padding: 11px;">
<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Our Board, however, believes that the benefits to the Company and our stockholders outweigh the risks and recommends that you vote in favor of the reverse stock split proposal. We urge you to read the risk factors relating to the Reverse Stock Split under &#8220;Proposal Two: The Reverse Stock Split Proposal &#8212; Reasons for the Reverse Stock Split.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>No Dissenters</u><u>&#8217;</u><u> Rights</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Under Delaware law, our stockholders will not be entitled to dissenters&#8217; rights or rights of appraisal in connection with the implementation of the Reverse Stock Split, and we will not independently provide our stockholders with any such rights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Vote Required and Other Matters </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Stockholder approval of Proposal Two requires a &#8220;FOR&#8221; vote from the holders of a majority of the shares of Common Stock issued and outstanding and entitled to vote at the Special Meeting as of the Record Date (as defined below).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If our stockholders approve Proposal Two, we expect the Board to determine a reverse split ratio within the range approved by stockholders and then file the Certificate of Amendment with the Secretary of State of the State of Delaware, substantially in the form as attached in <u>Annex A</u> hereto to effect the Reverse Stock Split, as soon as practicable following stockholder approval of Proposal Two. The Certificate of Amendment will become effective after filing with the Secretary of State of the State of Delaware and on the date and time set forth therein<b>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Pursuant to the Securities Purchase Agreement and the Reprice Letter Agreements, if Proposal One and Proposal Two are not both approved by stockholders, then until such proposals are approved, NovaBay will be required to continue to seek stockholder approval every four months until such proposals are approved. In addition, if such proposals are not approved, then pursuant to the Securities Purchase Agreement, NovaBay will be subject to restrictions on its ability to raise capital using Common Stock and Common Stock equivalents and incurring indebtedness, until such approvals are obtained, unless the Securities Purchase Agreement is terminated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposal Three (The Adjournment Proposal) </b>(page 28)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Reasons for Approval of Proposal Three</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If NovaBay fails to receive a sufficient number of votes to approve Proposal One, Proposal Two, Proposal Three or establish a quorum for the Special Meeting or we do not receive a sufficient number of votes to approve Proposal One and/or Proposal Two, then we may propose to adjourn or postpone the Special Meeting. The vote regarding adjournment or postponement of the Special Meeting will be disregarded if there are sufficient votes to approve Proposal One and Proposal Two.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Vote Required</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">The affirmative vote of the holders of a majority of the shares present in person or represented by proxy and entitled to vote at the Special Meeting is required for approval of Proposal Three.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">If you have any questions or require any assistance in voting your shares, please contact:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Alliance Advisors, LLC</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">200 Broadacres Drive, 3rd Floor, Bloomfield, NJ 07003</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">855-643-7304</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 6 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">This Proxy Statement and documents referenced herein contain &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;<b><i>Securities Act</i></b>&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;<b><i>Exchange Act</i></b>&#8221;), including, but not limited to, statements that are based upon management&#8217;s current expectations, assumptions, estimates, projections and beliefs, including statements about the commercial progress and future financial performance of the Company, as well as matters relating to the Warrant Reprice Transactions, the 2022 Private Placement, Proposal One (the Company Guide Proposal) and Proposal Two (the Reverse Stock Split Proposal). The use of words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; or &#8220;would&#8221; and similar words or expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the financial and business impact and effect of the completed Warrant Reprice Transactions, the expected timing of, our ability to complete, and impact of the 2022 Private Placement and the Reverse Stock Split, our partnerships, and any future revenue that may result from selling the Company&#8217;s products, as well as the Company&#8217;s expected future financial results. These statements involve risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by these forward-looking statements. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Other risks relating to the Company&#8217;s business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this Proxy Statement, are detailed in the Company&#8217;s latest Form 10-K, subsequent Forms 10-Q and/or Form 8-K filings with the U.S. Securities and Exchange Commission (the &#8220;<b><i>SEC</i></b>&#8221;), especially under the heading &#8220;Risk Factors.&#8221; The forward-looking statements in this Proxy Statement and documents referenced herein speak only as of this date, and the Company disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="7" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 7 -</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: center;"><img alt="logo01.jpg" src="logo01.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2000 Powell Street, Suite 1150</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Emeryville, California 94608</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; width: 100%; margin-left: auto; margin-right: auto;">

		<tr style="font-size: 12pt;">
			<td style="vertical-align: middle; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119); font-size: 12pt;">
			<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">P<font style="font-size:10pt;">roxy</font> S<font style="font-size:10pt;">tatement</font></font></b></font><br>
			<font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">F<font style="font-size:10pt;">or</font> T<font style="font-size:10pt;">he</font> 2022 S<font style="font-size:10pt;">pecial</font> M<font style="font-size:10pt;">eeting</font> o<font style="font-size:10pt;">f</font> S<font style="font-size:10pt;">tockholders</font></font></b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">This proxy statement (&#8220;<b><i>Proxy Statement</i></b>&#8221;), the accompanying Notice of the Special Meeting of Stockholders and proxy card are being furnished in connection with the solicitation of proxies by the Board of Directors of NovaBay Pharmaceuticals, Inc., a Delaware corporation (&#8220;<b><i>NovaBay</i></b><i>,</i>&#8221; the &#8220;<b><i>Company</i></b><i>,</i>&#8221; &#8220;<b><i>we</i></b><i>,</i>&#8221; &#8220;<b><i>our</i></b><i>,</i>&#8221; or &#8220;<b><i>us</i></b>&#8221;), to be voted at the 2022 Special Meeting of Stockholders to be held on Thursday, November 10, 2022 (the &#8220;<b><i>Special Meeting</i></b>&#8221;), and at any adjournment or postponement of the Special Meeting. This Special Meeting will be held at 11:00 a.m. Pacific Time and will be a virtual meeting of stockholders. You will be able to participate in the 2022 Special Meeting, vote, and submit your questions during the meeting via live webcast by visiting www.virtualshareholdermeeting.com/NBY2022SM. You must have your 16-digit control number on your proxy card to enter and participate in the virtual meeting. This Proxy Statement and the proxy card are being made available over the Internet or delivered by mail on or about September 30, 2022, to stockholders of record as of September 13, 2022 (the &#8220;<b><i>Record Date</i></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Except where specifically noted, the following information and all other information contained in this Proxy Statement does not give effect to the proposed Reverse Stock Split described in Proposal Two, beginning on page 19 of this Proxy Statement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Purpose of Meeting</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The three specific proposals to be considered and acted upon at the Special Meeting are summarized in the Notice of Special Meeting and the Summary of the Proxy Statement and are described in more detail below and in the description of each of the three proposals that has been included elsewhere in this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Notice of Internet Availability</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We are pleased to offer our stockholders the convenience of notice and access to our electronic Proxy Statement and the opportunity to vote online. This delivery method also helps NovaBay reduce the mailing of paper copies of our proxy materials. By participating in the &#8220;notice and access&#8221; process, we save printing and mailing expenses and reduce the environmental impact of the Special Meeting. Pursuant to rules adopted by the SEC, we are permitted to furnish proxy materials, including this Proxy Statement, to our stockholders by providing access to such documents on the Internet instead of mailing printed copies. Consequently, our stockholders generally will not receive paper copies of our proxy materials unless they request them, or unless we elect to send them to stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Beginning on or about September 30, 2022, we will send to our stockholders of record a Notice of Internet Availability (the &#8220;<b><i>Availability Notice</i></b>&#8221;) containing instructions on how to access this Proxy Statement and proxy card via the Internet and vote online. As a result, you will not receive a printed copy of the proxy materials in the mail unless you request a copy, or unless we elect to send a printed copy to you. All stockholders will have the ability to access the proxy materials on a website referred to in the Availability Notice and may request a printed set of the proxy materials free of charge by mail or electronically from such website. If you would like to receive a printed set of our proxy materials, you should follow the instructions for requesting such materials included in the Availability Notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Attendance at the Special Meeting</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As permitted by Delaware law and our Amended and Restated Bylaws (the &#8220;<b><i>Bylaws</i></b>&#8221;), the Special Meeting will be held solely as a virtual meeting live via the Internet. You will be able to attend the Special Meeting via live webcast by visiting our virtual meeting website (www.virtualshareholdermeeting.com/NBY2022SM) at the meeting time. Upon visiting the meeting website, you will be prompted to enter your 16-digit control number provided on your Availability Notice or proxy card if you receive proxy materials by mail. Your unique control number allows us to identify you as a stockholder and will enable you to securely log on, vote and submit questions during the Special Meeting on the meeting website.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 8 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Shares of which you are the beneficial owner but not the stockholder of record also may be voted electronically during the Special Meeting if you have a 16-digit control number. If there is no 16-digit control number included on your instructions, please refer to the information provided by your broker, bank or other holder of record for voting information and/or instruction on how to attend the Special Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Even if you plan to attend the Special Meeting virtually, we recommend that you vote your shares in advance, so that your vote will be counted if you later decide not to attend the Special Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Voting; Quorum</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Record Date for determining those stockholders who are entitled to notice of, and to vote at, the Special Meeting has been fixed as September 13, 2022. Only stockholders of record at the close of business on the Record Date are entitled to notice of, and to vote at, the Special Meeting and any adjournment or postponement thereof. Each stockholder is entitled to one vote for each share of Common Stock held by such stockholder as of the Record Date. The holders of the Series B Preferred Stock have no voting rights for Proposal One, Proposal Two or Proposal Three, and therefore will not vote at the Special Meeting. As of the Record Date, 64,988,364 shares of Common Stock were outstanding, and 11,620 shares of Series B Preferred Stock were outstanding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The presence at the Special Meeting, either in person or by duly authorized proxy, of holders of a majority of the voting power of all the outstanding shares of Common Stock entitled to vote will constitute a quorum for the transaction of business at the Special Meeting. Stockholders who log on and vote at our virtual meeting of stockholders with their 16-digit control number are considered present in person at the meeting. Abstentions are counted as present for purposes of determining the presence of a quorum. Shares of our common stock that are represented by broker non-votes will not be counted as shares present for purposes of determining the presence of a quorum at the Special Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">A broker non-vote occurs when the broker, bank or other nominee holding shares for a beneficial owner does not vote on a particular proposal because such broker, bank or other nominee does not have discretionary voting power to vote on that proposal without specific voting instructions from the beneficial owner. If a quorum is not present, the Special Meeting will be adjourned until a quorum is obtained.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">All votes will be tabulated by the inspector of election appointed for the Special Meeting, who will separately tabulate affirmative and negative votes, abstentions and broker non-votes. Broker non-votes and votes marked &#8220;ABSTAIN&#8221; will not be counted towards the tabulation of votes cast on the proposal presented to the stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Required Votes and Effects of Abstentions and Broker Non-Votes</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><i>Votes Generally</i>.&nbsp;&nbsp;Votes will be counted by the inspector of election appointed for the Special Meeting, who will separately count, for each proposal, votes &#8220;FOR&#8221; and &#8220;Against,&#8221; abstentions, and, if applicable, broker non-votes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><i>Abstentions and Broker Non-Votes</i>.&nbsp;&nbsp;Abstentions will count towards the quorum. Shares constituting broker &#8220;non-votes&#8221; are not counted or deemed to be present or represented for the purpose of determining whether stockholders have approved a matter or, unless the beneficial holder has provided voting instructions on at least one proposal, whether a quorum exists at the Special Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 9 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><i>Required Vote</i>.&nbsp;&nbsp;The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker non-votes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: bottom; width: 9%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposal</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>No. </b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 31%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposal Description</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 31%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Vote Required for Approval</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Effect of</b><br>
			<b>Abstentions</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 12%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Effect of</b><br>
			<b>Broker</b><br>
			<b>Non-Votes</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">One</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>The Company Guide Proposal</i></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To approve, as required by and in accordance with Sections 713(a) and 713(b) of the Company Guide, the issuance of an aggregate of 96,468,114 shares of Common Stock (i) upon exercise of the Amended Warrants and the New Reprice Warrants issued as part of our Warrant Reprice Transactions entered into on September 9, 2022 (each as discussed and defined in the Proxy Statement) and (ii) the conversion of the Series C Preferred Stock and the exercise of the Long-Term Warrants and the Short-Term Warrants to be issued upon the closing of the 2022 Private Placement, including any additional shares of Common Stock due to an increase as a result of applicable anti-dilution adjustments.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;FOR&#8221; votes from a majority of the shares present in person or represented by proxy and entitled to vote at the Special Meeting.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Against</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Effect</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 9%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Two</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>The Reverse Stock Split Proposal</i>&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To approve an amendment to the Certificate of Incorporation to effect the Reverse Stock Split, and to grant authorization to the Board to determine, in its sole discretion, the specific ratio at any whole number within the above share range and the timing of the Reverse Stock Split becoming effective or to abandon&nbsp;the Reverse Stock Split.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;FOR&#8221;&nbsp;votes of the holders of a majority of our outstanding shares of Common Stock outstanding on the Record Date.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Against</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Against</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 9%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">&nbsp;</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Three</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>The Adjournment Proposal</i>&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To adjourn the Special Meeting to establish a quorum or to permit further solicitation of proxies if there are not sufficient votes cast at the time of the Special Meeting in favor of Proposal One or Proposal Two.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 31%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#8220;FOR&#8221;&nbsp;votes from a majority of the shares present in person or represented by proxy and entitled to vote at the Special Meeting.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Against</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
			<td style="vertical-align: top; width: 12%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Effect</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As described under &#8220;Proposal One: The Company Guide Proposal&#8221;, each of the warrant holders that participated in the Warrant Reprice Transactions signed and delivered a voting commitment letter (referred to herein as &#8220;<b><i>Participant Voting Commitment</i></b>&#8221;) that provides for such participating warrant holder to vote its shares of Common Stock to approve Proposal One and Proposal Two. In connection with the Warrant Reprice Transactions, the Company also obtained voting commitments from its executive officers, directors, more than 10% stockholders and certain other significant stockholders similar to the Participant Voting Commitments to vote in favor of Proposal One and Proposal Two. As a result of having these voting commitment letters, we expect a significant number of shares of Common Stock, up to approximately 33% of the outstanding Common Stock as of the Record Date, to support Proposal One and Proposal Two; however, such number of shares will not be sufficient to approve these proposals.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>It is important to understand that we are not seeking stockholder approval of, and you are not being asked to vote on, the Warrant Reprice Transactions (which have already been completed) or the issuance of the Amended Warrants and the New Reprice Warrants (which have already been issued).</b> In addition, although we committed, in connection with the Warrant Reprice Transactions, to seek stockholder approval of the Reverse Stock Split, as well as any approvals as may be required by the Company Guide, and such approvals are conditions to the closing of the 2022 Private Placement, you are not being asked to approve the closing of the 2022 Private Placement or the issuance of the Units (including the Series C Preferred Stock and the 2022 Warrants). Instead, we are seeking your approval of the issuance of shares of Common Stock underlying the Amended Warrants, the New Reprice Warrants, the Series C Preferred Stock and the 2022 Warrants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 10 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Effect of Not Voting</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Stockholder of Record; Shares Registered in Your Name</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If you are a stockholder of record and do not vote by completing your proxy card, by telephone, over the Internet or in person at the Special Meeting, your shares will not be voted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Beneficial Owner; Shares Registered in the Name of a Broker, Bank or Other Nominee</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If you are a beneficial owner and do not instruct your broker, bank or other nominee how to vote your shares, the question of whether your broker, bank or other nominee will still be able to vote your shares depends on whether the New York Stock Exchange (&#8220;<b><i>NYSE</i></b>&#8221;) deems the particular proposal to be a &#8220;routine&#8221; matter. Brokers, banks or other nominees can use their discretion to vote &#8220;uninstructed&#8221; shares with respect to matters that are considered to be &#8220;routine,&#8221; but not with respect to &#8220;non-routine&#8221; matters. Under the rules and interpretations of the NYSE, &#8220;non-routine&#8221; matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), executive compensation (including any advisory stockholder votes on executive compensation and on the frequency of stockholder votes on executive compensation), and certain corporate governance proposals, even if management supported. Proposal One (the Company Guide Proposal) is believed to be a &#8220;non-routine&#8221; matter. Accordingly, your broker, bank or other nominee may not vote your shares on Proposal One without voting instructions from you. Proposal Two (the Reverse Stock Split Proposal) and Proposal Three (the Adjournment Proposal) are believed&nbsp;to be &#8220;routine&#8221; matters. Accordingly, your broker, bank or other nominee may vote your shares on such proposals even if you do not give it instructions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Voting Methods</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">If you were a stockholder of record on the Record Date, you may vote your shares at the virtual Special Meeting, www.virtualshareholdermeeting.com/NBY2022SM, which contains voting instructions. You may also vote your shares by visiting www.proxyvote.com or by calling (toll free within the United States and Canada) 1-800-690-6903 and following the voting instructions read to you by the automated operator. Internet and telephone voting facilities for stockholders of record will be available 24 hours a day beginning at 12:01 a.m. Pacific Time on September 30, 2022. Internet and telephone voting will close promptly at 11:59 p.m. Eastern Time on Wednesday, November 9, 2022. After that time, you will only be able to vote by attending the Special Meeting via live webcast and voting at the Special Meeting. The meeting starts at 11:00 a.m. Pacific Time. After voting is closed during the Special Meeting, you will no longer have the ability to vote your shares for the specific proposals considered at the Special Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Upon visiting the meeting website or calling the telephone number provided above, you will be prompted to enter your 16-digit control number provided to you on your proxy card. Your unique control number allows us to identify you as a stockholder and will enable you to securely cast votes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If you receive proxy materials by mail or if you request paper copies of the proxy materials, you can vote by mail by marking, dating, signing and returning your proxy card in the postage-paid envelope. Further instructions on how to vote by mail are included on the proxy card. Only proxy cards that have been signed, dated, and timely returned will be counted towards the quorum and entitled to vote.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If your proxy card does not specify how the shares represented thereby are to be voted, the proxy will be voted &#8220;FOR&#8221; Proposal One,&nbsp;Proposal Two and&nbsp;Proposal Three,&nbsp;as described in the Notice and this Proxy Statement.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Revoking Proxies</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If your shares are held in your name, you may revoke or change your vote at any time before the Special Meeting by (i) submitting another proxy on a later date on the Internet or by telephone (only your latest Internet or telephone proxy submitted prior to the Special Meeting will be counted), (ii) attending the Special Meeting live via webcast and voting during the meeting (simply attending the virtual meeting will not, by itself, revoke your proxy), or (iii) filing a notice of revocation or another signed proxy card with a later date with our Corporate Secretary, Mr. Justin Hall, Esq., at our principal executive offices at 2000 Powell Street, Suite 1150, Emeryville, California 94608.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 11 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Solicitation</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We will bear the entire cost of proxy solicitation, including the costs of preparing, assembling, printing and mailing this Proxy Statement, the Availability Notice, the proxy card and any additional solicitation materials furnished to our stockholders. Copies of these materials will be furnished to brokers, banks or other nominees holding shares in their names that are beneficially owned by others so they may forward these materials to such beneficial owners. In addition, we may reimburse such persons for their reasonable expenses in forwarding the solicitation materials to the beneficial owners. The original solicitation of proxies by mail may be supplemented by a solicitation by personal contact, telephone, facsimile, email or any other means by our directors, officers or employees. No additional compensation will be paid to these individuals for any such services. In addition, we have engaged Alliance Advisors, LLC, to assist in the solicitation of proxies and provide related advice and informational support. For additional information about this engagement, please see &#8220;Method of Proxy Solicitation&#8221; below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Results of Voting at the Special Meeting</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We expect to announce preliminary voting results at the Special Meeting. In addition, we expect that final voting results will be filed with the SEC on a Current Report on Form 8-K within four business days after the Special Meeting.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="12" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 12 -</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><b><font style="color:#0e4b77;"><font style="text-transform:uppercase;">M<font style="font-size:10pt;">atters</font> t<font style="font-size:10pt;">o</font> b<font style="font-size:10pt;">e</font> C<font style="font-size:10pt;">onsidered</font> a<font style="font-size:10pt;">t</font> t<font style="font-size:10pt;">he</font> S<font style="font-size:10pt;">pecial</font> M<font style="font-size:10pt;">eeting</font></font></font></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">P<font style="font-size:10pt;">roposal</font> O<font style="font-size:10pt;">ne:</font></font></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><b><font style="color:#0e4b77;"><font style="text-transform:uppercase;">T<font style="font-size:10pt;">he</font> C<font style="font-size:10pt;">ompany</font> G<font style="font-size:10pt;">uide</font> P<font style="font-size:10pt;">roposal</font></font></font></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Overview and Description of the Financing Transactions</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">At the Special Meeting, we are asking stockholders to approve, in accordance with Sections 713(a) and 713(b) of the NYSE American Company Guide, the issuance of an aggregate of 96,468,114 shares of Common Stock, subject to potential increase in the number of shares due to applicable anti-dilution adjustments, which will be issuable by the Company in connection with our Warrant Reprice Transactions (as described below) and, if closed, the 2022 Private Placement (as described below).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On September 9, 2022, we entered into written agreements relating to the following two private financing transactions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:36pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Warrant Reprice Transactions.</u>&nbsp;The Warrant Reprice Transactions with certain existing Company warrant holders provide for, pursuant to warrant reprice letter agreements, dated September 9, 2022, (i)&nbsp;amendments to previously issued Common Stock purchase warrants, which included a reduction of the exercise price to $0.18 per share and provided for exercise restrictions on such warrants (other than an initial cash exercise) until the later of (a) six months from September 9, 2022 and (b) or the Stockholder Approval Date and (ii) an initial cash exercise by certain of the participating warrant holders at the reduced exercise price and the issuance of a New Reprice Warrant (as defined below) to such exercising holders, which is described in additional detail in Proposal One. The Warrant Reprice Transactions became effective and resulted in us receiving approximately $2.1&nbsp;million in proceeds from the cash exercise of the Amended Warrants at the reduced exercise price.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:36pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>2022 Private Placement</u>. A private placement transaction with institutional accredited investors to sell, pursuant to the Securities Purchase Agreement, Units that will consist of Series C Preferred Stock and the 2022 Warrants. We expect to close the 2022 Private Placement in the fourth quarter of 2022, subject to receiving stockholder approval of Proposal One and Proposal Two and after satisfying other customary closing conditions as provided in the Securities Purchase Agreement. Upon the closing of the 2022 Private Placement, we expect to receive gross proceeds of $3.3&nbsp;million from the sale of the Units.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Since our Common Stock is currently listed on the NYSE American, we are required to comply with the continued listing rules of the Company Guide. Section 713(a) of the Company Guide requires stockholder approval in connection with any transaction, other than a public offering, involving the sale, issuance, or potential issuance, of common stock or securities convertible into common stock, equal to 20.0% or more of presently outstanding stock for less than the greater of book or market value (whichever is greater). Section 713(b) of the Company Guide requires stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) when the issuance or potential issuance of additional shares may result in a change of control of the issuer. Since the aggregate number of shares of Common Stock underlying the Series C Preferred Stock (18,057,000 shares of Common Stock) and the 2022 Warrants (36,111,114 shares of Common Stock) following the closing of the 2022 Private Placement, the issuance of Common Stock underlying the Amended Warrants (30,825,000 shares of Common Stock) and the New Reprice Warrants (11,475,000 shares of Common Stock), will collectively represent 148% of the total number of shares of Common Stock currently outstanding, we are seeking approval under both Sections 713(a) and 713(b) of the Company Guide. Stockholder approval of this Proposal One will constitute stockholder approval for purposes of Sections 713(a) and 713(b) of the Company Guide.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 13 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In addition, as a material condition of the Warrant Reprice Transactions and the 2022 Private Placement, we agreed to submit and recommend this Proposal One and, as described below, Proposal Two to our stockholders. If we do not obtain stockholder approval of this Proposal One and Proposal Two at the Special Meeting, we have agreed to call a meeting of stockholders every four months thereafter to seek stockholder approval until stockholder approval is obtained. These contractual obligations address the Company&#8217;s obligation to satisfy the Company Guide requirement and for the Company to have a sufficient number of shares of Common Stock available for future issuance, as described under Proposal Two. Approval of this Proposal One and Proposal Two will result in the restrictions on exercise under the Amended Warrants and the New Reprice Warrants no longer being effective. The Board approved the Warrant Reprice Transactions and the 2022 Private Placement and believes that satisfying our contractual obligations in those transactions by submitting this Proposal One to stockholders for their approval at this Special Meeting is in the best interests of our Company and our stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>It is important to understand that we are not seeking stockholder approval of, and you are not being asked to vote on, the Warrant Reprice Transactions (which have already been completed) or the issuance of the Amended Warrants and the New Reprice Warrants (which have already been issued).</b> In addition, although we committed, in connection with the Warrant Reprice Transactions, to seek stockholder approval of the Reverse Stock Split, as well as any approvals as may be required by the Company Guide, and such approvals are conditions to the closing of the 2022 Private Placement, you are not being asked to approve the closing of the 2022 Private Placement or the issuance of the Units (including the Series C Preferred Stock and the 2022 Warrants). Instead, we are seeking your approval of the issuance of shares of Common Stock underlying the Amended Warrants, the New Reprice Warrants, the Series C Preferred Stock and the 2022 Warrants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Description of the Warrant Reprice Transactions </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We previously disclosed that we issued (i) Common Stock purchase warrants to a limited number of accredited investors (the &#8220;<b><i>2020 Investors</i></b>&#8221;) in connection with our prior warrant reprice transaction that closed on July 23, 2020 (the &#8220;<b><i>2020 Original Warrants</i></b>&#8221;), and (ii) Common Stock purchase warrants to a limited number of accredited investors (the &#8220;<b><i>2021 Investors</i></b>&#8221;) in connection with our private placement financing transaction that closed on November 2, 2021 (the &#8220;<b><i>2021 Original Warrants</i></b>&#8221;). Prior to the completion of the Warrant Reprice Transactions, the 2020 Original Warrants had an aggregate of 6,898,566 underlying shares of Common Stock, exercisable at $1.65 per share, and the 2021 Original Warrants had an aggregate of 37,500,000 underlying shares of Common Stock, exercisable at $0.53 per share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Reprice Letter Agreements </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On September 9, 2022, certain of the 2020 Investors holding 2020 Original Warrants (the &#8220;<b><i>2020 Participants</i></b>&#8221;) entered into separate latter agreements with the Company (the &#8220;<b><i>2020 Reprice Letter Agreements</i></b>&#8221;) and all of the 2021 Investors holding 2021 Original Warrants (the &#8220;<b><i>2020 Participants</i></b>&#8221; and together with the 2020 Participants, the &#8220;<b><i>Participants</i></b>&#8221;) entered into separate letter agreements with the Company (the &#8220;<b><i>2021 Reprice Letter Agreements</i></b>&#8221; and, together with the 2020 Reprice Letter Agreements, the &#8220;<b><i>Reprice Letter Agreements</i></b>&#8221;) that provided for their respective warrants to be amended to reduce their exercise price to $0.18 (&#8220;<b><i>Reduced Exercise Price</i></b>&#8221;) and, in the case of the 2021 Original Warrants, extend the term of those warrants. The Amended Warrants also provide for a new restriction on exercise until the later of (i) six months from September 9, 2022 and (ii) the Stockholder Approval Date, except for an Initial Exercise (as described below).<b> </b>The Reduced Exercise Price of the Amended Warrants and the number of shares of Common Stock underlying the Amended Warrants will be adjusted to reflect the Reverse Stock Split if Proposal Two is approved and becomes effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Also pursuant to the Reprice Letter Agreements, (i) the 2020 Participants had the opportunity (but were not required) to elect to make a cash exercise of a portion of their Amended 2020 Warrants at the Reduced Exercise Price, which resulted in the exercise of an aggregate of 2,100,000 shares of Common Stock (the &#8220;<b><i>2020</i></b> <b><i>Initial</i></b> <b><i>Exercise</i></b>&#8221;) and (ii)&nbsp;the 2021 Participants all agreed to exercise an aggregate of 9,375,000 shares, or 25% of the shares of Common Stock underlying their respective Amended 2021 Warrants, at the Reduced Exercise Price (the &#8220;<b><i>2021 Initial Exercise</i></b>&#8221; and, together with the 2020 Initial Exercise, the &#8220;<b><i>Initial Exercise</i></b>&#8221;). The Company received $2,065,500 in aggregate gross proceeds from the Initial Exercise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In exchange, the Company issued to each 2021 Participant, as well as each 2020 Participant that participated in the 2020 Initial Exercise, a New Reprice Warrant to purchase a number of shares of Common Stock equal to 100% of the shares of Common Stock received by such Participant in its Initial Exercise. The form of New Reprice Warrants issued to all 2021 Participants (the &#8220;<b><i>New 2021 Participant Warrants</i></b>&#8221;) is substantially similar to the 2021 Original Warrants, and the form of New Reprice Warrants issued to the 2020 Participants that elected to make a 2020 Initial Exercise (the &#8220;<b><i>New 2020 Participant Warrants</i></b>&#8221; and, together with the New 2021 Participant Warrants, the &#8220;<b><i>New Reprice Warrants</i></b>&#8221;) is substantially similar to the 2020 Original Warrants. All of the New Reprice Warrants will be initially exercisable on the later to occur of (i) the six-month anniversary of the date of issuance and (ii) the Stockholder Approval Date. In addition, the New Reprice Warrants have a term of exercise of six years and an exercise price equal to $0.18, which exercise price and the number of underlying shares of Common Stock will be adjusted to reflect the Reverse Stock Split if Proposal Two is approved and becomes effective. The New Reprice Warrants are also subject to a provision prohibiting the exercise thereof to the extent that, after giving effect to such exercise, the holder of such Warrant (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of outstanding Common Stock. The New Reprice Warrants do not have any preemptive rights or a preference upon any liquidation, dissolution or winding-up of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 14 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In addition to entering into the Reprice Letter Agreements, each Participant also signed and delivered a Participant Voting Commitment to vote to approve this Proposal One and Proposal Two, and also entered into a Leak-Out Agreement, dated September 9, 2022, which agreements were effective only until September 13, 2022, the Record Date for the special meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Other Post-Closing Obligations and Anti-Dilution Adjustment of Series B Preferred Stock </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Resale Registration</i>. Pursuant to the Reprice Letter Agreements, we are required to prepare and file a registration statement with the SEC that will cover the resale of all of the Common Stock underlying the New Reprice Warrants within 30 days of the Stockholder Approval Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><i>Voting Commitments</i>. Each of the warrant holders that participated in the Warrant Reprice Transactions signed and delivered a Participant Voting Commitment that provides for such participating warrant holder to vote its shares of Common Stock to approve Proposal One and Proposal Two. In connection with the Warrant Reprice Transactions, the Company also obtained voting commitments from its executive officers, directors, more than 10% stockholders and certain other significant stockholders similar to the Participant Voting Commitments to vote in favor of Proposal One and Proposal Two. As a result of having these voting commitment letters, we expect a significant number of shares of Common Stock, up to approximately 33% of the outstanding Common Stock as of the Record Date, to support Proposal One and Proposal Two; however, such number of shares will not be sufficient to approve these proposals.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Anti-Dilution Adjustment to Series B Preferred Stock</i>. The Certificate of Designation of Preferences, Rights and Limitations for the Company&#8217;s issued and outstanding Series B Preferred Stock (the&nbsp;&#8220;<b><i>Series B Certificate of Designation</i></b>&#8221;) provides for anti-dilution protections in the event that the Company grants any right to reprice any Company security that would entitle the holder to acquire Common Stock at an effective price per share that is lower than the conversion price of the Series B Preferred Stock, which is referred to as &#8220;full-ratchet&#8221; anti-dilution protection. As a result of the consummation of the Warrant Reprice Transactions, which resulted in the Amended Warrants being exercisable at the Reduced Exercise Price and the issuance of New Reprice Warrants at the same Reduced Exercise Price, this anti-dilution protection in the Series B Certificate of Designation was triggered. Accordingly, the conversion price of each share of Series B Preferred Stock, which was $0.40 into 2,500 shares of Common Stock, was automatically adjusted downward and is now $0.18 into 5,556 shares of Common Stock. The adjusted conversion price of the Series B Preferred Stock is the same as the Reduced Exercise Price of the Amended Warrants and the exercise price of the New Reprice Warrants. Therefore, based on the 11,620 shares of Series B Preferred Stock currently outstanding, there are an additional 35,510,720 shares of Common Stock that are issuable upon conversion as a result of the reduction in exercise price.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>2022 Private Placement </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Securities Purchase Agreement </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On September 9, 2022, we entered into the Securities Purchase Agreement with each of the purchasers named therein (the &#8220;<b><i>2022 Purchasers</i></b>&#8221;) that provides for the Company to sell in a private placement up to $3,250,000 of Units, with each Unit consisting of (i) one share of Series C Preferred Stock, (ii) one Short-Term Warrant, and (iii)&nbsp;one Long-Term Warrant. The closing of the 2022 Private Placement is conditioned upon the Company obtaining stockholder approval of this Proposal One and Proposal Two, in addition to satisfaction other customary closing conditions set forth in in the Securities Purchase Agreement. The Securities Purchase Agreement also provides for customary termination rights, including the right of the Company or any Purchaser to terminate the Securities Purchase Agreement if the consummation of the 2022 Private Placement has not occurred on or before the fifth trading day following the date of the Stockholder Approval Date. Accordingly, the Units (including the Series C Preferred Stock and the 2022 Warrants) will not be issued unless and until both this Proposal One and Proposal Two are approved and become effective. If Proposal One and Proposal Two are approved by stockholders at the Special Meeting, we expect to close the 2022 Private Placement after the Stockholder Approval Date. We intend to use the net proceeds from the 2022 Private Placement for working capital and general corporate purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 15 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Description of Series C Preferred Stock </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Series C Preferred Stock will be a newly-created series of stock that will have the powers, preferences, rights, qualifications, limitations and restrictions, including anti-dilution protections, as set forth in the Certificate of Designation of Preferences, Rights and Limitations of Series C Preferred Stock (the &#8220;<b><i>Series C Certificate of Designation</i></b>&#8221;). The holders of Series C Preferred Stock will not have any voting rights, except as required by law and in other limited circumstances, such as to alter or change adversely the powers, preferences or rights given to the Series C Preferred Stock or alter or amend the Series C Certificate of Designation, to amend the Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders of the Series C Preferred Stock, to increase the number of authorized shares of Series C Preferred Stock, and to enter into any agreement with respect to any of the foregoing. The holders of the Series C Preferred Stock will be entitled to receive, and the Company will be required to pay, dividends on shares of the Series C Preferred Stock equal (on an as if converted to Common Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. The Series C Preferred Stock will not be entitled to any other dividends. In the event of the Company&#8217;s liquidation, dissolution or winding up, the holders of Series C Preferred Stock will be entitled to receive the same amount that a holder of Common Stock would receive if the Series C Preferred Stock were fully converted (disregarding for such purposes any conversion limitations hereunder).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Each share of Series C Preferred Stock will be convertible at a current conversion price of $0.18 into 5,556 shares of Common Stock, or an aggregate of 18,057,000 shares of Common Stock (which conversion price and number of shares will be adjusted to reflect the Reverse Stock Split if Proposal Two is approved and becomes effective). Pursuant to the Series C Certificate of Designation, the Series C Preferred Stock will be subject to another limitation on conversion to the extent that, after giving effect to such conversion, the holder of such Series C Preferred Stock (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of the outstanding Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Series C Preferred Stock also has anti-dilution protections that could result in an increase in the number of shares of Common Stock to be issued upon conversion of the Series C Preferred Stock in the future, in certain circumstances, including if the Company: (i) pays a stock dividend or otherwise make a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of the Series C Preferred Stock or payment of a dividend on the Series C Preferred Stock); (ii) subdivides outstanding shares of Common Stock into a larger number of shares; (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares; or (iv) issues by reclassification of shares of Common Stock any shares of capital stock of the Company, then in each case the conversion price of the Series C Preferred Stock will be adjusted as provided in the Series C Certificate of Designation. In addition, these anti-dilution protections also apply if the Company sells or grants any Common Stock or any securities of the Company, subject to certain limited exceptions, which would entitle the holder thereof to acquire Common Stock at an effective price per share that is lower than the applicable conversion price of the Series C Preferred Stock, and, as a result, the conversion price of the Series C Preferred Stock will be reduced to such lower price, which is referred to as a &#8220;full-ratchet&#8221; anti-dilution protection. This full-ratchet anti-dilution protection is subject to termination as provided in the Series C Certificate of Designation upon the earlier of: (x) the Common Stock achieving an average trading price of 250% of the conversion price during any 10 days during a 30-consecutive trading day period and (y) 75% of the Series C Preferred Stock issued on the original issue date has been converted. The holders of Series C Preferred Stock will not have any preemptive rights as a result of their ownership of Series C Preferred Stock. The powers, preferences, rights, qualifications, limitations and restrictions applicable to the Series C Preferred Stock, including the anti-dilution protections, set forth in the Series C Certificate of Designation will be filed with the Secretary of State of the State of Delaware prior to closing of the 2022 Private Placement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Description of 2022 Warrants</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The 2022 Warrants will have an exercise price equal to $0.18, subject to customary anti-dilution adjustments as provided in the 2022 Warrants. The Long-Term Warrants will be immediately exercisable for a period of six (6) years after the date of issuance and the Short-Term Warrants will be immediately exercisable for a period of eighteen (18) months after the date of issuance. The 2022 Warrants will be exercisable for an aggregate of 36,111,114 shares of Common Stock. The exercise price for the 2022 Warrants and the number of shares of Common Stock underlying the 2022 Warrants will be adjusted at the time of issuance to reflect the Reverse Stock Split.<b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 16 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The 2022 Warrants are subject to a provision prohibiting the exercise of such 2022 Warrants to the extent that, after giving effect to such exercise, the holder of such 2022 Warrant (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of the outstanding Common Stock. The 2022 Warrants will not have any preemptive rights or a preference upon any liquidation, dissolution or winding-up of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Reasons for Stockholder Approval</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>NYSE American Company Guide Requirements</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Since our Common Stock is currently listed on the NYSE American, we are required to comply with the continued listing rules of the Company Guide. Section 713(a) of the Company Guide requires stockholder approval in connection with any transaction, other than a public offering, involving the sale, issuance, or potential issuance, of common stock or securities convertible into common stock, equal to 20.0% or more of presently outstanding stock for less than the greater of book or market value (whichever is greater). Section 713(b) of the Company Guide requires stockholder approval of a transaction, other than a public offering, involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) when the issuance or potential issuance of additional shares may result in a change of control of the issuer. Since the aggregate number of shares of Common Stock underlying the Series C Preferred Stock (18,057,000 shares of Common Stock) and the 2022 Warrants (36,111,114 shares of Common Stock) following the closing of the 2022 Private Placement, the issuance of Common Stock underlying the Amended Warrants (30,825,000 shares of Common Stock) and the New Reprice Warrants (11,475,000 shares of Common Stock), will collectively represent 148% of the total number of shares of Common Stock currently outstanding, we are seeking approval under both Sections 713(a) and 713(b) of the Company Guide. Stockholder approval of this Proposal One will constitute stockholder approval for purposes of Sections 713(a) and 713(b) of the Company Guide.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Required Pursuant to Our Financing Transaction Agreements</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As a material condition of the Warrant Reprice Transactions and the 2022 Private Placement, we agreed to submit and recommend this Proposal One and, as described below, Proposal Two to our stockholders. If we do not obtain stockholder approval of this Proposal One and Proposal Two at the Special Meeting, we have agreed to call a meeting of stockholders every four months thereafter to seek stockholder approval until stockholder approval is obtained. These contractual obligations address the Company&#8217;s obligation to satisfy the Company Guide requirement and for the Company to have a sufficient number of shares of Common Stock available for future issuance, as described under Proposal Two. Approval of this Proposal One and Proposal Two will result in the restrictions on exercise under the Amended Warrants and the New Reprice Warrants no longer being effective. The Board approved the Warrant Reprice Transactions and the 2022 Private Placement and believes that satisfying our contractual obligations in those transactions by submitting this Proposal One to stockholders for their approval at this Special Meeting is in the best interests of our Company and our stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Effect and Consequences of the Issuances of Underlying Common Stock</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Dilutive Effect of Issuances of Common Stock</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">If stockholder approval of this Proposal One and Proposal Two is received and they become effective, then the Amended Warrants and the New Reprice Warrants will be exercisable for an aggregate of 42,300,000 shares of Common Stock, subject to adjustment to account for the Reverse Stock Split. In addition, after the Stockholder Approval Date, we intend to close the 2022 Private Placement and issue the Units, consisting of the Series C Preferred Stock (which will be convertible into 18,057,000 shares of Common Stock) and the 2022 Warrants (which will be exercisable for 36,111,114 shares of Common Stock). Accordingly, an aggregate of 96,468,114 shares of Common Stock, 148% of the total number of shares of Common Stock currently outstanding, will be issuable pursuant to exercise or conversion (as applicable) of the Amended Warrants, the New Reprice Warrants, the Series C Preferred Stock and the 2022 Warrants, subject to adjustment to account for the Reverse Stock Split and any applicable anti-dilution adjustments. If the Amended Warrants and New Reprice Warrants become exercisable and we close the 2022 Private Placement and issue the Series C Preferred Stock and the 2022 Warrants, then existing stockholders of the Company will experience significant dilution in their ownership interests and voting rights.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 17 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Obligations Upon Failure of Stockholder Approval</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If only Proposal One or Proposal Two is approved (but not both) a condition to closing the 2022 Private Placement will not be satisfied and the Amended Warrants and the New Reprice Warrants will not be exercisable. In addition, the terms of the Securities Purchase Agreement will require us to continue to seek stockholder approval every four months until both such proposals are approved, and we will be restricted in our ability to raise capital using Common Stock and Stock equivalents or to incur indebtedness.<b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Rights of Purchasers</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If stockholder approval of this Proposal One and Proposal Two is received and they become effective, then the shares of Common Stock issuable upon exercise of the Amended Warrants and the New Reprice Warrants, and, assuming the closing of the 2022 Private Placement, the shares of Common Stock issuable upon conversion of the Series C Preferred Stock and exercise of the 2022 Warrants, will have the same privileges and rights as all other shares of Common Stock that are currently issued and outstanding, including the right to vote on all matters presented to the holders of Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the Securities Purchase Agreement, we will enter into a registration rights agreement with the 2022 Purchasers at the closing of the 2022 Private Placement to register the Common Stock underlying the Series C Preferred Stock and the Common Stock underlying the 2022 Warrants. Pursuant to the Reprice Letter Agreements, we also agreed to file a registration statement providing for the resale by of the shares of Common Stock underlying the Amended Warrants and the New Reprice Warrants. <b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Stockholder Approval</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The affirmative vote of the holders of a majority of the shares of Common Stock present or represented and entitled to vote at the Special Meeting is required for approval of this Proposal One.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>It is important to understand that we are not seeking stockholder approval of, and you are not being asked to vote on, the Warrant Reprice Transactions (which have already been completed) or the issuance of the Amended Warrants and the New Reprice Warrants (which have already been issued).</b> In addition, although we committed, in connection with the Warrant Reprice Transactions, to seek stockholder approval of the Reverse Stock Split, as well as any approvals as may be required by the Company Guide, and such approvals are conditions to the closing of the 2022 Private Placement, you are not being asked to approve the closing of the 2022 Private Placement or the issuance of the Units (including the Series C Preferred Stock and the 2022 Warrants). Instead, we are seeking your approval of the issuance of shares of Common Stock underlying the Amended Warrants, the New Reprice Warrants, the Series C Preferred Stock and the 2022 Warrants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Recommendation of the Board</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"><b>For the reasons described in this Proxy Statement, the Board unanimously recommends that you vote </b>&#8220;<b>FOR</b>&#8221;<b> the approval of the issuance of an aggregate of 96,468,114 shares of Common Stock upon exercise of the Amended Warrants and the New Reprice Warrants and the conversion of the Series C Preferred Stock and the exercise of the Long-Term Warrants and the Short-Term Warrants to be issued upon closing of the 2022 Private Placement, including any additional shares of Common Stock due to an increase as a result of applicable anti-dilution adjustments, as required by and in accordance with Sections 713(a) and 713(b) of the Company Guide.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 18 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">P<font style="font-size:10pt;">roposal</font> T<font style="font-size:10pt;">wo:</font></font></b></font></p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">T<font style="font-size:10pt;">he</font> R<font style="font-size:10pt;">everse</font> S<font style="font-size:10pt;">tock</font> S<font style="font-size:10pt;">plit</font> P<font style="font-size:10pt;">roposal</font></font></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: middle; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt;"><font style="color:#0e4b77;"><b>Overview</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Board has unanimously approved resolutions to (i) effect a reverse split of all of our outstanding shares of Common Stock or held in treasury by a ratio of not less than 1-for-10 and not more than 1-for-35 (each 10 to 35 shares of Common Stock, as the case may be, shall be combined to become 1 share of Common Stock) that will be effected by amending our Certificate of Incorporation and (ii) directing that a proposal be submitted to our stockholders at the Special Meeting for the prior approval of the Reverse Stock Split, which proposal has been submitted at the Special Meeting as this Proposal Two. The proposed Reverse Stock Split is a commitment the Company made to its investors both as part of the Warrant Reprice Transactions, and is as a condition to close the 2022 Private Placement, as described below, in Proposal One and elsewhere in this Proxy Statement. In addition, the Reverse Stock Split is also being presented to our stockholders to remain in compliance with the NYSE American&#8217;s continued listing requirements under the Company Guide and for the other reasons detailed below under &#8220;&#8212; Reasons for the Reverse Stock Split&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If this Proposal Two is approved by our stockholders, the Board will have sole discretion pursuant to Section&nbsp;242(c) of the Delaware General Corporation Law to elect, as it determines to be in the Company&#8217;s best interests and without further action by our stockholders, whether or not and when to effect the Reverse Stock Split, or to abandon it. The Company reserves the right to abandon the Reverse Stock Split without further action by our stockholders at any time before the effectiveness of the filing with the Secretary of the State of Delaware of the Certificate of Amendment, even if the authority to effect the Reverse Stock Split has been approved by our stockholders. By voting in favor of Proposal Two, you are expressly also authorizing the Board to delay, not to proceed with, and/or abandon, the Reverse Stock Split if it should so decide, in its sole discretion. No further action on the part of stockholders will be required to either implement or abandon the Reverse Stock Split.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If this Proposal Two is approved by stockholders and if the Reverse Stock Split is made effective, the number of authorized shares of Company capital stock, consisting of 150,000,000 authorized shares of Common Stock and 5,000,000 authorized shares of preferred stock, will remain unchanged, which will result in the number of authorized shares of Common Stock that will be available for future issuance to increase significantly. If Proposal Two is approved by our stockholders and the Reverse Stock Split is effective, then these additional authorized shares of Common Stock will be available for issuance for any proper corporate purpose as determined by the Board, without further approval by the stockholders, except as required by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Should the Board proceed with the Reverse Stock Split, the exact ratio will be set at a whole number within the above range as determined by the Board in its sole discretion without further action by our stockholders. If the Board elects to effect the Reverse Stock Split with a ratio of 1-for-10 (the low end of the range set forth above), each 10 shares of Common stock will be combined to become one share of Common Stock. Following a 1-for-10 Reverse Stock Split, the Company would continue to have 150,000,000 authorized shares of Common Stock, but would only have approximately 6,498,837 shares of Common Stock outstanding (as compared to 64,988,364 shares outstanding as of the Record Date). If the Board elects to effect a Reverse Stock Split with a ratio of 1-for-35 (the high end of the range set forth above), each 35 shares of Common stock will be combined to become one share of Common Stock. Following a 1-for-35 Reverse Stock Split, the Company would similarly continue to have 150,000,000 authorized shares of Common Stock, but would only have approximately 1,856,810 shares of Common Stock outstanding (as compared to 64,988,364 shares outstanding as of the Record Date). The foregoing numbers of shares of Common Stock outstanding will be subject to adjustments that may result from the treatment of fractional shares as described below under the heading &#8220;&#8212; Fractional Shares&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Board believes that the availability of alternative Reverse Stock Split ratios will provide it with the flexibility to implement the Reverse Stock Split in a manner designed to maximize the anticipated benefits for the Company and its stockholders. In determining the specific Reverse Stock Split ratio, the Board may consider, among other things, factors such as:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the historical trading price and trading volume of our Common Stock;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 19 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the then prevailing trading price and trading volume of our Common Stock and the anticipated impact of the Reverse Stock Split on the trading market for our Common Stock;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">compliance with the NYSE American continued listing rules under the Company Guide with respect to minimum share price requirements for our Common Stock;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">our ability to have our shares of Common Stock remain listed on the NYSE American;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the anticipated impact of the Reverse Stock Split on our ability to raise additional financing, including the 2022 Private Placement; and</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">prevailing general market and economic conditions.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If the Board determines that effecting the Reverse Stock Split is in our best interest, the Reverse Stock Split will become effective as provided in&nbsp;the Certificate of Amendment, which will set forth the number of shares to be combined into one share of Common Stock within the limits set forth in this proposal. The Reverse Stock Split, if effected, would affect holders of Common Stock and holders of Series B Non-Voting Preferred Stock, which are convertible into shares of Common Stock, uniformly, as described below under the heading &#8220;&#8212; Principal Effects of the Reverse Stock Split&#8221;. Except for adjustments that may result from the treatment of fractional shares as described below under the heading &#8220;&#8212; Fractional Shares&#8221;, each stockholder will hold the same percentage of our outstanding Common Stock immediately following the Reverse Stock Split as such stockholder held immediately prior to the Reverse Stock Split. The following description of the proposed Reverse Stock Split and Certificate of Amendment is a summary and is subject to the full text of the proposed Certificate of Amendment, which is attached to this Proxy Statement as <u>Annex A</u>. The text of the form of Certificate of Amendment accompanying this Proxy Statement is, however, subject to revision to reflect the exact ratio for the Reverse Stock Split and any changes that may be required by the office of the Secretary of State of the State of Delaware or that the Board may determine to be necessary or advisable to comply with applicable law and to effect the Reverse Stock Split.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Effective Date</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If our stockholders approve this Proposal Two, we expect our Board to determine a reverse split ratio within the range approved by stockholders and then file the Certificate of Amendment with the Secretary of State of the State of Delaware, substantially in the form as attached in <u>Annex A</u> hereto to effect the Reverse Stock Split, as soon as practicable following stockholder approval of this Proposal Two. The Certificate of Amendment will become effective after filing with the Secretary of State of the State of Delaware and on the date and time set forth therein<b>.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">If this Proposal Two is approved and the Board determines to proceed with the Reverse Stock Split, the exact timing of the filing of the Certificate of Amendment will be determined by the Board. We refer to this time and date as the &#8220;<b><i>Effective</i></b> <b><i>Date</i></b>.&#8221; Except as explained below with respect to fractional shares, each issued share of Common Stock immediately prior to the Effective Date will automatically be changed, as of the Effective Date, into a fraction of a share of Common Stock based on the exchange ratio within the approved range determined by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><font style="color:#0e4b77;">Reasons for the Reverse Stock Split</font> </b><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Board currently believes that a Reverse Stock Split is desirable and in the best interest of the Company and its stockholders for four primary reasons listed and described below. Notwithstanding these reasons, the Board reserves its right to abandon the Reverse Stock Split if it determines, in its sole discretion, that it would no longer be in our Company&#8217;s and our stockholders&#8217; best interests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Board has determined that the Reverse Stock Split will allow us to fulfill our obligations in connection with the Warrant Reprice Transactions and the 2022 Private Placement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Board believes that effecting the Reverse Stock Split will cause the minimum bid price of our Common Stock to increase and may reduce the risk of a delisting of the Common Stock from the NYSE American in the future.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Board believes that the Reverse Stock Split will result in additional share capacity for future capital raises, including closing the 2022 Private Placement.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 20 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Board believes that the Reverse Stock Split could improve the marketability and liquidity of our Common Stock.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Required Pursuant to Our Financing Transaction Agreements</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As a material condition of the Warrant Reprice Transactions and the 2022 Private Placement, we agreed to call the Special Meeting within 75 days to seek stockholder approval of the Reverse Stock Split. If we do not obtain stockholder approval of the Reverse Stock Split at the Special Meeting, we have agreed, in connection with the Warrant Reprice Transactions, to continue to hold stockholder meetings every four months to seek such approval until it is obtained. Any need to continue to seek such approval would result in increased expense to the Company and diversion of management&#8217;s attention, time, and effort.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Maintain Compliance with NYSE American Continued Listing Requirements</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We are also seeking approval of Proposal Two so that the Company will continue to comply with the continued listing rules of the NYSE American under the Company Guide. Our Common Stock is listed on the NYSE American under the symbol &#8220;NBY.&#8221; In order to maintain continued listing on the NYSE American, among other requirements, our Common Stock must maintain an average minimum closing stock price of $0.20 over any 30-day consecutive trading period, with $0.20 being the current NYSE American internal precedent threshold of what the NYSE American considers to be a &#8220;low price per share&#8221; and constitute &#8220;low selling price issues&#8221; of the issuer pursuant to Section 1003(f)(v) of the Company Guide.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">As of September 16, 2022, our 30-day average closing stock price was $0.22 per share, which is above the $0.20 &#8220;low price per share&#8221; minimum threshold. However, the Company&#8217;s closing stock price has dipped below $0.20 per share on individual days in the month of September 2022. Pursuant to the Warrant Reprice Transactions, the exercise price of the Amended Warrants was reduced to, and the exercise price of the New Reprice Warrants is, $0.18 per share. Should the Company&#8217;s 30-day average closing stock price go below the $0.20 per share threshold, the NYSE American may issue to the Company a formal &#8220;Early Warning Letter.&#8221; The Early Warning Letter may initiate a six-month period under which the NYSE American urges the Company to effect a reverse stock split and closely monitors the performance of the Common Stock. At the end of the six-month period, the NYSE American may evaluate the Company&#8217;s most recent 30-day average closing price, as well as the Company&#8217;s absolute closing price before the end of the six-month period, to determine whether the Company is below the NYSE American compliance standards. While the NYSE American will evaluate the totality of the circumstances, there is a potential that the NYSE American could initiate delisting procedures against the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We expect that the Reverse Stock Split will increase the market price of Common Stock so that the Company will be able to satisfy the continued listing requirements of the NYSE American for the foreseeable future. We also expect that the Reverse Stock Split will provide for sufficient authorized shares under our Certificate of Incorporation in order to permit the issuance of shares of Common Stock upon the exercise of the Amended Warrants and the New Reprice Warrants and upon conversion of the Series C Preferred Stock, as well as the exercise of the 2022 Warrants if the 2022 Private Placement closes and/or in any future offerings or potential strategic transactions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Additional Authorized Common Stock</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Due to the number of shares of Common Stock that we will be required to issue if all of the Amended Warrants and New Reprice Warrants in the Warrant Reprice Transactions are exercised and the Series C Preferred Stock and the 2022 Warrants to be issued in the 2022 Private Placement are converted or exercised, as the case may be, we will not have a sufficient number of shares of Common Stock to issue upon exercise and/or conversion of these Company securities. If Proposal Two is approved by stockholders and the Board determines to effect the Reverse Stock Split, the number of authorized shares of Company capital stock, consisting of 150,000,000 authorized shares of Common Stock and 5,000,000 authorized shares of preferred stock, will remain unchanged. As a result of there being no change to the number of shares of our authorized capital stock in connection with the Reverse Stock Split, the number of authorized shares of Common Stock that will be available for future issuance will increase significantly.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Therefore, the Reverse Stock Split will provide for a sufficient number of authorized shares under our Certificate of Incorporation in order to permit the issuance of shares of Common Stock upon the exercise of the Amended Warrants and the New Reprice Warrants and upon conversion of the Series C Preferred Stock and the exercise of the 2022 Warrants if the 2022 Private Placement closes. In addition, it will provide for additional shares of Common Stock that may be issued in any future offerings or potential strategic transactions that we may pursue.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 21 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We plan to use the additional authorized shares resulting from the Reverse Stock Split to continue to pursue our historical financing strategy of raising additional capital in order to fund our operations and meet our ongoing obligations. As discussed elsewhere in this Proxy Statement, we intend to close the 2022 Private Placement as soon as possible after the effectiveness of the Reverse Stock Split. Following the completion of the 2022 Private Placement, an additional 54,168,114 shares of Common Stock will be issuable upon exercise or conversion, as the case may be, of the Series C Preferred Stock and 2022 Warrants issued in the 2022 Private Placement. The effectiveness of the Reverse Stock Split is a condition to closing the 2022 Private Placement. If we do not obtain stockholder approval of the Reverse Stock Split, we will not benefit from the anticipated proceeds from that financing transaction. We also committed, in connection with the Warrant Reprice Transactions, to seek stockholder approval for the Reverse Stock Split, and to effect the Reverse Stock Split after receiving such approval.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In addition to allowing us to satisfy our obligations in connection with the Warrant Reprice Transactions and to close the 2022 Private Placement and receive the proceeds from that transaction, we believe that maintaining our current number of authorized shares in our Certificate of Incorporation will better equip us to engage in additional capital raising efforts in the future. While we do not have any current and/or definite plans, agreements or arrangements, whether written or oral, to issue any newly authorized shares in connection with a capital raising transaction other than the previously disclosed Warrant Reprice Transactions and 2022 Private Placement, such a transaction could arise at any time following the date of this Proxy Statement, either prior to or after the Special Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Improve the Marketability and Liquidity of the Common Stock and Appeal to a Broader Range of Investors and Generate Greater Investor Interest</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We also believe that the expected increased market price of our Common Stock resulting from the Reverse Stock Split will improve the marketability and liquidity of our Common Stock and will encourage interest and trading in our Common Stock. A Reverse Stock Split could allow a broader range of institutions to invest in our Common Stock (namely, funds that are prohibited or discouraged by internal policies and practices from buying stocks whose price is below a certain threshold), potentially increasing the liquidity of our Common Stock. Additionally, because brokers&#8217; commissions on low-priced stocks generally represent a higher percentage of the stock price than commissions on higher-priced stocks, the current average price per share of our Common Stock can result in individual stockholders paying transaction costs representing a higher percentage of their total share value than would be the case if the share price were substantially higher.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Risks Relating to the Reverse Stock Split</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">There are risks associated with a reverse stock split, and we may fail to realize the expected benefits.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>The proposed Reverse Stock Split, if effected, may not increase our stock price, and could lead to a decrease in our overall market capitalization.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On September 16, 2022, the closing sale price of our Common Stock on the NYSE American was $0.14 per share. We expect that the Reverse Stock Split, if effected, will increase the per share trading price of our Common Stock. However, the market price per share of our Common Stock after the Reverse Stock Split may not rise (or remain constant) in proportion to the reduction in the number of shares of Common Stock outstanding before the Reverse Stock Split. We cannot predict the effect of the Reverse Stock Split on the per share trading price of our Common Stock, and the history of reverse stock splits for other companies is varied, particularly since some investors may view a reverse stock split negatively. In many cases, the market price of a company&#8217;s shares declines after a reverse stock split, or the market price of a company&#8217;s shares immediately after a reverse stock split does not reflect a proportionate or mathematical adjustment to the market price based on the ratio of the reverse stock split. Accordingly, our total market capitalization after a Reverse Stock Split may be lower than our total market capitalization before the Reverse Stock Split, and it is possible that a Reverse Stock Split may not result in a per share trading price that would attract investors who do not trade in lower priced stocks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Even if we implement the Reverse Stock Split, the per share trading price of our Common Stock may decrease due to factors unrelated to the Reverse Stock Split. Other factors, such as our financial results, market conditions and the market perception of our business, may adversely affect the per share trading price of our Common Stock. As a result, we cannot assure you that the Reverse Stock Split, if completed, will result in the benefits that we anticipate, that the per share trading price of our Common Stock will increase following the Reverse Stock Split or that the per share trading price of our Common Stock will not decrease in the future.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 22 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>The proposed Reverse Stock Split, if effected, may decrease the liquidity of our Common Stock.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The liquidity of our Common Stock may be harmed by the proposed Reverse Stock Split, given the reduced number of shares that would be outstanding after the Reverse Stock Split, particularly if the per share trading price does not increase proportionately as a result of the Reverse Stock Split. While the Board believes that a higher stock price may help generate the interest of new investors, the Reverse Stock Split may not result in a per-share price that will attract certain types of investors, such as institutional investors or investment funds, and such share price may not satisfy the investing guidelines of institutional investors or investment funds. As a result, the trading liquidity of our Common Stock may not improve as a result of a Reverse Stock Split and could be adversely affect by a higher per share price. Accordingly, the Reverse Stock Split may not increase marketability of our Common Stock. In addition, investors might consider the increased proportion of unissued authorized shares to issued shares to have an anti-takeover effect under certain circumstances, because the proportion allows for dilutive issuances that could prevent certain stockholders from changing the composition of the Board or render tender offers for a combination with another entity more difficult.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>If we do not obtain stockholder approval of the Reverse Stock Split at the Special Meeting, we may not be able to satisfy our obligations in connection with the Warrant Reprice Transactions and the 2022 Private Placement.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the Warrant Reprice Transactions, we committed to seek stockholder approval for the Reverse Stock Split, and to effect the Reverse Stock Split after receiving such approval. In addition, the effectiveness of the Reverse Stock Split is a condition to closing the 2022 Private Placement. If we do not obtain stockholder approval of the Reverse Stock Split at the Special Meeting, we have agreed, in connection with the Warrant Reprice Transactions, to continue to hold stockholder meetings every four months to seek such approval until it is obtained. Any need to continue to seek such approval would result in increased expense to the Company and diversion of management&#8217;s attention, time, and effort.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>The proposed Reverse Stock Split, if effected, may result in some stockholders owning </i>&#8220;<i>odd lots</i>&#8221;<i> that may be more difficult to sell or require greater transaction costs per share to sell.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If the proposed Reverse Stock Split is implemented, it will increase the number of stockholders who own &#8220;odd lots&#8221; of less than 100 shares of Common Stock. A purchase or sale of less than 100 shares of Common Stock may result in incrementally higher trading costs through certain brokers, particularly &#8220;full service&#8221; brokers. Therefore, those stockholders who own less than 100 shares of our Common Stock following the Reverse Stock Split may be required to pay higher transaction costs if they sell their shares of Common Stock.</p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>The proposed Reverse Stock Split, if effected, will result in a significant increase in our authorized Common Stock and may result in future dilution to our stockholders</i>.</p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Reverse Stock Split will reduce the number of outstanding shares of our Common Stock without a proportionate reduction in the number of shares of authorized but unissued Common Stock in our Certificate of Incorporation, which will give the Company a significantly larger number of authorized shares, as a percentage of total outstanding shares, available for future issuance without further stockholder action, except as may be required by applicable laws or the rules of any stock exchange on which our Common Stock is listed. The issuance of additional shares of Common Stock may have a dilutive effect on the ownership of existing stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Principal Effects of the Reverse Stock Split</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Common Stock and Preferred Stock.</i> If Proposal Two is approved by the stockholders at the Special Meeting, we expect the Board to establish the Reverse Stock Split ratio and proceed to effect the Reverse Stock Split, including the filing the Certificate of Amendment with the Secretary of State of the State of Delaware. Except for adjustments that may result from the treatment of fractional shares as described below, each issued share of Common Stock immediately prior to the Effective Date will automatically be changed, as of the Effective Date, into a fraction of a share of Common Stock based on the exchange ratio within the approved range determined by the Board. In addition, proportional adjustments (i.e., in proportion to the Reverse Stock Split ratio determined by the Board) will be made to any convertible or exchangeable securities entitling the holders thereof to purchase, exchange for, or convert into shares of Common Stock. The Reverse Stock Split, if effected, would affect holders of Common Stock and holders of Series B Non-Voting Preferred Stock, which are convertible into shares of Common Stock, uniformly.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 23 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Voting Rights.</i> Except for adjustments that may result from the treatment of fractional shares as described below, because the Reverse Stock Split would apply to all issued shares of our common stock, the proposed Reverse Stock Split would not alter the relative rights and preferences of existing stockholders nor affect any stockholder&#8217;s proportionate equity interest in the Company. For example, a holder of 2% of the voting power of the outstanding shares of Common Stock immediately prior to the effectiveness of the Reverse Stock Split will generally continue to hold 2% of the voting power of the outstanding shares of Common Stock immediately after the Reverse Stock Split, and the number of stockholders of record will also remain unaffected by the Reverse Stock Split.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Stock-Based Plans.</i> Proportional adjustments (i.e., in proportion to the reverse stock split ratio) will be made to the maximum number of shares issuable under, outstanding awards under, and other terms of the Plans, including adjustments (based upon the Reverse Stock Split ratio) by the Board or a committee thereof, as applicable, to the number of shares available for future grant under the Plans, the number of shares underlying outstanding awards, the exercise price per share of outstanding stock options, and other terms of outstanding awards issued pursuant to the Plans to equitably reflect the effects of the Reverse Stock Split, so as to avoid the effect of increasing the value of awards previously granted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Listing.</i> Our Common Stock currently trades on the NYSE American. The Reverse Stock Split will not directly affect the listing of our Common Stock on the NYSE American, although we believe that a Reverse Stock Split could potentially increase our stock price, thereby facilitating compliance with the NYSE American&#8217;s continued listing standards. Following the Reverse Stock Split, we expect that our Common Stock will continue to be listed on the NYSE American under the symbol &#8220;NBY&#8221;, although our Common Stock would have a new committee on uniform securities identification procedures (or &#8220;CUSIP&#8221;) number (which is a number used to identify our Common Stock). Any stock certificates with the older CUSIP number will need to be exchanged for stock certificates with the new CUSIP number by following the procedures described below &#8220;&#8212; Stock Certificates&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>&#8220;Public Company</i>&#8221;<i> Status</i>. Our Common Stock is currently registered under Section 12(b) of the Securities Exchange Act of 1934, as amended (the &#8220;<b><i>Exchange Act</i></b>&#8221;)<i>,</i> and we are subject to the &#8220;public company&#8221; periodic reporting and other requirements of the Exchange Act. The Reverse Stock Split would not affect our status as a public company or our registration under the Exchange Act. The Reverse Stock Split is not intended as, and we do not believe that it will have the effect of, a &#8220;going private transaction&#8221; covered by Rule 13e-3 under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Authorized but Unissued Shares; Potential Anti-Takeover Effects. </i>Our Certificate of Incorporation currently authorizes 150,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, and the Reverse Stock Split would not change those numbers. Therefore, the number of issued and outstanding shares of Common Stock would decrease, and the number of shares remaining available for issuance by us in the future would increase.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In addition to shares of Common Stock issuable in connection with the Warrant Reprice Transactions and the closing of the 2022 Private Placement, these additional shares would be available for issuance from time to time for corporate purposes, such as issuances of Common Stock in connection with capital-raising transactions and acquisitions of companies or other assets, as well as for issuance upon conversion or exercise of securities such as convertible preferred stock, convertible debt, warrants or options convertible into or exercisable for Common Stock. We believe that the availability of the additional shares will provide us with the flexibility to meet business needs as they arise, to take advantage of favorable opportunities and to respond effectively in a changing corporate environment. For example, we may elect to issue shares of Common Stock to raise equity capital, to make acquisitions through the use of stock, to establish strategic relationships with other companies, to adopt additional employee benefit plans or reserve additional shares for issuance under such plans, where the Board determines it advisable to do so, without the necessity of soliciting further stockholder approval, subject to applicable stockholder vote requirements under Delaware General Corporation Law and the Company Guide rules. If we issue additional shares for any of these purposes, the aggregate ownership interest of our current stockholders, and the interest of each such existing stockholder, would be diluted, possibly substantially.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The additional shares of Common Stock that would become available for issuance upon an effective Reverse Stock Split could also be used by us to oppose a hostile takeover attempt or delay or prevent a change of control or changes in, or removal of, our management, including any transaction that may be favored by a majority of our stockholders or in which our stockholders might otherwise receive a premium for their shares over then-current market prices or benefit in some other manner. Although the increased proportionate number of authorized but unissued shares to issued shares could, under certain circumstances, have an anti-takeover effect, the Reverse Stock Split is not being proposed in order to respond to a hostile takeover attempt or to an attempt to obtain control of our Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="24" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 24 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Board Discretion to Implement or Abandon Reverse Stock Split</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">After stockholder approval, the Reverse Stock Split will be effected, if at all, only upon a determination by the Board that the Reverse Stock Split (with an exchange ratio determined by the Board as described above) is in the Company&#8217;s and its stockholders&#8217; best interests. Such determination will be based upon certain factors, including, but not limited to, the Board&#8217;s consideration of our commitments made in connection with the Warrant Reprice Transaction and the 2022 Private Placement, our need for the proceeds of the 2022 Private Placement, which will not be consummated prior to the effectiveness of the Reverse Stock Split, the historical trading price and trading volume of our Common Stock, the then prevailing trading price and trading volume of our Common Stock and the anticipated impact of the Reverse Stock Split on the trading market for our Common Stock, our ability to have our shares of Common Stock remain listed on the NYSE American, the anticipated impact of the Reverse Stock Split on our ability to raise additional financing, and prevailing general market and economic conditions. No further action on the part of stockholders would be required to either implement or abandon the Reverse Stock Split. If our stockholders approve the proposal, and the Board determines to effect the Reverse Stock Split, we would communicate to the public additional details regarding the Reverse Stock Split, including the specific ratio selected by the Board. The Board reserves the right to elect not to proceed with the Reverse Stock Split if it determines, in its sole discretion, that the Reverse Stock Split is no longer in the best interests of the Company and its stockholders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Fractional Shares</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We will not issue fractional shares in connection with the Reverse Stock Split. To the extent any holders of pre-Reverse Stock Split Shares are entitled to fractional shares as a result of the Reverse Stock Split, we will instead issue one whole share of Common Stock to all holders that would otherwise receive a fractional share of Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>No Dissenters&#8217;&nbsp;Rights&#8217;&nbsp;</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Under Delaware law, our stockholders will not be entitled to dissenters&#8217; rights or rights of appraisal in connection with the implementation of the Reverse Stock Split, and we will not independently provide our stockholders with any such rights.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Certain United States Federal Income Tax Consequences</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The following is a summary of certain United States federal income tax consequences of the Reverse Stock Split. It does not address any state, local or foreign income or other tax consequences, which, depending upon the jurisdiction and the status of the stockholder/taxpayer, may vary from the United States federal income tax consequences. It applies to you only if you held shares of pre-reverse stock split Common Stock as capital assets for United States federal income tax purposes. This discussion does not apply to you if you are a member of a class of holders subject to special rules, such as (a) a dealer in securities or currencies, (b) a trader in securities that elects to use a mark-to-market method of accounting for your securities holdings, (c) a bank, (d) a life insurance company, (e) a tax-exempt organization, (f) a person that owns shares of Common Stock that are a hedge, or that are hedged, against interest rate risks, (g) a person who owns shares of Common Stock as part of a straddle or conversion transaction for tax purposes or (h) a person whose functional currency for tax purposes is not the U.S. dollar. The discussion is based on the Internal Revenue Code of 1986, as amended (the &#8220;<b><i>Internal Revenue Code</i></b>&#8221;), its legislative history, existing, temporary and proposed regulations under the Internal Revenue Code, published rulings and court decisions, all as of the date hereof. These laws, regulations and other guidance are subject to change, possibly on a retroactive basis. We have not sought, and will not seek, an opinion of counsel or a ruling from the Internal Revenue Service regarding the United States federal income tax consequences of a reverse stock split.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">PLEASE CONSULT YOUR OWN TAX ADVISOR CONCERNING THE CONSEQUENCES OF THE REVERSE STOCK SPLIT IN YOUR PARTICULAR CIRCUMSTANCES UNDER THE INTERNAL REVENUE CODE AND THE LAWS OF ANY OTHER TAXING JURISDICTION.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="25" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 25 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Tax Consequences to United States Holders of Common Stock.</i> A United States holder, as used herein, is a stockholder who or that is, for United States federal income tax purposes: (a) a citizen or individual resident of the United States, (b) a domestic corporation, (c) an estate whose income is subject to United States federal income tax regardless of its source, or (d) a trust that (i) is subject to the primary supervision of a U.S. court and the control of one or more U.S. persons or (ii) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person. This discussion applies only to United States holders.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Reverse Stock Split should constitute a &#8220;recapitalization&#8221; for U.S. federal income tax purposes and, therefore, a reorganization within the meaning of Section 368(a)(1)(E) of the Internal Revenue Code. As a result, a stockholder should not recognize gain or loss upon the Reverse Stock Split. A stockholder&#8217;s aggregate tax basis in the shares of Common Stock received pursuant to the Reverse Stock Split (including any whole share received in exchange for a fractional share) will equal the aggregate tax basis of the shares of Common Stock surrendered. The stockholder&#8217;s holding period in the shares of the common stock received (including any whole share received in exchange for a fractional share) will include the holding period in the shares of Common Stock surrendered. Treasury regulations promulgated under the Internal Revenue Code provide detailed rules for allocating the tax basis and holding period of the shares of Common Stock surrendered to the shares of Common Stock received pursuant to the Reverse Stock Split. Stockholders who acquired their shares of Common Stock on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Accounting Consequences</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Following the Effective Date of any Reverse Stock Split, if any, the net income or loss and net book value per share of Common Stock will be increased because there will be fewer shares of Common Stock outstanding. We do not anticipate that any other accounting consequences would arise as a result of the Reverse Stock Split.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Stock Certificates</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As of the Effective Date, each certificate representing shares of Common Stock outstanding before the Reverse Stock Split will be deemed, for all corporate purposes, to evidence ownership of the reduced number of shares of Common Stock resulting from the Reverse Stock Split. All&nbsp;options, warrants and other securities exchangeable or exercisable for, or convertible into, Common Stock also automatically will be adjusted on the Effective Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Our transfer agent, Computershare Shareholder Services, Inc., will act as the exchange agent for purposes of exchanging stock certificates subsequent to the Reverse Stock Split. Shortly after the Effective Date, stockholders of record will receive written instructions requesting them to complete and return a letter of transmittal and surrender their old stock certificates for new stock certificates reflecting the adjusted number of shares as a result of the Reverse Stock Split. Certificates representing shares of Common Stock issued in connection with the Reverse Stock Split will continue to bear the same restrictive legends, if any, that were borne by the surrendered certificates representing the shares of Common Stock outstanding prior to the Reverse Stock Split. No new certificates will be issued until such stockholder has surrendered any outstanding certificates, together with the properly completed and executed letter of transmittal, to the exchange agent. Until surrendered, each certificate representing shares of Common Stock outstanding before the Reverse Stock Split would continue to be valid and would represent the adjusted number of shares, based on the ratio of the Reverse Stock Split.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Any stockholder whose stock certificates are lost, destroyed or stolen will be entitled to a new certificate or certificates representing post-reverse stock split shares upon compliance with the requirements that we and our transfer agent customarily apply in connection with lost, destroyed or stolen certificates. Instructions as to lost, destroyed or stolen certificates will be included in the letter of instructions from the exchange agent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Upon the Reverse Stock Split, we intend to treat stockholders holding Common Stock in &#8220;street name,&#8221; through a broker, bank, or other nominee, in the same manner as registered stockholders whose shares are registered in their names. Brokers, banks, and other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding Common Stock in &#8220;street name.&#8221; However, such brokers, banks, and other nominees may have different procedures than registered stockholders for processing the Reverse Stock Split. If you hold your shares in &#8220;street name&#8221; with a bank, broker or other nominee, and if you have any questions in this regard, we encourage you to contact your broker, bank, or nominee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="26" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 26 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">YOU SHOULD NOT DESTROY YOUR STOCK CERTIFICATES AND YOU SHOULD NOT SEND THEM NOW. YOU SHOULD SEND YOUR STOCK CERTIFICATES ONLY AFTER YOU HAVE RECEIVED INSTRUCTIONS FROM THE EXCHANGE AGENT AND IN ACCORDANCE WITH THOSE INSTRUCTIONS.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If any certificates for shares of Common Stock are to be issued in a name other than that in which the certificates for shares of Common Stock surrendered are registered, the stockholder requesting the reissuance will be required to pay to us any transfer taxes or establish to our satisfaction that such taxes have been paid or are not payable and, in addition, (a)&nbsp;the transfer must comply with all applicable federal and state securities laws, and (b) the surrendered certificate must be properly endorsed and otherwise be in proper form for transfer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Book-Entry</b><b>&nbsp;Shares</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Registered stockholders are stockholders who hold some or all of their shares electronically in book-entry form with our transfer agent and do not have stock certificates evidencing their ownership of Common Stock. They are, however, provided with a statement reflecting the number of shares of Common Stock registered in their accounts. If you hold registered shares of Common Stock in book-entry form, you do not need to take any action to receive your post-Reverse Stock Split shares of Common Stock in registered book-entry form. If you are entitled to post-Reverse Stock Split shares of Common Stock, a transaction statement will automatically be sent to your address of record by our transfer agent as soon as practicable after the Effective Date indicating the number of shares of Common Stock you hold.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Stockholder Approval</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The affirmative vote of a majority of the shares of Common Stock outstanding as of the Record Date is required for approval of this Proposal Two.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If our stockholders approve this Proposal Two, we expect the Board to determine a Reverse Stock Split ratio within the range approved by stockholders and then file the Certificate of Amendment with the Secretary of State of the State of Delaware to effect the Reverse Stock Split, as soon as practicable following stockholder approval of Proposal Two. The Certificate of Amendment will become effective after filing with the Secretary of State of the State of Delaware and&nbsp;on the date and time set forth therein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Recommendation of the Board</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>For the reasons described in this Proxy Statement, the Board unanimously recommends that you vote </b>&#8220;<b>FOR</b>&#8221;<b> the approval of an amendment to the Certificate of Incorporation, as amended, to effect a Reverse Stock Split of all of our Common Stock issued and outstanding shares or held in treasury at a ratio of not less than 1-for-10 and not more than 1-for-35, and to grant authorization to the Board to determine, in its sole discretion, the specific ratio at any whole number within the above share range and the timing of the Reverse Stock Split becoming effective or to abandon the Reverse Stock Split.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="27" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 27 -</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">P<font style="font-size:10pt;">roposal</font> T<font style="font-size:10pt;">hree:</font></font></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;text-align:center;margin:0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">T<font style="font-size:10pt;">he</font> A<font style="font-size:10pt;">djournment</font> P<font style="font-size:10pt;">roposal</font></font></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Overview</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">A proposal will be submitted to the stockholders at the Special Meeting to approve the adjournment of the Special Meeting to establish a quorum or to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting to approve Proposal One or Proposal Two. Any adjournment of the Special Meeting may be made without notice, other than by an announcement made at the Special Meeting. Any adjournment of the Special Meeting for the purpose of soliciting additional proxies will allow stockholders who have already sent in their proxies to revoke them at any time prior to the time that the proxies are used.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Stockholder Approval</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The affirmative vote of the holders of a majority of the shares of Common Stock present or represented and entitled to vote at the Special Meeting is required for approval of this Proposal Three.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#0e4b77;"><b>Recommendation of the Board</b></font><b>&nbsp;</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>The Board recommends unanimously that you cast your vote </b>&#8220;<b>FOR</b>&#8221;<b> the approval of the adjournment of the Special Meeting to establish a quorum or to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting to approve Proposal One or Proposal Two.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="28" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 28 -</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 12pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 12pt;">
			<td style="vertical-align: middle; width: 100%; border-bottom: 2px solid rgb(14, 75, 119); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 12pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 12pt; text-align: center; margin: 0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">S<font style="font-size:10pt;">ecurity</font> O<font style="font-size:10pt;">wnership</font> o<font style="font-size:10pt;">f</font> C<font style="font-size:10pt;">ertain</font> B<font style="font-size:10pt;">eneficial</font> O<font style="font-size:10pt;">wners</font></font></b></font></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 12pt; text-align: center; margin: 0pt;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">a<font style="font-size:10pt;">nd</font> M<font style="font-size:10pt;">anagement</font></font></b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The following table indicates information as of September 13, 2022 regarding the beneficial ownership of our securities by:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">each person who is known by us to beneficially own more than five percent (5%) of our securities;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">our current executive officers;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">each of our directors; and</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">all of our directors and executive officers as a group.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The percentage of shares beneficially owned is based on 64,988,364 shares of Common Stock outstanding as of September 13, 2022. Except as indicated in the footnotes to this table, and as affected by applicable community property laws, all persons listed have sole voting and investment power for all shares shown as beneficially owned by them and no shares are pledged.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><font style="color:#0e4b77;"><b>Name and Address of Beneficial Owner (1)</b></font></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#0e4b77;"><b>Number of</b><br>
			<b>Shares</b><br>
			<b>Beneficially</b><br>
			<b>Owned</b></font></b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#0e4b77;"><b>Percent</b><br>
			<b>of Class</b></font></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(14, 75, 119);">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><u>Beneficial Owners Holding More Than 5%</u></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Pioneer Pharma (Hong Kong) Company Ltd. (&#8220;<b><i>Pioneer Hong Kong</i></b>&#8221;) (2)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,188,421</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">8.0</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">682 Castle Peak Road</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Lai Chi Kok, Kowloon, Hong Kong</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Hudson Bay Master Fund Ltd. (3)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,971,292</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7.1</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">c/o Hudson Bay Capital Management LP</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="padding-left: 9pt;">28 Havemeyer Place, 2<sup style="vertical-align:top;line-height:120%;font-size:pt">nd</sup> Floor</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="padding-left: 9pt;">Greenwich, CT 06830</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">FGP Protective Opportunity Master Fund SP (4)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,212,906</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9.9</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">94 Solaris Ave, 2<sup style="vertical-align:top;line-height:120%;font-size:pt">nd</sup> Floor</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Camana Bay</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">P.O. Box 30 745 Grand Cayman</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Jian Ping Fu (&#8220;<b><i>Mr. Fu</i></b>&#8221;) (5)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,000,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6.2</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">11 Williams Road</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Mt. Eliza, Melbourne VIC 3930, Australia</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><u>Executive Officers and Directors </u></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Justin M. Hall, Esq. (6)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">527,282</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Andrew Jones (7)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">327,461</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Audrey Kunin, M.D. (8)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">575,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Jeff Kunin, M.D. (9)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">500,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Paul E. Freiman, Ph.D. (10)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">154,409</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Julie Garlikov</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Swan Sit (11)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">50,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Mijia (Bob) Wu, M.B.A. (12)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">85,244</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Yenyou (Jeff) Zheng, Ph.D. (13)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">50,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Yongxiang (Sean) Zheng</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">All directors and executive officers as a group (10 persons)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(14, 75, 119);">1,769,396</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(14, 75, 119);">2.7</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding: 0px; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<hr class="hr-custom" style="text-align: left;height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 0pt auto 0pt 0pt;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less than one percent (1%).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; vertical-align: top;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The address for each director and officer of NovaBay listed is c/o NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, CA 94608. Number of shares beneficially owned and percent of class is calculated in accordance with SEC rules. A beneficial owner is deemed to beneficially own shares the beneficial owner has the right to acquire within 60 days of September 13, 2022. For purposes of calculating the percent of class held by a single beneficial owner, the shares that such beneficial owner has the right to acquire within 60 days of September 13, 2022 are also deemed to be outstanding; however, such shares are not deemed to be outstanding for purposes of calculating the percentage ownership of any other beneficial owner.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="29" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 29 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon information contained in the Schedule 13D/A filed by Pioneer Hong Kong and China Pioneer Pharma Holdings Limited, the parent company of Pioneer Hong Kong, with the SEC on January 13, 2017, Pioneer Hong Kong beneficially owned 5,188,421 shares of Common Stock as of December 9, 2016, with shared voting and dispositive power of all shares and sole voting and dispositive power of no shares.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon information contained in the Schedule 13G filed by Hudson Bay Capital Management LP and Sander Gerber with the SEC on February 4, 2022, Hudson Bay Capital Management LP beneficially owned 4,971,292 shares of Common Stock (including 4,804,326 shares of Common Stock issuable upon exercise of warrants and/or conversion of shares of the Series B Preferred Stock) as of December 31, 2021, with shared voting and dispositive power of all shares and sole voting and dispositive power of no shares.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon the Company&#8217;s records, as of September 13, 2022, FGP Protective Opportunity Master Fund SP owned at least 7,212,906 shares of Common Stock issuable upon the conversion of shares of the Series B Preferred Stock (with such number of shares of Common Stock representing the maximum amount convertible up to a beneficial ownership threshold of 9.9%).</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(5)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon information contained in the Schedule 13D/A filed by Mr. Fu with the SEC on August 24, 2020, Mr. Fu beneficially owned 4,000,000 shares of Common Stock as of August 1, 2020, with sole voting power over 4,000,000 shares, shared voting power over no shares, sole dispositive power over 4,000,000 shares and shared dispositive power over no shares.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(6)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of (i) 73,172 shares of Common Stock held directly by Mr. Hall and (ii) 454,110 shares issuable upon the exercise of outstanding options which are exercisable as of September 13, 2022 or within 60 days after such date. Does not include 500,000 performance restricted stock units granted to Mr. Hall on May 4, 2021 that will vest based on the achievement of three performance goals at the end of a three-year performance period ending December 31, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(7)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of (i) 127,461 shares of Common Stock held directly by Mr. Jones and (ii) 200,000 shares issuable upon exercise of outstanding options which are exercisable as of September 13, 2022 or within 60 days after such date. Does not include 250,000 performance restricted stock units granted to Mr. Jones on May 4, 2021 that will vest based on the achievement of three performance goals at the end of a three-year performance period ending December 31, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(8)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of (i) 500,000 shares held by The Audrey G. Kunin Trust of which Dr. Audrey Kunin serves as the trustee (with sole voting and investment power) and (ii) 75,000 shares issuable upon exercise of outstanding options which are exercisable as of September 13, 2022 or within 60 days after such date. Does not include 300,000 performance restricted stock units granted to Dr. Audrey Kunin on November 8, 2021 that will vest based on the achievement of three performance goals at the end of a three year performance period ending December 31, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(9)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of 500,000 shares held by The Audrey G. Kunin Trust of which Dr. Jeff Kunin's spouse (Dr. Audrey Kunin) serves as the trustee (with sole voting and investment power).</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(10)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of (i) 32,311 shares held by the Paul Freiman and Anna Mazzuchi Freiman Trust, of which Dr. Freiman and his spouse are trustees (with sole voting power over 625 shares, shared voting power over 1,061 shares, sole investment power over no shares and shared investment power over 1,686 shares) and (ii) 122,097 shares issuable upon exercise of outstanding options which are exercisable as of September 13, 2022 or within 60 days after such date.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(11)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of (i) 30,000 shares of Common Stock held directly by Ms. Sit and (ii) 20,000 shares issuable upon exercise of outstanding options which are exercisable as of September 13, 2022 or within 60 days after such date.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(12)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of (i) 30,000 shares of Common Stock held directly by Mr. Wu and (ii) 55,244 shares issuable upon exercise of outstanding options which are exercisable as of September 13, 2022 or within 60 days after such date. As Non-Executive Director of China Pioneer, the parent company of Pioneer Hong Kong, Mr. Wu disclaims beneficial ownership of the shares of the Common Stock held by China Pioneer Pharma and Pioneer Hong Kong.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 36pt; vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(13)</p>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of (i) 30,000 shares of Common Stock held directly by Dr. Jeff Zheng and (ii) 20,000 shares issuable upon exercise of outstanding options which are exercisable as of September 13, 2022 or within 60 days after such date.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="30" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 30 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 108.4%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><font style="color:#0e4b77;"><b><font style="text-transform:uppercase;">Deadlines for Receipt of Future Stockholder Proposals and Nominations for Our 2023 Annual Meeting</font></b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Under applicable SEC rules, to be considered for inclusion in our proxy materials next year, your proposal must be submitted by November 30, 2022; however, if our 2023 Annual Meeting of Stockholders is held on a date more than 30 calendar days from May 11, 2023, then the deadline will be a reasonable time prior to the time we begin to print, mail or electronically deliver our proxy materials. If notice is received after November 30, 2022 it will be considered untimely, and we will not be required to present the matter at the stockholders meeting. All stockholder proposals must comply with applicable rules and regulations adopted by the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Pursuant to our Bylaws, if you wish to submit a proposal to be included in next year&#8217;s proxy materials or nominate a director, you must do so no earlier than the close of business on the 120<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>&nbsp;day, and not later than the close of business on the 90<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>&nbsp;day, prior to the first anniversary of the preceding year&#8217;s annual meeting (for next year&#8217;s 2023 Annual Meeting, these dates would be January 11, 2023 and February 10, 2023, respectively);&nbsp;<i>provided</i>,&nbsp;<i>however</i>, that in the event that the date of the 2023 Annual Meeting of Stockholders is held more than 30 days prior to or more than 30 days after May 11, 2023, your notice must be delivered not earlier than the close of business on the 120<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>&nbsp;day prior to the 2023 Annual Meeting of Stockholders and not later than the close of business on the later of the 90<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>&nbsp;day prior to the 2023 Annual Meeting of Stockholders or the 10<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>&nbsp;day following the day on which public announcement of the date of the 2023 Annual Meeting of Stockholders is first made. Stockholders are also advised to review the Bylaws, which contain additional requirements with respect to advance notice of stockholder proposals and director nominations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Stockholder proposals must be in writing and should be addressed to our Corporate Secretary, at our principal executive offices at 2000 Powell Street, Suite 1150, Emeryville, California 94608. It is recommended that stockholders submitting proposals direct them to our Corporate Secretary and utilize certified mail, return receipt requested, to provide proof of timely receipt. The presiding officer of the Annual Meeting reserves the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these and other applicable requirements, including conditions set forth in the Bylaws and conditions established by the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="margin: 0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 102.5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><font style="color:#0e4b77;"><font style="text-transform:uppercase;"><b>Householding of Proxy Materials</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers, banks or other nominees) to satisfy the delivery requirements for proxy statements with respect to two (2) or more stockholders sharing the same address (and who do not receive electronic delivery of proxy materials) by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">For those who receive proxy materials by mail, a single proxy statement may be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker, bank or other nominee or NovaBay that it will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you notify your broker, bank or other nominee or NovaBay that you no longer wish to participate in &#8220;householding.&#8221; If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate proxy statement in the future, you may (1) notify your broker, bank or other nominee or (2) direct your written request to our Corporate Secretary, NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, California 94608, (510) 899-8800. Stockholders who currently receive multiple copies of the proxy statement at their address and would like to request &#8220;householding&#8221; of their communications should likewise contact their broker, bank or other nominee or NovaBay using the above information. In addition, we will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of this Proxy Statement to a stockholder at a shared address to which a single copy of the documents was delivered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="31" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 31 -</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 102.5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><font style="text-transform:uppercase;"><font style="color:#0e4b77;"><b>Method of Proxy Solicitation</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">We will pay all costs of preparing, assembling, printing and distributing the proxy materials. NovaBay has engaged Alliance Advisors, LLC, to assist in the solicitation of proxies and provide related advice and informational support, for a services fee, plus customary disbursements, which are not expected to exceed $100,000 in total. No fees will be paid for solicitation of any stockholder to vote in favor of one of the Proposals.&nbsp;Our employees may solicit proxies on behalf of the Board through the mail, in person, by telephone or by other forms of electronic communication, without additional compensation. We will reimburse brokers, banks and other nominees who hold shares of Common Stock in their names for the expenses of furnishing proxy materials to beneficial owners of the shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 102.5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(14, 75, 119);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><font style="text-transform:uppercase;"><font style="color:#0e4b77;"><b>Where You Can Find More Information</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">NovaBay files reports, proxy statements and other information with the SEC as required by the Exchange Act. You may read and copy reports, proxy statements and other information filed by NovaBay with the SEC at the SEC&#8217;s website, which contains reports, proxy statements and other information, at: http://www.sec.gov.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">This Proxy Statement is available without charge to stockholders of NovaBay upon written or oral request. If you would like additional copies of this Proxy Statement or if you have questions about the Proposals to be presented at the Special Meeting, you should contact NovaBay in writing at NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1550, Emeryville, CA 94608 or by telephone at (510) 899-8800.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Information and statements contained in this Proxy Statement and the Annex hereto are qualified in all respects by reference to the copy of the Annex.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">September 30, 2022</p>
			</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 35%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board of Directors,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<div><img alt="sig01.jpg" src="sig01.jpg"></div>
			</td>
			<td style="vertical-align: top; width: 12%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&nbsp;</td>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 35%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Paul E. Freiman, Ph.D.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chairman of the Board</p>
			</td>
			<td style="vertical-align: top; width: 12%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="33" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">- 32&nbsp;-</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><u>Annex A</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTIFICATE OF AMENDMENT OF</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOVABAY PHARMACEUTICALS, INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>NOVABAY PHARMACEUTICALS, INC.</b>, a corporation organized and existing under, and by virtue of, the General Corporation Law of the State of Delaware, hereby certifies that:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>FIRST</b>: The name of the Corporation is NovaBay Pharmaceuticals, Inc. (the &#8220;<b>Corporation</b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>SECOND</b>: The Corporation was originally incorporated under the same name and the original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on April 19, 2010.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>THIRD</b>: The Board of Directors of the Corporation, acting in accordance with the provisions of Sections 141 and 242 of the General Corporation Law of the State of Delaware, adopted resolutions amending and restating Paragraph C of Article IV of the Certificate of Incorporation to read in its entirety as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">&#8220;Each outstanding share of Common Stock shall entitle the holder thereof to one vote on each matter properly submitted to the stockholders of the Corporation for their vote; provided, however, that, except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon by law or pursuant to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Upon [Date/Time] (the &#8220;<b>Effective Time</b>&#8221;), each ____________ outstanding shares of Common Stock (the &#8220;<b>Old Common Stock</b>&#8221;) shall be combined and converted into one (1) share of Common Stock (the &#8220;<b>New Common Stock</b>&#8221;). This reverse stock split (the &#8220;<b>Reverse Split</b>&#8221;) of the outstanding shares of Common Stock shall not affect the total number of shares of capital stock, including the Common Stock, that the Corporation is authorized to issue, which shall remain as set forth under this Article IV.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Reverse Split shall occur without any further action on the part of the Corporation or the holders of shares of New Common Stock and whether or not certificates representing such holders&#8217; shares prior to the Reverse Split are surrendered for cancellation. No fractional interest in a share of New Common Stock shall be deliverable upon the Reverse Split, all of which shares of New Common Stock shall be rounded up to the nearest whole number of such shares. All references to &#8220;Common Stock&#8221; in these Articles shall be to the New Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Reverse Split will be effectuated on a stockholder-by-stockholder&nbsp;basis. Certificates dated as of a date prior to the Effective Time representing outstanding shares of Old Common Stock shall, after the Effective Time, represent a number of shares equal to the same number of shares of New Common Stock as is reflected on the face of such certificates, divided by ______ and rounded up to the nearest whole number. The Corporation shall not be obligated to issue new certificates evidencing the shares of New Common Stock outstanding as a result of the Reverse Split unless and until the certificates evidencing the shares held by a holder prior to the Reverse Split are either delivered to the Corporation or its transfer agent, or the holder notifies the Corporation or its transfer agent that such certificates have been lost, stolen or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation from any loss incurred by it in connection with such certificates.&#8221;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>FOURTH</b>: Also pursuant to a resolution of the Board of Directors, thereafter this Certificate of Amendment was submitted to the stockholders of the Corporation for their approval, and was duly adopted at the Special Meeting of Stockholders held on ________ __, 202__, in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="34" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>FIFTH</b>: All other provisions of the Certificate of Incorporation shall remain in full force and effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><b>IN WITNESS WHEREOF</b>,&nbsp;<b>NOVABAY PHARMACEUTICALS, INC.</b>&nbsp;has caused this Certificate of Amendment to be signed by its Chief Executive Officer &amp; General Counsel this ____ day of _________________, 202__.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="2" style="vertical-align: top; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOVABAY PHARMACEUTICALS, INC.</b>&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 97%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 97%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: bottom; width: 97%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 97%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 97%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Justin M. Hall&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 3%;">&nbsp;</td>
			<td style="vertical-align: top; width: 97%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer &amp; General Counsel&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="35" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">A-2</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%; margin: 0pt;">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div style="text-align: center;">
<div><img alt="prxy01.jpg" src="prxy01.jpg"></div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div style="text-align: center;">
<div><img alt="prxy02.jpg" src="prxy02.jpg"></div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="36" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MX'W6786.&PT*$5:R7W]?Q/Q4_P""G_\ P5X'C<ZQ9Z1XB\4F&35K_2-"\/\
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M ,&LGPW\57CS^#/B/XO\-KR4M=5MH=8A0^@;]U(!]6)]Z]7"TL#45JU64/\
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<JM:I5FZE5MM]6=-&C3I05.E%)+H@HHHK,T/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>prxy01.jpg
<TEXT>
begin 644 prxy01.jpg
M_]C_X  02D9)1@ ! 0$ EP"7  #_X0 B17AI9@  34T *@    @  0$2  ,
M   !  $       #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R
M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M            ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
MA..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,8XS*C3&-
MF(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?E<F6-):?
MEPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY GJZ?'9^+G_J@
M::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H<
MJH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+LL*S.+.NM"6T
MG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_
MOWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(O,DZR;G*
M.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&U$G4R]5.
MU='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<BMT0W9;>'-ZBWRG?K^ VX+WA
M1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1
M[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX&?BH^3CY
MQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____X  2 !!*1DE&  $"  4$!GX  /_;
M $,  @$! @$! @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(
M!P<*#0H*"PP,# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$(!$P#4@,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0           0(#
M! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @, !!$%$B$Q008346$'
M(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&
M1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:
MHJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CI
MZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!         0(#! 4&!P@)"@O_
MQ "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&A
ML<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X
M^?K_V@ , P$  A$#$0 _ /W\HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **S?%/C31_ ]@EUK6K:;H]K)((EFOKI+>-G()"AG(&[
M )QUP#6"/VAO #,%_P"$X\'Y;@#^V;;G_P ?H ["BN/7]H?X?O\ =\<^#SCK
MC6;;_P"+H_X:'^'_ /T//@__ ,'-M_\ %T =A16=X;\7Z3XRTS[;H^J:=JMF
M6*">SN4GBW#J-RDC(R,CWK1H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _'O
M_@Z]^&VM_&B^_9H\&^';!]8USQ-XAU6QT[3O."+=W,L=C#']]EC#YD*JSG@.
MW(W&OSY\/?\ !OS^UAH][-)>?LZV^M0RVTT"PW?B/2ECA=T*I./+OE+-&Q#J
MK$HQ4!U9<J?U>_X+DQJW[>W[ N>_Q.;_ -*-,_PK]*C"I/\ ]>@#^<&;_@C)
M\?YOAJ-%/["O@G^VO[.^Q?\ "0_\)XYNA+LP;KR?[9\CS2WS8V! 6(VX^4^3
M#_@WC_:\(_Y(;,3_ -C!H@S_ .3>*_J7\E?\FFO N]/E[]?3@T ?EK_P:O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPHXQ[#M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MMK@^*7QF95_: N_!<\VO_$W7K&VCT.T^W^2C7<(N)[='9(@T\4,C2%4!!!R
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MY<^F: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1139!F-OEW<=/6@#YV_;M^!/B;X^6?AJ^\-ZEX=T>\\!+?^(=+N];O
M[J&PAUM;<0V#S10J/-MU\VY\Q_,1X3L9%9B"GS9X_P#^":U_IOA+Q)X+O/%G
MPNTK2;'2-/'A6269M-O8&LO"DFC6-A*BH!!91:A<ZA?AP\YS<R1B/[Y/OO\
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ME:.WA:^O=-TKPXP,::7K*1QJTUS:164&FP6SK<7J-#>9B=%NK:'S)$#(TI0
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M/A]>Z?;>)Y;+Q5.EN%U.[-M#%:/';PG4K=Y(-MW;78MH,Q;66?8-H!:\/?\
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MD^%?Q*\0:\VMM?6.IO>&RLWL?)DL_M>HW.HS^9+O/F_O[EPF$CV1A5.]@SD
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M)RQH ]DHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"*ZM?M.W_9S^1_K[]13T78N.OUIU% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >3_M,_ >X^.LWA6*&^AT]O#^K7&II<.&,
MEO(VE7UI!-$JD;I(;BZCF7<5VM&&#*RH:\6^$_["7B#X>6OAF;4(O"_B"/2=
M3U"ZFTC4;O.GZ--<?V:L>J6(M=/MH?MEO]@G=$CMK9B^IW)%RKF22;U?]LSQ
M%8Z5H?A.PUF_N=-\/ZYXEM[75IXI[BU7[-%;W%Z4>:#$B*[6L:_*0'R(V)61
ME/ENC_M%^+/A9;0Z3#I>M-ILUY!=Z+'J6A:C<7PTA=5O9;HR$J9$V:1:'REG
M <3W%I&V7E5* *OA?_@GKX@'@K3-)U+6-#TFXTT>3_:&GR7$LUWJ*:3>6:^(
M'&V'.HSW%S%<R!F=EDMHV%S*ZQO&W2?V%/$C:QI^K6^D_#[PO)!XQ;7+;2M/
MOGO=,T6 Z?IEFKPI+8(&E5M/9T\E+.6,3A8;N)#*LK;OXY?&K2+,I=6?A]O%
MVDZ#]JUF9/#UZUG=S6]A%=S6EJ!<,HWW6J:= DF2SB.^.!Y*[?1O@5\=O%GQ
M*^/FLZ+?2:1!9Z-ITUWJFCMI\D=_HDTE^;;3U\\R%)TEALKV5]L2[6\H@D.H
MH Y']L/]BSQG\>_BDFN^'-:T/1;5?#VIZ1OE00WLIN]'U.S$+.ML\QC%S=VM
MP=DZ1@VQ)MY) LM5?BE^P5K&M^*@/#L?A>3PU;Z[+>Z5I%[?W-I'H,4PT.26
M\M_+BD#7/GZ?J3,@V+/_ &M<&24&697P=8\$ZAX$\#SZ]H$GBW1#KWBV_P!7
MNCOU#59=+T'15EEMX;:W>X!+7<NF6;M$V"XU"YCQ@X'I'[/'Q\^)WQ)^,MWH
M7BO0=-T6'3;::'5[2V1I!I]S$Z0QRI/NW/'<MYDL7FQQ$P%"H?9(Y */[0G[
M'%]\3OV@+[QG9Z!X!\0:?J&F:3::GI&ON\2^(/LAUA?LUV1:SH85.IV]RC,D
MH\[3(E\L96:+I?'?[.6M>(/"'P[LY)-"\<W7A&T2SO3XH>>..XNQ#;HNL@A9
MG^V0^2[QJ61R;IQ]IA;+/\U^+_&/Q.N_&NO/9Z?\0M4FNO%8\=Q6$,EY:IJU
MO:F5]-TH,%V00SZ?IERDD42$&[MK?SEW79>X] 3]K/XPW>G:/%8Z3HE_-KU]
M=QZ-J_V+;9WT\8LEAM659FVQ2S7%SF:)Y2L5LY/S(^ #1\&?L!ZQX2^*GP]\
M06NN6<%KX9T:&WO/*F4R6]_%+=23W$;26KW$@NQ/##*L5U9$Q6T:OYZ!(8\#
MP-_P3H\7^']/UXWU_P"#;?4M2T[Q/IVEZE86Z1W7A+^U=-TJ#[19B&SA7>;J
MQN9G0!'(NV)EG<.TC_!WQR^*<L%Q>6^H+<:;;MJNMSZKJWAN[N+JQT\-J=]+
M9"WC=5DN(5GT"W14W'=%?(AE$7/I7P#_ &@/&WQ&^.;:#K=MI.AM;Z/JEQJ7
MAG[#+_:&BSV]_;VUHPO&D\N:*XC^TS@"( )+;X8J-\@!7TG]D36M)_8_7X=,
MVB/>75Z+JXT^46EUIL-NTP=K6(+IL=H$&"RYTWRPV<QEV,U97[-O[$_B+X0S
M>%=:US6=*UCQ9IEQ8KK&KP33F;4K&+PE;:3<6V\H&,<VI6L5V4;Y7$,$C9DB
M0)Z7\<-1UB_^#NDW6I:?JGA^SFU6U/B6WM[KS);+33(1/NF@.?+^Z7>(@K&6
M+$*'(\8^&_Q\\<:'XATG3])T2WL?#>H>);6WT6"34+W74U^QEN+&"[DM;J:"
MWF@2V2:\N#'*LAS;.5<VY0* 3_$7]@+Q7XP^+GCK7X/%4=C_ ,)'/8RV5V)T
M62*.+6-/U ;TBM8YR]LEG)';F2\G&9W\L6BNRF3X1_L*>)/AGIWA9KJW\*Z]
M#I&I7]R='U"YC6QT:6X_LX0ZG8BTT^UB^UP&QF=42WMF+ZE<G[2K;Y)K_P"T
M)\:/B!\(?C+XJ72=56?29M(T22PBET26ZM]-9H-?=]I1@)'N;JSLH,D@KY\0
MQDJ6A_;C_:#^.'P:N_!O_"L/ ]GXL_X3JTFT=(YM.N)ET'6B]M-!-=O%(9!9
M_9EU ./*PLD*%I!O6-@#*TC_ ()Z77ABVO)K;PQ\-]5CM[UQ!X9G=H-#U6P-
M]J]Q]CN,6CK C-?V5RRI;3 SZ?$IR(XIDN:%^P%XDT+2;J0>)=-U'7M26WM;
MW7;DSQW>I00Z#I>G$2G]XP#W5A)<F,NRY=&)9P37C=U_P4\_: TRVD\3W7P-
MUZX\*WX_X3&PLO\ A'KY]0A\,)=WEE-:2>09"-3P-.OU#HG[F[FC\IFMC)(W
MX>?\%$/VH-0N_">B^+_@[)X7UC4;V+0/$>H1:!=7]MHM_I]Q]MU6ZW12F&:T
MFT;)MA#*[&Z26-&E=5C< ^HO /[*MU9> ?B%X=U2S\/Z0_C)I@->T21I-3U*
M1I)W34;I9(E1;J-I8@HS-CR 6F==J)RY_8JUC4O$?ARZU#_A%=4C\NSDU2YF
M,LDVBW1U.ZU'5?L"-&PECU;[6UG<AGMO]'B5I!<*1 GA_P"U]^UQ\;=:\-?%
M[PGX?\#WVLZ'9^%=<\8Z7K%IHNJZ;<:WHLND6;Z59P^1/#<Q7S:A=W<<C12K
M<JND-NMX/M<,JP_%S]JC]J#0M*M/&^EVLUP(=+^)JVWANW\'W+6EQ?:1JB6V
MBPS?.9WDN+.&YN8]I02B.4JK!D* 'I$'_!.'7KWX-6&@W5UX3M=2TGP<ND:;
M':S7*VNF:I%HUI96EW&RQQDB"ZMS/&^Q7C(B=%65%*]1\"_A/K5C^U5X^N+C
M2)XH9K?7;>?5KBSN[9M4EO=1BNK,R/-^YN/+M<6Z-;/-LALHEE:$M%:0>5?&
M[_@HA\:O!GPRUS6M!\%7%Y?6?C+Q)9Z9!=>%-0CMM1TC3Y+<6B,1ND:YNDE;
MR56-1.!)(LD:P,DOD_PW_:'^/NF?!CXH?#W6-.\7W$,GASX@R:#J$7A_59=;
MCDBDU*6T^T7<LD4UNY+PBUFMDN() $@#PSQKO /I_P -_L#ZKH&E:I-]LT5]
M2U?09=)OI([B6/[>4M-'BMHG=H70VZO87A*R12PXO)2]O,LUS"]3X<?\$\=2
MT32;2UU>S\!VL?\ PE$7B"XGTNVPTD<7ARZTF"!XEMX(Y#:3/!*C*(HFVR-%
M;V@$< \X\8?MN?'KX,_LPZ^(?#,FJ>,/#-^VE:+=W/AR^6VUB*+PC8ZR'G+2
M2.)&NI;FR0(&-S<11Q[H&,C@\;?MS?M':/\ "]M>M?"VGVMQJGBSQ9I<$=WX
M8OGM]+M],@NCI:3!&:>47<D<0,D:%Y A6"-I)$! /5/"G[%GC+^V+>[\3Z?X
M UZ(ZDVW1KO4KJ[L+5?[,T2QM]:1C:HQU&W_ +)G,<2K&0NHRA;R,@E\"P_X
M)X>*=/T+P99VW_""Q6^@_#^Q\$QVR23"'0M1@DNBOB6T46RC[=;+*6BCVP.6
MO+E1<P[=TWEGA']IW]H3X(Z)\3+>V\+:EXDBO+SXA>(=(;4=%U.\DTQ[;Q?:
MVMO'YC.#/;_8M0N)HH41 8;) @ 5R9O"'[47QXG^.7C+Q4N@ZY<02Q^&_#-G
M,^AWL^BG3?\ A.O$6GRZ[%:*PS*^DK9W3[''R/$Y/E[30!]:? ?]F63X3?$/
MQ5JEU_9$EKXH>^N+V*$2,UV]QK.H7L1F,@&_9:WB0_,2%",B@( #XGX._P""
M;/B#PE\.%\)V]QX5MH6\)P:%_:]M)/;WJ*-"@TM])14A4QV'VJ*74@ZR@BXF
M.;8.3.?GOX(_ML_M-?"/]F62SL_"=]JFJ>%_!MWJMD/$N@:O>ZIK<O\ 8^L7
MZR'&Z8N+^"TMMDNQ0NZ/S#-)"K>Y_$_]J+]H[PW\8]2\.:-8Z+<:3INM6^B1
MZA/X%OII+I&\&WVM3W&4N%3B^MK>U1%!56GV,TCX2@#O_C!_P3]7QSK'C2ZT
M]?#NG_V[=W#:8 )(5LK9?#EKI]E 0J[52"_MENDC&8T>*&51YT2%/ISP]/<0
M:<JW5O;PW6,,MO*9(VQD AF5225 )R.#D<A<U^??BG_@H;^TG]FUB\T3X6V:
M36_@F#7-.T2XT'4Y)M0GE\*2ZF?*\L,Q\O5A'9%9!&NU'C#&X>-&Q/'G[0W[
M0/Q%\=[;^*_U3P?(]A:Z9;:/H^IZ;%?,GC;0;>2[DGMVBE:>.RFN-T<,S6S1
MQN3YT;SJ #]-5;<H/KZT5^=_PB_;X_:1USX?>'Y_$?@VTL;O6K3P)J-S>VW@
MC4O+T>+6)=3CU"$VGG-),UO]AM0=KJRM?<J/W:UM>$/^"D/Q ^(O[+'P#\06
MHM])USQYH-KKGC775\&ZCJ>E>'XKK1-0O;-X(HF N!-=V<</E1322@S1IA7F
MBR ?>U1RW(CDV\<#)YZ?YY_*OS_^)'[?W[0GAQ?BG)I'@N+4)?#6C>);S2[4
M^$-15X)+&?1TTIW3S-\@U""\OYA%\KK]E(4_NWW6%_:+^._Q*^)LGPV\4:2?
M[)\9:MXL\/6^K:)X8U'2Y[2TTO5-.C6;[49G6,W6FW&HE) \3%K9/(D,I 8
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MSCK3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH_ABTMK"^OY-(NVLHK>TT^.:V11'"ZS6T5K-(LK%A%"B 2Y& O8?$;QW\)]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*LH%O#<P73PH2J2LGEM')O'F'T#P)H'P[\'_ !&T(Z/K^G3Z_/8:YJ^FV/\
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ML8HY,C.3#JMV&="CD^6=PV\^O"11'NSA0,Y/&!31=1E]NX;LXQW[?XC\Z /
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MK]@?X?>$]%ATNSM=072(8HX%LVNV:,1)/J4RQY^]LSJMVN,YV^6 1LR?:J*
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M"+&\TQGG/F+&)YO,G)D'VF6;RLE(?*B)C/IU% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% 'S3_P4QE\4^ ?ASX5^)W@G1]?\
M2>(OA5XBM]8ET/1;6:\O?$.F3H]A?6:VT($ES^[N1<+#N5#-9P.[!8\'X_\
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M\T_[)X;\1Z!KSW&OJTD6V2>2VGL1;VTD3,&B(DN58J"R@96OAO6_#WQTT/\
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M3R^[ 50%4 ]FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#P?\ ;K\0ZE;>&/"OAVQT/P_X@M_&6O\ ]FZA9:QX6?Q)!-;QZ=>W
M@VV:W-N&?S+2,;G<@+N^4D@KQ5U\<OA[H_BS3])\=>!]+U#QYI?A.X=9[?P]
MIL%U+:+:S3RV$-A)>3WUO'Y"R@B0?9224\[<ZH>O_;V^(O@OX;>#M&OO&6F^
M*+W[')J6JZ7/HU]?Z6+*>STB]N97FO[5T^S*UK%<QC>V&,HX*J[)EZ;IWP)'
MB+29W6\NM:UP'2HKK4?[5GN89'#Z;_ITEQN-K<7! LUENRDUR;>WA#RM;PJ@
M!ROA[]MOX=^%/ASJVFMX!L= ^'=E:Z=:Z7;17OAZ'2]7;4/MYFAB*7WV".)!
M:S;C+,JR,65?,8J'6W_:E^$/P\\&ZA<:+\(=:7P_IIM9F.G^&M.LXV2'3U\3
MK,L+S1/&+5;PS_.BNMS(WEAY22=G3[CX$WWP#\3>.O#O]N:QX?T+0X_$-Y>:
M1>ZLFM75M'#=7<5Y:RF1+J26=;B[7[5&^Z??/$\KA71:T_C'X6W/A(VEUX2T
MF/6M9O\ 3K*_T:VBO;6T(U&2P\.3FVEN+:W6X%K;RVUO<1Q1JUNRQPRK#*X)
M .I^*V@>,/V9?@YH,?@'Q%H+22>*;6UU2Y\5:"^IW&HSZSKL,4ER/LES91Q,
MLM]<2[1&5;*JHC )/#W/Q'^%_P "?%VN>$[KX4Z7J%SI>G-X=U";PWX.TZUM
M(=+M;'0RUJT3W)EDM=VLVZQVZ*2%#1^6PB$LW=>%_P!JGX;_ !S^'WA)M:F6
MSFUFWT#7!ILT%Q+!I][<26-[8VYN$186N(Y9[.0QAMZH\<K*D3%C0^(?Q!^#
M-IH'BCQU+I\OBCR$M;S5#HMC=ZA?W$=[=6UC&Z0Q#<P,VCVRD("0MB6( R7
M,#X1?';X(Z[\9O"?@G1/ASI7AWQ1IK:G!IULVDZ/#/X>NUFO6O8%CBE>>/=+
M;W;/<01O;2.QS,SR ':^,?QX^&'P,TWQ=X;U7P!<2^';;1[BSUD6.CZ>VFWW
MV?19;XZ48&E$DK'2[5PJM&;<H@B,@X05_AO\3?A#INM^(?$WV.[\.ZYX<UO6
M[>YL[9;ZZ%Y<C6;JREN8+:,-'=WDTT@.((Y+F%=0AA)5)T638^+[_!O64L_%
M'BAM#NM!\6:)=M/>7.H72PS6SQ164EQ]G53$93#>?9GN7\N>*&4QAMA<* 5_
M%'B/PSX1_9Y^+7CSP_\ #S0?#_BSP;8WM_=VFK:-9B5]0T^S-W:O<-:R,LJC
M="ZLDVY0VW,<@8#B= _:.\(^!OBU(O\ PK31[7Q!H.@Z7H5G9Z#I5I#K&G79
M.OM>V"7%Q) @LH;?13-$ 8Q)%\Z"19HE'9?%7]I+X-^%/@YXVOK^/4/$.C:_
MH6HZYXATK3=$O;B[N8E@DM)XKF,*/LEQ)]CFMA%<M QEM9XP \4NR;X@7GP+
M\9^+_&TVL364>M:99-J/B.[@CO=/N[>+3K<LY:XA".)8;;4BLBHWF&"^".K1
MR*I .;^*/[3'P0\1:;KFN^)/!&FZX8+?3[6\EUC3-*1KF(ZA>0Z9&T]Y.D2J
M[_;+B 2R(J),Q/ERR>6T4_[5WPK\12Z7XCA^$^N:Q]BO(]0TS51H6EJ8M0N-
M%@UMRKS7"/'-_9\C3/(VU=UJZ>89# LNW\0_B9\'[+6)?"46EZLUUXDUF6PF
MO-+T[4-/MK2]T[3)V,HU*W5!"D$6FM;,]F[&*4>655O, F'CGX%Z1;7-G>?V
M)I\=FUOJLZK:7:V;336=OH8^SR^4J3>7;W-K:/Y66A6>(2I$SJ: /,_A;\9_
MA1^S?\)]0\,ZUX+C_L?PB)X=,U.XTC3K9/$T=LUGHWGR2RR1H;MX]2LX9[B<
M6\#+<R#<J)*J>O\ P>\:_#;XW^/;IM&^'L N-1TG3-<OM9ETFP$4NV\FCLXS
M/%(S3RPS:<\L<D>^%%@26.8AX2U3P_X8^"/B3Q1]ATZUN[K5O&5D95CQJFW2
MP)R6"LWRZ/=FZL<E5-M<&YT\$@S6HV>N^"OAIH_@>2:31[/[/=7%M#;3S-*\
MLL\<;3.K2-(S,\A>XG<R/EG>1F<LQ+4 >#_LC>*)/B7\4+YO%G@#PKHGBOP[
MH5IJ=K+%X)GT:\T*6_N+X7>G+/<LS72I-$2UU!Y<%P9'95()PG[=NIP_"_1-
M8\3/X1^&/C.VOM/C;4_#6J^'EN-4\2P6!EE:1KQY0D<%BDTD_P"]MI@N71"K
MSI7L&E?LY:%X9T&33]%76=!CDU&ROVGL]3F-P([2Z2X2R1Y7D,=B=KQ?9(]L
M2PSS1HL8<T[QU^S9X5^(WC)M>UC3]3OKZ2Q73IX5UN^AL;ZV!<_9[BT29;>X
MA8R/N26-E<.0P(Z@'@_QSU3Q=-X \5Z+K]E\'?&=UX#,,UCI]_X)N)+379[F
MT>.UTZTM9+^06]Q+YDMOYP>7*W 7R=H8'NH?A];_ !!_:/U;2_&'AWX:>.+6
MWTNZ5M3C\,A;SP\L@$,6FW-Q<S7'VE[JRN[IF5%A"QH^]"ETF>BN_P!BWP/?
M26<DUOXP^VZ?+)/#J*>-]:74"SQ^7E[H78GDQ&NU0[,(Q+($P))-VYX+_9UT
M/X>:CJ5QI;>(HY-7O#?W2/XFU*: SM<?:7D6&2<Q1[Y<EQ&BAU9D(*$H0#Q#
M]K+XJZ7\-_%WQ+OI/ACH/BK4O ?@J#QUH^I2>&TO?LVJR+JD32W$A9611'I-
MDNZ,K)M0C>0L>R[XJ_:?^"?P_P#%^L>'=9\)Z38P_#^]2[FG6RTJZ@TC[+;&
M&*[,4$SSVQC4PVT7FPQRD7,0B5H1+)'[QXF^#^@^,)?$3:II,%Y_PEFD)H.K
M@Y7[=8)]IV6[$-PH^UW)R.?WS<_=QAQ?LM>"8_$&J:HWAJQ>^U>3S;N1BY60
MFYCNCM3=L0-<Q"X9455:=YI2"\TI< \\\"?&CP+\0?%7B/X(^&;'4OA_J6C:
M6T\]MIL.D1MI!E2">>(6\;SB*0&^3<\MN(79W,<DA4O5;5?B/\*/A[XUOM)_
MX0*34/$WA?3$\*>8=+LKB_F@9M-M[;3OM,L@)6Z;5+146601G$C2M&HRWLVF
M_"'1]"\>:CXFM;&XAUG5HRES)%=R>2V=@+B%F\I9&$<89T16D$48<L%7&+/^
MSW8Z]XR\6:IKK+JD?B:UTW34MX8C:BQM[%YI[>59%<R"[6XN)'%Q&T;)Y=ML
M5'A\UP#ROX:?M _"?X<Z1/#X;\ MX.72$"WEGIVC6%B^G237VJV\\#>3*(]T
M=WI%YYC(7B=O*>-Y=VX==XW^(_AG4_A#IOB;4?AOK/B!OB1%9Z-_8DNFV%QJ
M6I0OY\MM;W2RS"'R0'EDVRS;8_/?<$+/C<C_ &0? )GTJ3_A'IA)I$#6\9;4
MKK_2U9IG+7>)?]-F\RYN9?.N?-D$MU/('#RNS6_BO^SOI?Q7\)Z#HEXDT.EZ
M!J%M?0Q0,8V#6Z.L6R17$D3(65TDC82QO$C*P8!@ >'#]HWX-ZCX6DUO3_A+
M/JNF6UI8:):S6_A_28A-8-H#ZRMO&)IHR((-/OKDM&X0+]HFC1'\P[Y/C5XE
M^%/B/XE:?J&N:;XFT*Q^'.M6>JZC<P:1I\&GQ37%W#=V-Y-.R-=;+BZ2-LV;
MAW<,ERN RCVC5?V4/ NI>%VT7_A&;6STF2XANOLNG32V(BDBLX[! C0-&R)]
MCA2W**0C0@HRE2P:C\2OV4]#\;Z%K-IIMI9^'[SQ.GV76M2AMO,N+ZV8QAE7
M]XJ^<B01+!+*L@MPH5$*%EH /&'CO1M'\.^$?&$_@#5-0\5>)3:1:5I2V=@-
M=@G^R7,ZV[2S3K!$T,+WP)^T!!OF5&9I?G\A\6?''X*>&_'6H>&S\([*^\1:
M/;Z+:0Z=9Z+HDEY-#_:&EVMG!Y1N-]LMK=W.GNB7@MP!"LD'F"#(^F/B-\,]
M'^*'AX6.KVMTRQRBXAGLKV>PO;27:R>9#<V[QS0OL=T+QNI*2.I)5F!X_3OV
M0?A[I6M07]OX1TN"XM60VRPAXK>Q*7=K>J+>%6\J&/[79V\Y2-0IE0N07DD9
M@#S[X4:QX1_:(^/VK:?)\-_#T>C_  _TW3=4\+:C?Z':"Y^T7&HZLDUQ:R!I
M##%YNFPN@VQ3*^]W7F,C(^$/Q#^$^N>./#^@6/PLT_3[S6))K2+58_"VG6EC
M]JN(6U&2 %)9'5Y8]+\YL*Z,]G#O=6\H'V[X<? ;P[\*_%&M:QH>F36.H>(E
MA2\8WL\\0CB>>2.*..1RD$:R7-PX2!43=.YVD\DT+]G_ ,+^&[S3KBQT&TM9
M]*NQ>6CHSL8IQ;36HD.6[07$\8'(Q*>X! !Y%:_$CP?\.?VD?$F@WGP]TNR'
M]JB\L-<TO1+6&.XU)M%N+N87,I<.UV]LFH*)53:L99)) TJA\7P+^T[\(=7U
MGP[J7A[X;PK?:XR:6^IZ9INB72:(EK<:?:VRS7=M=/')&DM[8A!;/.$'!"&&
M0)[WXH^ WA;QG?376K>'=-U22ZN3<W"W40F2Y=K*6P8R(WR.&M;B:%E92I1V
M&TGD9?A_]EKP5X<BV6OAR%&#B=Y9[J:XGN)A+;3&:2:1VDDD:6SMI'DD)>22
M/<Q+%RX!R?PJ^/"_M!_$SQ%:+X5F;PWHNAZ)XFT+[=;0FZU22XN=3VW4>96C
M5"ME;-")/)FC=F\U4(0)Y5XI_:R^%6LP+>>#? .DZUXJUS7_  YJUW = L6N
MKVVEO+$QZHQ\Q2\L,ET+>%R_F1WH4[#"IEKZ0^''P#\-_"76-5O= TVXLKC6
M%@BG+7MQ<)';PM,T-M"DLC);P1F>8I!"$B3SG"H.M,B_9S\)0S)(/#^G^9'/
M]K1\-N$PU$:F&SN.,7@$P7H&   4;2 >*^#OVU?A#\.?'C>&M%\*OX:U_P 4
M)>:SJUG8V>FV-VMU#<:A:SK/''<"2XF6XTN\C:>%9X1Y:N\HC=9#M?"'P_X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFT,-WI_GZBGT %%%% !135G5VV@\_3I3J "BBHYKN.!]KMM.W=R.U $E%%%
M!114<MS'"VUF ;!;'? QD_AD?G0!)1110 4444 %%%% !1110 4444 %%%%
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M.NV,6DZB->U[37M"$W016.KW=E&'*.ZEA'!'N8,06R0!G: #TFBBB@ HHHH
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M_LT>"=8U#6;JXT&QEF\0;6OF9,F1A*DP=.T3^;''(6BVDR(LA)=58):?LP^
M=/U:&^M_"^DPW4!MC&RP#:C6[0O"X4\!T:W@(<?,?)3)(4 =[10!XM\:_P!A
M?P7\8?AY'X62SLM#T22#[!=6]KIT#^?:?9!9K&I92T31PJBQNIPA125;:NWT
M.?X3:3J-GX@M=06YU6R\1WGVRYMKV4S11-Y44>V('_5J/)5QMY5RS @FNFHH
M X&R_9>\ Z=X*_X1RW\+Z3!HGVW^TOLT46S-T4V/.7!#F5QN#R%BT@=PQ;>V
M;?CC]G[PC\1K?3X]7T:WN%T='BT\QL]NUDC["R(T3(50^5%E0<?NU]!79T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI\-A&9A9VMDJI''_  B&TCR9&D<DGYL!57YZL?\ @D3:6GA?PCII^(NK2?\
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M,_\ ".Z_=02W$/A^XU1)Y(@68V\4\J1^7',4\OS%C\U(GD90\RJLC>2>,/\
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M5;BZU2>_AO;D36EN\,:+IT7DQ(8590&=3(DLN7)8&=ESM5 H!J4444 %%%%
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MM[X)L_ ,WASQIXXUSPKJ<^K3W:7"6UA=ZALN+98UVLTEGI=R2'P/-DAQ\@;
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M 6M7G@+4]>L],L+:_O3?6%OIM^]HE[JL1B\N.VN"C(DL<P)EPB12_O##[?\
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ML^(#H7A/XF>$V\-FV$P\8^&9]$^UF?SMOD"4_O=HA?=C&W<F>HKQBW_X+G^
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M(/% 'G7[(W[??A_]LC7];T_1?!WQ5\*R:#!#<ROXM\*W&BQW"RLZ*(6D)$C
MHQ91RH*DXR,^3ZA_P6[\"Z9J-Q:M\)_VEI6MYGB+P_#6]DC?:<;E8$AE/4$<
M$$&OI;PE^T+X%^).F6>H:#XT\(:UI^H:D=)M;FQUJVNHKB]$)G^S1R1R$--Y
M(:3RUR^P;L;>:@\4?M1_#?X=Q0R>(/B)X'T47$UQ:QC4/$-G;&6:VD,4\8WR
M &2*161U!^1E(;!!H \5^!G_  5C\)?M ?&#0_!NG_#SX]:#?>()7BM[S7O
M=UING1%(9)29;A\K&-L3 %N"Q"X)(%6OVA_^"J/A3]F?XR:MX+U3X>_'3Q#?
M:7'!+)>^'/ UUJFFR>;$LH\NX3Y6P& 8#[K!AU%>S77[1WP]AU[1M+N/'G@V
M+4/$<%O=Z19OKEL)]6CG;$#V\9;=,DIX1D#!B"%S7::7(9E;[PVG# KM^;N<
M>_Y=QP02 ?%UQ_P7,\!Q6\C?\*C_ &G5VJ3G_A6%\<?K7L?Q[_;LT']GGX*^
M$/'.I>%_BAK&G^,! +33]"\,SZEJEIYMLUR!=6Z_-"0BE6+\*XV<$\^Q>(_&
M6G^%Q#_:&H6.GK>74=A;O<W"0^=<2G;%"FX@-([$!4!W,2,#FLN[^)7AW3)=
M1\[Q!H,+Z/=065_G484&GSW/E&"*4ELHTIFA**V&?SH\*P9: /E'_A^'X&V[
M/^%1_M/;\8_Y)C?9S^?6O8/@#^W7H/[17P;\7>-M-\+_ !1T:P\'^<+NPU[P
MS/INIW?EVPN2+:W;YIB48!2G#.=O)''H_A#X[>#/B%XLOO#OA[QAX5U_7-)+
MC4-/T[6H+F]L CB-S+$C%TVN0IW 88@=>*ZLZ?N<,7W'(SD=<<_AS@_A0!\5
M6W_!<SP)+;QM_P *C_:>;<H.?^%87PS^M>E?LN?\%*_#/[6OQ*N/"^B^ _C)
MX8O+;3I=3-WXL\'7.C6#I')$AC$TAP9295(0#)"N>QKV#P_\>_!?B?QQJ/A;
M3?&/A35/$VCB3[;I5KK%O-?6WEE5D,D"N9(]K,JMN48+ 'J*F\3?%[PWX5@U
MJ75?$6@Z7'X;MH[O5FO-3BMUTF&7=Y<UP7(\E&V/M9\ ['QG% 'S=\3/^"QO
M@SX6?$?7_#-Y\+_VB-2N_#NHSZ;-=Z7\.[RZL;IX9&0R02J=LD3%<JXX92#W
MK'LO^"WW@34+Z"W7X3?M+QM-(D>Z7X:WL:)N.-S,2 %'4D] ":^@K+]M3X07
M%O=M#\5OA>\>FP?:+@Q>*K$K;0[D02/^\^1-TD:Y/ +J,DD9=<?MB?"E?#"Z
M\WQ1^'4>AO=26$>H'Q/9"U>Y1%=HEE\S9Y@1T8IG<%=20,B@#@/VK?\ @I#X
M;_8_^)UKX7UKP-\9?%-Y=Z;'JBW7A/PA<ZS8QQR331!'FCX$P:!B8^2JO&?X
MLUYM_P /R? ?_1(OVG?_  V-]_C7V3IMU'>+&T,D<D<@$@>)BRL"H.=W1LY!
M![@Y[9J_M]Z /"?%7[=NB^$?V4]+^+\_A#XGW6B:L8O+T6T\,3S>(H1+)Y8\
MRQ!\Q-I&6S]U2#WX\=_X?D^ _P#HD7[3O_AL;[_&OM06V)=^[D^PZ?YS^9J3
M;[T ?)6D?M1^ _\ @IO^SI\9O!MYX-^-7AOP['X:ELM=BUOPS-HM]>6MY!<H
MRV'F!A++LADXP=I>+(^<"OE_4_VO?@U_PN>U^('ACP3^V=X#UJQ_M&6WMM$^
M&N^QMI=2:V-_+'!>6LZ(URUG;O(JX4R))+L6::9Y/1_C]_P4-^-'PE^''[07
MC"QD\$ZKHO@7Q3XD\+:/8W&DRPWNE&P\.2ZM;W;R_:#'=HTT:Q-"8HFVREQ*
M=GEOW_BK7?VC+#X,6>N:3\;O"<EY)XIT_0IGU?X*:AI#[+^^TZQB*VUUJ4<G
M[EKB:4ORLH94'EF,L0#QCX.^,/AA^UGXC\5?!JWL_P!KW1= ^.<NL3^(+;Q!
MX)M=*T>YN;G3W-S/)>M9>=;,WD;D5)%3SBJA"C;*^C/V@?\ @JSX1_9R^,VN
M^"M6^'7QR\0:AH;0":^\/>!;K4]-F\V"*<"*X0[9-HF4-C[KAES\IKE?$G_!
M1/Q%X8^/WQ&^'UI=>#?%6I>$_#$=I82_:/L8E\0VT=D]X]S%"\\D-G*-5M0H
M;8\;Z?=QCS"RN/6=<^+WB[]GOQ1X6TOQQJ<7B2WUZYU60W?AOPE?S3NB*LD$
M9M+<W+QB,,R&0%E<*I;8S$$ ^;-3_P""J7PDO%UB:7X1_M6_\3;Q%9>*KD+\
M.+WF[LQ:"'9D?+&180@H.OS<C=FNX_:F^,G@W]F ?"35)K#]H6XM;C6-7\=:
M79>#_",6LG[5>/)-<IJ&^WD>#*ZK<Q1QJT9VR2#)>-'3T3XO?M::W\/_ /@G
MIX?\??VAX9TOQOXKT;18=/GU::.UTR/4]1%N@DD\R5!Y,33-*R[]WEQ/@-C!
M\._:=_X*>>-?!7@A?%GA"UT1?"_B'X7Z3XCT=IXFN9K'6KTZA<HDHD,1FMFL
M]-NE! 5A+&A*GS?D .<^&O\ P4M^&OPU\;VVNR^#?VTM?;2[2]TW2+36O =U
M<P:1:W<\5Q,B,J+-*/W$"(UW)-(B0A5(W2%_7?#OCKX9^+?V+?CE\1W\%_&2
M3PC\6K^^OO%GAR\T6YM?$<[/8VFB7$=K:QM'.BM;6T)0HQ8$/(K9*@:_[#G[
M3OQ/^,>K:!-XRNO"NH:+XTA\5WVGR:;ITMA>:1_96M16$,$FZ65+I)H9O,\T
M+"T;1 %9!+E/#?VD/^"G7Q0^#?Q>_:$L=,U#PS?I\/\ ^VX= T:Y\+W4/V.U
MT[PE;:S+J4NKM-]EF*75W!$]EL\_RG$BX7+  XO6?VJ/@-XVU>VU#QA\+?VP
MO'6I1Z=J&B7UUK?P]N2=;LKNS;3VM;A88X4\E('F5(XA& \\TC!I9)'/TM^P
M1^U1X+^-OQ1A\.Z#X;^/]AK/AOPJMF-5^('AF;3H;JQ@NHPL37#JJS70:=0&
M.7D2-F)=@SM@#Q[^T5>_L^Z5XJL_C-X12^U/Q'HVE$:I\$]0TCRDU&[LK+ A
MN=31Y?+DO%D$R?(_EM&,'++F1?MV_%'P=J\VB:MJ_AK6-2TGXR7?PWN[V'1V
MM8;^VM_ 4NMM,D)GD\EVU",L 7;9$WE'>5#D \SU+]NGX=6\*VMQHO[;C:QH
M/B:X\3:;K,7PUA6?2[V:*YM9_+6.S%M/'+%=S@QSQ3 ;U90C(K+I?#'XW_L^
M_%SQ[X$\)Z=\'OVE]&F_X3S2O$&C:CJ?@N]MX;+4($LK=&N+R4LXMG^Q6\EQ
MYQ+2R R,2P!6]^S)_P %,OC!X]^&O@'6KQ?"_C"U6XT2^\:7-KH%SX;FM(+[
M1[_5+VPAM[F61I9;.U%E>)>)MAO(RT4:B1]R_2G[*?Q-^)'[77_!.[PCXML_
M$GAWPK\1?%FFI<G59-#.I:=:RK<D.?L8N(BX:)&3'G+M9@W.W:0#A/VK/VM?
MA[^R?^VI8^(M8\#?''Q+XQ_X0X:5%=>%_"DVJZ/]@N+XSE&=-H%PLEJ"V6 5
M77(.[-?,_B/]J#X$^*=,:QU'X=_MI7NDVNK?VYI-G)X&NC%X=G;6H-<N$MOD
M\UUEO+6$'[09S#"&@A:!))$;WS1?VR?B=\)_V</"WB3QIKVG>*M9\;?#37O'
M=G-H7@*^CBTRXCM]'ELK6:*"6Y/EQF\N/,F=HU?]WGR]IW=SX]^('QY\*>,/
MC%-X>U+0_&UOH5E8-X:\-VGAC[+>:?\ ;)U#W#3R7X6^-K;I<2"WQ;_:618U
MDB+ D -=^.?@?]@+X-6OB*S\*?%S6/#?Q-UV77;;P_H?AR75KC0;G4(VO[G-
MO&/,M4DG>:9UD=@MQ<2*FQ2J#Y]\6?\ !1'X2^(_!VFZ3;_#?]L30KG1/%%Y
MXQTO5=-^']W'?:=J-S<75S/(HD5XI(V%]=1>3+%)'Y<Q4J2JLOVA^R#\0M:^
M(_PI9?$FL:9KVO:/?W&E:C?6>@W_ (>>X>,AE:;3KW]_92-'+&WEEY$9662-
MS'*@7X__ &%?^"A'QS_:E^#?P_:2;0;C6?B;:VD:^++OP)JFAZ7X6OY;"[OY
MK2.VGG UH+!:/LN+:6& ,R%G<.$(!N?";_A3OQ&^#_C#XMV/@OXZ:;X=\)RZ
M>?$'AK6/"AAU+QE=Z;>-K-K?FWDB-W/-'?:@\^^&:)7E4JZ-&FT\-^SK^W5\
M$?V7_P#A'_\ A$OA/^UQ;-HW@_3/!,GG_#J[D&M6.FHJ6+W0V@&XMXS,BR)Y
M>X7$@8.%C$?3>#_^"D?Q7U;]L2;P7J3>$X?LVH:;X9'AVRT"^FCUN^DU?5;.
M]NH=9\U8=/,=GI,]\EM<H[2CS($:21?,/HVK>*_VC/ 7[/GQYU[4_B]\/]8U
MCX;VLITN6#X;R6D#26=K!J%PTD9U.0L)H7>W4!AY;?O<O_JZ /)OA)X(^!W_
M  4(U_7_  +I/@W]H_P3J%S)XB\47FLZWX>DT..XAU34+.ZU&P2:ZB>)DDN_
ML<Z1,N]39@I(%1@TWQN_;4\%Z)X[\1:#KMK^VAJ7BCP]<:IX:G\5:'X!B2:X
MT]Y(X[BUM;BUM(X6MFEMDEBN4C6[4G=%.BNRGW_6OC!\7/!_BE4FU#P+K^E>
M"M;\,^#O$2-I5S9W7B.\U*338[K4;=A.T5C'$-0#QVK"Y,A1T:9,HZ\9^Q?^
MW'\1/C%^T3X/\%^+8=%A6^\%:WXBU&2S@8)=R)/X=N--DB;>?+7[#KICE1AG
MSH2P.P*6 /GOQK^T?\"_C>GBSPUJ7PY_;._X1GXBRW<-YHTW@N[^P65]?:8-
M&EOHI)%:XC=;1W 1Y7ME>1Y_),P21>^_;<M?A'^SC^U)#<W6B?M/6?B34M(?
M5;J\^&N@R7^FR2WD TJZF-PL+R0WLMKIUNC&%XW1(8)8]DKF1O4OVI?VJOC%
M\./!GCSQ)X5_X0-/#^AW^J^&-.L[VRNYM0MKFWTF>XM]3DE5PDP^VQQQFR6$
M9A;>+@,/+J#]EW]N+QU\9/VA=0\-ZY9Z;HL&E^)-.\.7^G(//DL+G_A'M3N=
M1A%P&"RA-1T_:DH4 QIP!OX /%/"O[??PE\%>*=!N-/\!_MH6_AGPO>)J.C>
M%IO =U-HNF3K9_8T,8*&Z$20LY6V,Y@5W+"+>$V_H=\"/BK:_'#X1:#XLL=-
M\0:/9Z[;"YALM<L#8ZA;KDC;- >8VXS@]B*\<T[XT?$RZ_:1D^'4FD16ZZ;J
M,WB&Y\1R(?LD_AEB#:V\:*A'VY[AI+0H2"([)[C)\R%&^B[ ?Z*N"3NRW/OS
M_GK^- $U%%% !1110 4444 %%%9OB#Q98>%8?,U"Z@LXV.%:1\;CZ =3^ H
MTJ*YK_A</AG_ *#5G^9_PH_X7#X8_P"@U9_F?\* .EHKFO\ A</AC_H-6?YG
M_"C_ (7#X8_Z#5G^9_PH Z6BN:_X7#X8_P"@U9_F?\*/^%P^&/\ H-6?YG_"
M@#I:*YK_ (7#X8_Z#5G^9_PH_P"%P^&/^@U9_F?\* .EHKFO^%P^&/\ H-6?
MYG_"C_A</AC_ *#5G^9_PH Z6BN:_P"%P^&/^@U9_F?\*/\ A</AC_H-6?YG
M_"@#I:*YK_A</AC_ *#5G^9_PH_X7#X8_P"@U9_F?\* .EHKFO\ A</AC_H-
M6?YG_"C_ (7#X8_Z#5G^9_PH Z6BN:_X7#X8_P"@U9_F?\*/^%P^&/\ H-6?
MYG_"@#I:*YK_ (7#X8_Z#5G^9_PH_P"%P^&/^@U9_F?\* .EHKFO^%P^&/\
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M&B54C,BLP<QEMSEBQ[UOBMX98Y_MVU'ICM^GT_+ZU./C#X8 _P"0U9_F?\*
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M>?\ @4U>@44 >?\ _#-7A?\ Y][S_P "FH_X9J\+_P#/O>?^!35Z!10!Y_\
M\,U>%_\ GWO/_ IJ/^&:O"__ #[WG_@4U>@44 >?_P##-7A?_GWO/_ IJ/\
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MFKPO_P ^]Y_X%-7H%% 'G_\ PS5X7_Y][S_P*:C_ (9J\+_\^]Y_X%-7H%%
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M!Y__ ,,U>%_^?>\_\"FH_P"&:O"__/O>?^!35Z!10!Y__P ,U>%_^?>\_P#
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MH%% 'G__  S5X7_Y][S_ ,"FH_X9J\+_ //O>?\ @4U>@44 >?\ _#-7A?\
MY][S_P "FH_X9J\+_P#/O>?^!35Z!10!Y_\ \,U>%_\ GWO/_ IJ/^&:O"__
M #[WG_@4U>@44 >?_P##-7A?_GWO/_ IJ/\ AFKPO_S[WG_@4U>@44 >?_\
M#-7A?_GWO/\ P*:C_AFKPO\ \^]Y_P"!35Z!10!Y_P#\,U>%_P#GWO/_  *:
MC_AFKPO_ ,^]Y_X%-7H%% 'G_P#PS5X7_P"?>\_\"FH_X9J\+_\ /O>?^!35
MZ!10!Y__ ,,U>%_^?>\_\"FH_P"&:O"__/O>?^!35Z!10!Y__P ,U>%_^?>\
M_P# IJ/^&:O"_P#S[WG_ (%-7H%% 'G_ /PS5X7_ .?>\_\  IJ/^&:O"_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?![_ ))EH_\ UP_J: .EHHHH **** "BBB@!LO\ JS7E?P<_Y+!XR_Z^9/\
MT<:]4E_U9KROX.?\E@\9?]?,G_HXT >K4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ]BUUON+  VRDNB@L,->6R]/O28ZA@.+_;;_ ."=FG?MK>+SJ&N>//%WAO\
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MH **** "BBB@#D/CS_R2;6/]V/\ ]&I5KX/?\DRT?_KA_4U5^//_ "2;6/\
M=C_]&I5KX/?\DRT?_KA_4T =+1110 4444 %%%% #9?]6:\K^#G_ "6#QE_U
M\R?^CC7JDO\ JS7E?P<_Y+!XR_Z^9/\ T<: /5J"<45G>(7O)M.NK?3YX;6\
MFA9(;B6'SDMY"I"NR;EW@$JQ7*Y /- %N&XAD(C7;]W(&,<# _3(%.>:-&.X
M?=_V:\Q_9$NM6C_9[^'5KXD;7I?$R^#]*DU235X)?MSW/V6)9S<R,H G\W?O
M1L.&W$J,UYS^V1H?BK3?CAX9\2>&)OB!'':^';R+4&T>XU*ZL;2,:KHT3W(T
M^)VM;B^BL;K598(Y+>9I6A&8IQ"(Z /I+[1&#C:?0X7I]:!<1N.FX9XXX/TK
MY)_:?_:'^+WPK_9F^&_B#3/#TT7BK4=.M[GQ9;0:++<V&F3-! +I)RBSM#'"
M9KF55<QQYM07N@(_LM[P/PW_ &AOCA\3O$OCK0['4/%GV6PUVRT.SU:Z\%BW
MO=(M)KKP]Y-VT<EI%&]S-9ZAJUQ<QO&R0I:6S^7:KGS0#[R-]"F68,OJ2G0<
M]?\ Z_K4D;(8-RK\HZ#;Z>U? NN_M&?M00^!/#=Y9^&=?DFU2Z9-;=_#+Q7&
MD1"#3C=/#&+>:1/)N;W58[<FVNO.CT>T95N=\TEY]5>$OBYK=[\(=0M[JTBN
MOB-X>\.6UYJVGZ99R-"VHSV9F$-LEQ+ 65I0ZHDLT9QM#R(26 !Z<+J+M^@Z
M9H-U%SSNVGJ!QG.,9Z9SVZU\W_L3?%;XE?$.>V_X3C3=8M;?^S[DAKG0[BP(
M>'5;JU@DF>XM[0F:YM8X[AE2U0$?.8;-?*^U\$OQ/_:'LO$GAV.2._O-"U;2
M_P"T=0G?P_(EWIRRR7*W,,4<-HZ-<6@BLW@29X6>.ZF4QZ@ZJ(P#[,-Y$.?P
M!QU__5C\*1;N$C=MVYQRR[>O3K7Q7\$/CE\8/B?H$E]??\)3=:3:2^#]0TV[
M'AUK(:S#=M.+\S,D2<(!#),D>PPL@$BA&>)^-^-/Q0_:;TGX6W&DG_A++B#5
MO"LTEQJ6D^&KDZ]:S3:5)<6WDQV=B8HIQJ+)83,LWFK"%D6WMF!O" ?H.MY"
M#]Y1N^8\=>E*;B)(R>%X!((P?2OF+]L_X@_$CX;_ !9T_5O <.M7EC8^$-<O
MKZ V;3:*7MH'NX6FD;;$DSW$-K;!?,65H+ZZ*#*">W@^-OQL^+/@WX)?!_4_
M#^CZAKOB+6?[+'B)K/1I;N'S+C[)#.SBWBF>(".XNIEQ'%"&M@9+N%4^SW8!
M]2+=1&3;_$#CIW_^MC\*3[?#NV[AD'L.A_S_ %]#7R)^REX^^+7CO]IBU7Q_
M!XPT_2]+T'7;*."70)M.TF_CBO-'2SU*>0Q")M0F U ; Z 11;HK>%'9I.H\
M ^./B7IO[2=MI-W;^(K_ ,(WVKZO%<SWFD2F*. R:C-;.MP(QL6,6UM%'\PC
M:.X.0\DD;@ ^E6O(T/WNV>/KBD^WQX4_,H89R5(Q]?3TKXZ^*'[0WQOT7]I_
MQ!H.@^$O$6H>&;?3Y;O3)$\,RW%O?:GYR06UE+.4C@2SDM/M%R\ZWDDJR01;
MC 773IJ$/QD^.GB74];TC3U\=6>FM>V&GZ?KVI>"DL[J*T?4]&M_[2"/#Y3R
MO#=ZX9DDB4)#IEK*;>TW,]P ?:@O8R2/FW#/&.3C'(]N12B\CQR=OKGC'>OS
MW\'?'G]HI=4\B;3?B)%<>+-6DCOKFX\)W#0:'*WARTEG^Q1M9R1I!:ZC%)!
MTK)#)YKMNU*661[?K?AA^T7^T1XR^)7P[M=2\.W^BV>M2K>^*(M1\-75CIND
M[IXT2RMY1#,[*^G&6Z;SY(A%>^5&;IQYFG* ?;37\2#YFQ]?KC^=(VHQ*N<G
MIGI]?\#^5?*/Q.\>?&X?M(^-=!M=/U*W\ 69T:]\/7^EV#S-.@DM/M\$DOE!
MD;?(P*JS[H#(496CD$3/A!KOQ+\+_$3X#Z;?S_$#7K-K/Q#H?C:YUS3GVP3(
MJW-O<SRQQ11!UDMU@@N #%)'/,!O=U< 'UDM]&S[1NR#C[I'^1[TU-5@DW;9
M-Y498*-Q YQD#UP<>M?$/Q2^)?Q\^'.K^.V^'VA^)/$%]'K5]/;2^(]/OOL-
MY+YMQ]CTZ"&)+E/LHMU3]_ UI#('M/-GM[E+J.7K-)UKXB:GXYN;Y=4^+%SI
MNJVGA,::+_P^;$2PV_B>X@U&:6"*$"UGFL);2:97\EY(Y7;R(D@:"W /K(:E
M$P!!9E;HP4E>YZ_A3VO8TZD\8R<=,]_IQUKXN\,_'#X^ZAX@L([C1]7A6[CU
M&VG>]\)7"V5C>?V(UX'(BCWO#!JD3VD+!F6>%E&ZZE:&XKU[QUI.L?$GP_\
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M^QCL?",RVUM$L4*N]G>[V"* H9MHR0.<"@#ZAV+C[H_*EHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y#X
M\_\ ))M8_P!V/_T:E6O@]_R3+1_^N']357X\_P#))M8_W8__ $:E6O@]_P D
MRT?_ *X?U- '2T444 %%%% !1110 V7_ %9KROX.?\E@\9?]?,G_ *.->J2_
MZLUY7\'/^2P>,O\ KYD_]'&@#U:C'-%%  !BO!OVD?C!XX^'OQ%U9/"[^$[[
M3]#\"ZIXHGL=2L;CSEN[92MHIN8Y\)%/(S9"VTC*MI-\V98PGO->1?'7XV^!
M_AEXYMM'\2:=]HU;Q19+I]HK:<DO]M"20QQZ<CO@2-([L-C$1)O4R-'YB;P#
MC+'X^:MXK^.]EX%O&\'ZUX?\5?9TPED\SQVS6&H_;;68><\3R+<V#)RJ"-)M
MC1R-N>J_[!7[0UY^T)X9MM1O-#\/:#J.M>&]*U[4#I-F88Y[Z0W-A<,Q+L70
M?V="(MV66)$4R. N.=LOVL/@KK_B;PMXJT_2=<TV6ZN;'78-6TSP\D(OH9=.
MO81)=LJEVAMK=+E920#%Y:X/E@DP_"S]L3X"_#_5-6UCPO'>:7I>G:+]AN(]
M.TN&+2-#ATR9'N84$.(XVB_M>&5\%HW^T(L3/(3&0#HOA9^VCKG[06I_#W_A
M'- TG1]-\0ZJZZR^IW<EQ<6UDVD6VL6@MHXT17GFM;VV$I>15MI?.51=HJR-
MA_%C]O'6/V>?%OC:\\3>'-'N/"GA?Q8^CW)TF5YM5EL#I&EW4,W[[RH7G^TZ
M@H="RH(2=KF2/$W5? []I7X:ZOJG@?0;?PW8>"O$/B>YU.[T?16LK>*>TF\[
M4?-D"Q@?O+A;*]F8Q[N(Y/,8%E\ROXU^-WP^UKXS6.GZ3X!TOQ9XXU7Q-9Z"
M;R]TV&W53;G4I?M4ET\4DICMGTC55C"1LPN+= !'#(+@ '+_ +3O_!0;Q)\)
M/V--+^*&F^$5T_4KJZU>UU#2M7M[O-D;#3]8F>=4=;6X:$3::DH\R.*22V9@
M8XG<;,OQ+^W9\0O"ND^-[^^A^'UG#X=T36#ID<5O+<7&IZMIUKJ?F)+&+M9(
M(3=:/J#1ETV3103*)TDC4S7/C?\ M8_#KX%>,Y?A?=_#/0)])T&=K#3+/RX(
M]-M8AI:75_-) L#K9VOV&^FB27:T<C+>K,UK DLY[3]KOXG_  __ &>+KPS9
M:A\.](\6:MXLFU;3H+5-'2=T@GMY;J])6.&61TN9S%'-%%&\LQN6<1S,NQ@#
M+_:Z_:PU3]A[]EWPOXBL?#NEWS6:&;6-+ALGTD66G6]E-/=306ZO(+<><EM;
MJ9)&CB>\C!>1F1),/P1_P4UG^*W@OPOJ7AOX<ZO>7GBS0-#U>R2ZOIK>S2[U
M*&QG%FU\MJ]LLBPZC#L&_P V1DEWPPPA)I.R^ 'B7X9_M%:/X@\#VGPT\*Q^
M&/"ME:VD=JMC97>BW4>H1M<3VL"*@3"S0'S8RB@D(S@-N1.7UG]J7P!X&^&.
MD_$"Z^%EC8W"_#>#Q1IZ"QM1/#'#*C6VD1R+&2&BEDW?+A(B0RJ23@ TO'/[
M9UNWB?Q]X,\3>&_#]_9Z?+)I+6]SJ2&WUAKT7:6-DMO)$TEVT\=G>&:*"*:9
M2T4<-O>;G9)O"'_!0:/XD_ KXG>,=)\/76FS^"?!D7C*PBU&7]S?6UQ8W-Q
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MGNKR_O\ Q99QKIM[$IDET:[NXDM8/M$B":XFBM'95)4?NY7(2-7V0_LM^/\
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M,M_#.J6^NV&E>)+W1TL(K^W;=!<$6.GVTI9"6PHD\L[SN4X7'TK110 4444
M>&_'_P#8BM_C3\7H?'>C_$+XE?#/Q9_8\?A^YU+PE>6*M>V$<TL\<,L=[:W,
M0VRS2,'C19#P"Q7Y:UOV8_V1[#]F_6O$VM2>*?&GCGQ3XP%JFKZ]XGNK:6]N
MX[59%MH]MK!! JQK*X!6(,V<L6/->N44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(?'G_ ))-K'^[
M'_Z-2K7P>_Y)EH__ %P_J:J_'G_DDVL?[L?_ *-2K7P>_P"29:/_ -</ZF@#
MI:*** "BBB@ HHHH ;+_ *LUY7\'/^2P>,O^OF3_ -'&O5)?]6:\K^#G_)8/
M&7_7S)_Z.- 'JU%%% !7@W[8'P=\!:K!?>._$EW8Z-JWA72FU-=2O+JZ^SV,
M-@7F%V]O!+&[?9_M,Q653NB:96Y.W'O->._M%_LVK\:M?FNEOK?36F\/W^@R
M2?V=]IFE%U"\:'<T@553S)&PH$A)VB1$DE60 \S^$?[&W@#X*Z[#8Z_XIT/7
M(]+TS3?"&FZ;<W;6["8V-S$ZR1-<.IN;R*ZG8HBKO#;PK,-U5=?_ &'OAC>7
MFK>+M6UR:\\ ZCHD]A']AU*_GN+Q[W[!;RS_ &I;B0R2.EE# GV=$+)((\-Y
M<9K/\)_\$O%M;NPAUSQ=9:QIFFZ'9Z/! NB;9#);V%Y:_:E5IWABD$MW'.C)
M$&W0J7:1SO7T2[_9LU#P-^R]I?A?37_MK5M+\4:9XDG,9F#WQ@U^VU2=%:[N
M)'W.L4BJ9)MH9ARB\* 9/P\\1? G2OBC=7>@Z]-%K&@S7L5\[W%^FGZ7^[EN
M7CN6?$,<02YNI(5E948M<F+<8Y/+[#P_\)/A7H_QD34K.ZTE?&4FLRWL5NFL
ME[@7J6][YZI!OZ*NKW\S1!,!KQI"H)!%#X_?LNZS\3?&?]M:'XJM="6X71IM
M0@N-(%U#>OI&H2ZA9HQ\U"D;S3MYV/G98D"LGS!_ESPE_P $"]'\*?%#2]<?
MXE:E);Z3-XFF,/\ 847VIQK/AZ#0OEG\T[7A@MHY=VPAW9AM5<!0#ZK\7?L[
M_"K]I#Q!=:G?-8^*+VZTZ&5?(UR2:*ULKJ)X?W*+(5CMKN%7C<(%2=!)]XEZ
MXP>&O@7^T-+X9C\2:M8^,->T*;6_'7A^^U=)K/5=)M9+MV>XA>4))#:PB]M_
M(<D*RPVD\9(BCD7H/@!^QW>?!;XO3>,KKQ):ZK?WUKK"W,-MI1M8WGU'48-0
MD*$S/B*-TD1 V6VR#+$@[L#1?V$M3T?PIH&GKXKTZ3^P[.YLTAB\.K;6,4!E
MTVX@B@MDE401+<:9'(\(RF+JY2(0IY0C -7P[\,/A%\"9UTGPCXBM?!]Q?:A
M:7UQ);:K+*US':WD=\UF\C,P19Y=5,C1DYE.J,P#>=FHO"OP^^ G[5WPT/A*
MRM=-\8>&;+PNNB"QN([B2.+39;N>W1OWPR)!<Z5.$D_UBO:[@PRA/*_"?_@F
MQ>?":\\-2MXYM=4A\'ZC/J%D&T(*[^?JDFI3)+)YS/(H:>YAC5RRPH(2BB19
M'E]S3PA?7?[2":PMG-:Z38>%WLEN2ZA+N>XO!(R(%8N&A6W4NS!0WVE-A8B3
M8 <C\:+[X2>*]'U0>*KN1M-\(Z+KGVR&%[R""PL8;5;;49$2' )BAN3$'C!9
M=\B(=ZD+FW'[$GP7^%?AYH;_ $^WTC1'B-J5U'7YUMD4VFI6\D>Z27&7AU74
MG/)+-.SG!12*^C_ 76]!T#Q!JK6=Q=:IHT/CVVL-+A6!9-<76=634K=H9&D4
M1X$2PD2[ SL6)V*LC8?[>O[%_B#]I#]A_3_!6DZA%_PE/A&W@U"RC:T%Q;ZW
M=VUA/!]D8O)%L$Q<@2N0$)4L&&5(!ZEX0T3X?^$]=T/6K/7;.XU&ST:'3=/G
MN?$;W;R6-_<B2%XU>5E;[7<0J$<#,IA5 S"-4$/PV^ 'PY^ GB2RDT6&ST75
MK?3;QH8)M2D=HK*1=.BE)C=^8H5T_3H%;!$4<,: KN.[Q?Q?_P $P;CQ7=Z]
M(WCJ,2^()]9OI7.C,WD7NJBV,Y3_ $@%88S:6XA3.Y TNYW)4CO_ -H7]C2X
M^-_Q*UKQ)9^(H]%N-9\,MX=B$T,URMC(R7L1NTC$ZV\DGV?4;E5$T,H4I&0=
MNY& '^+_ -F[X(_$#QB^L:M/I<VJ:I=BS7/B!HQ+)=,EXMM'&LH4-/-'%>*B
M ;Y8HYE!*@US_P *_P!A7]G/P=;^(=/\&Z38VD.L:7I<NI3:?KETZ?8+>&]L
M;-5F\THD0@>]@PK?,CR*P.03FV'_  3/LI;RX.I:]I]Q'<*=\=KILL"6;M8W
MD.;6&2ZDAM1%<7IGA$48*")0S2,!)78W'['%UX@\/^(;74]:\/W%]XBTNQLW
M:+PRL=G:SVNK7FHQ3"#S</M:Y&%E9]SQ!Y/,\QT8 Z_PG\.O /PY^&WBR30K
M^'2?#.KW-Y?:S?0ZT\:VTZ(EK<2_:#)_HYB^S!6VLH1XGW#<6QPNJ?LZ_ ?Q
M9X]U[PU/9V>H7WAG2K637=%^WW+:;I]G]FMHH4NT+>1$7BL+*01RD.PL89,8
M3?3OA?\ L32?"O\ 9I;P'I_B19M:@U72-7CUFXM;F=+J?3#IOV7SXGN6)#Q:
M9;)(L3Q1@,XC5.E=M^SI^S?:?L[Z<UE!J#:K$NC:-HRO<VZQW#)I]F+422L"
M0S2+R<  9Q0!Y[\(_ GP?U/POK6J?#?Q8^EW/B[^Q]3U/61K=Q]JO%OI8I[&
M61IG#%KHLZH/E):[F7&YV%:WQE^%?PV\0?M-'5O'6OVL5_K7A53H^FS7<MH+
M*/2Y;U+O4_,20)\BZY!$'<+Y1EX8F7"^7Z[_ ,$JG\3:;H,-]XTCD7P[H+^'
M%CM].NK1;ZR:PBTT+*8+V.4M]EC;.R0!I9,Y$>Z-NU_;S_X)]2?MR6U]9W_C
M$^'[*ZT2XT.%$THW+V*7<-Y#>R*?-16DE$FG['=28A82HA"7<RD ],^#?@OP
M!\'/"/\ PCOAF\TV&QFO(K)[>75Q>-)<FRA6*/,CL=[V<43B,<LA#@?,6/D_
MAOP'^S;X.\ _\)MI&JZ39^&/!>FFW:Z769VA6&SU. ?:&0N7GDDO](B3[1AV
MNG@.#-YA+\1XP_X(]VWC'X,7WA"3QQ)%]NO1(^HBPGFF2 6^KH84CDO#%$5F
MUFY=/+5%"HH=9'9I*D\6_P#!)[5/&DFJ:E<>/K&+7=9F\07AN4TJ\DLX)-:@
MO+:Z6*T^W"(1K!=AD9@TIEB!,@C/DT >O6'PX^#O[//QN\5>)(;C_A'/%.K3
M1:QK;3:I=BU8WC7:0S2(7,"J6@U!L9"(S3.0NX&LJT_99^!>A?&O6/%DFI:6
M_BK4/$\>HD77B+(LM0N/L5RMK'$)%VK//IMK>>0<F26W1QE$54L?M'_L.-\<
M?CC9^.H?$3:1?V5AI]BEI/8?:X9%LKB[O4^82(\;&[FLY/-B=94%D?+>-V$B
M\]X9_P"":]OH'P)\+>$YM<T>\U3PY.ES-JTWAF*Z%Z\6A7>EVV^*>1PX@GNC
M=IYID&4*XRY>@#I;_P"&/P/\,>(/"^I7FL6+:EXBET2UT:YE\17%Y)J<ZO:7
M&GR"0R,97N?[#M<S,3]H&GHI9\,&V/B9^SAX-\??$7Q%XY\6ZDLFE6VE6$"J
M]Z]K;^'Y]-EO;@WQD$HC69/M)VR$ PB)OFPQ \Y\(_\ !.K4O"GQ3\-^,&\9
M:?=:QX>TZYAB^T:3/-#+<3:W<:FS.\MVTS*([F6(!W9\J)#)RR-Z?<?LXW5O
M\.?&V@:?K-EILWBKQ%)XCM9X]*"Q6#27,$_EL1()G=Y(F)N%D2>-ILPM;^5
M(P#<TC6/AU^S8=0235M-T>3Q%KVF:=,EQJ+W4]SJ4]O9Z=90GS':3S9(K>U4
M#JP0R'/SO7J"G<H.",]CVKXE\ ?\$L+SX>_$CPWXAM/'EG-_9-GX?TR[@?P^
M^V\@TO\ L!W97%T666230(MK,&"+<NI60J&/VM:MNMHS@#*C@#@<4 24444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[-^C_#/4(9;SP1I]GI=E!$][+&T\-F\#6RO*I!E4F"+>K'$HRC@J[*>!\+?
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M-->\1?9]4:\\5R:A=:@3?;A+)?6[V\Q1BF^-?*EE 5&527#.KLD;)SO[)O[
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MY\9-)\&,CZ==%K?1[W0K.XD=6$Q59DN9BWF[?**[D,0=C+0!P'PET'X^^ _
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MU9V4R>68W#K<)YYZW0/V3/#_ (;^%_B3PC:WFL?V5XJF:XO3+.DDFXVT%OM
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#D/CS_P DFUC_ '8__1J5:^#W_),M'_ZX?U-5?CS_ ,DFUC_=C_\ 1J5:
M^#W_ "3+1_\ KA_4T =+1110 4444 %%%% #9?\ 5FO*_@Y_R6#QE_U\R?\
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MN+&^NK73+5KR$31".1IC;ZA=2B5"HFOVRLIW2$ Z;7?#WPYTOP?X3\+S^/\
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M  5#U3XA7W@S[-X-M_*\;:MX:L[2**Z9YK2WUB*YF+2$ AGMX]/OG<)\I62
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R'QY_Y)-K'^['
M_P"C4JU\'O\ DF6C_P#7#^IJK\>?^23:Q_NQ_P#HU*M?![_DF6C_ /7#^IH
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M\=:U8:-IND^;#))IEG<W 2UN9XV41Q%%VR-%&9 A*JKR !A@_#*\^#=_\"_
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MHAFA=A)][RV68.\1RKR6EF_RF'YO4$F5SA6SQG\*:US&DA4NNY1N*YY ]<4
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MJFH>+]<L[?5M/CTZ.U2-9ET^,7NDW4JP;R4C1_[)B&%0-NN)G9GQ$L7T)YZ
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M.U)=6>:Z5+JST2YF>Y@6U\F#RV\06*KNN2)1%<;2L@AAG *GQ+_:S^('AO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH Y#X\_P#))M8_W8__ $:E6O@]_P D
MRT?_ *X?U-5?CS_R2;6/]V/_ -&I5KX/?\DRT?\ ZX?U- '2T444 %%%% !6
M7XO\2MX4\.:CJ*:??:HVGVLMR+.R0275V40L(HE) :1\;5!8 LP&1UK4K&\;
M:M)X=\-ZEJ4=CJ.J2:=:RW*6EC$)+JZ*(7\N)25#.VT*H+ %B >* /FCP]^V
M*OBCQ-X/TF^\7_"S6]4\3:Q9VZ^'? _B2>YUG1I%</(K'9OO;<&.62X:6WL1
M##%(K+(>:]8^#(9?BYXPW-N;[3*3SR,SDX_ 8Q[8KRC0?VP)/&>O>%=)N_&W
MPM\0:IXEUNS@F\.^"=>N+G5M&D1E:17)^:ZMU\N5[@RV]B(XHI$*,QKU?X+M
MN^+?C _]/$F3G()\XY(Y/&>U 'K%%%% !7D'[3/[1'@[X"6&J:AK^F7VH:GI
M^A7EY;P0:-+<MJ,"QF6:TBE$91G9+<R/"&W>7 9&79'N'K]?.7[1>@?!_P 5
M?M#R1^.-0N],UK3?"DWVBXNB;72TL+BWU-&+WCILB=;>/4Y"BRI\D;22*WE1
M,@!W/BR_\)_#WQ=X"\(_\(O;R+XOU/RK#R-'#6>GSV%F]Q#-)M39$R):HD9)
M5EV*%P(\#B_V6?VCOA+^TG9:>WA.QTG3]:U32;34+O3O[+%O-9B#R+G[,[F)
M5D>TEU&%]JD^6U['(,><I/17OCKX<^-O$7@734^)&AZAXFTVZ@U'0_(UZP.H
MZPQLLL?+'RRK<6DQ<^6@RDP=-@(<<;^S?\%O@7^R[IEUXD\&^*M @L=4LK1I
M-1G\0VTT$T;R16L5PTV1YGFM:VT"%F9 UN1$$>2<R@%+XU_M^?"7P#^S5:_$
M#XH:?=:+X"U*'48;Q=:\/7=YY$,=S_9[I+;I;R$><\D8$;*"T;2':523'J%O
M\<?A[J6N>+KK^TM-6X^':'4-;OI[1D6PC07D#3^<R@.J-;7\3.A.PPSH<885
MX]^T/\!_@O\ '']C_P 7V_C:#QEJGPRT?4]4EO[6U2[CNK!H+XB\2-(4%TT2
M75O)+D!R5+,K&/:!U?@7PS\%]0O/$FBPZMHZWOQN%[#?^'KW5(K34-2*F<W\
M"VX*W'F(]Q=-+G=+$9-FZ..&)(P#0^%WQ2\ ?&3Q%-X \-^$[>X\/VOAJ(:K
M]JT06EG;V_VN[L8M-^SO"$+12V=^DD#;1"8R K[GVX'AC]J7X6:;8^ -2O/"
MR>%5\:VVL^)]):ZT$P74-["\<-R/+$6\7=RES*00 \R[P-Q;GU+X1_ #0OA-
MKFH:CI?VZ>^U:!(K^[GN0SWS"]O[]IBJ;45WN=3NY&"*J?O55554"CDO%W[!
MW@KQ[INAV6L6NK7EKX8.H1Z/&]TCQV,5VI1H]C(5DC0 %%E$GH^\9! *'Q-_
M: ^'OPF^'WAWQ?%X9M]0\*Z^?^$@FU>VTH);VD-O9Q@W;_)_Q\+:HL<<; 2.
MD!C3+I'$\MS^U_\ "&\\:V:M.MYXAUHG3HD3PW=SWTTMG(\KV;[8&D$MH_FS
M/"?GA&Z0JHY,O[1_[$6D_';]F&^^'4,U]I<?_".W6AV#FZ9H0LD.V-;A0/GC
M6:.WE(7:<P@*0I=7CO/^"=_P]O?$C:RUIK$6L3O--<WT%V(+B]FN1<+>S2.B
M@[[B*[N8V"[4C\YF@$#XD !EZM\1?AS%\5_&7B2;0&OO'D^C77@U(]1TN:"'
M58-,^VWK:>EU);B-?.WW$AC#.LD4"R!65,F'XV_M-?#'X&Q>#/%&O>#[<0^-
MH4\2'55TB.1M-?S]'M6N[J18V9'2*ZMF,K$9%E'$&+M"A[#7/V*/!_BCXK?\
M)I<6^I0ZYY]S.2+@,C-/:7%HW!4E L-U/\L;*K,ZEP_E0[+'Q;_8P\&?&[P?
MI>@^(]/N[[2=*T8Z!' ;LKYUH;FPN663 ^8M)IEJ"?[N\?Q< '(O^U7\)K7Q
M_P"']%T73_[2US7+VT\->38>'IO,TS[+-D13MY/[E+*6:(M&Q7[,UY&Q"F12
M=S6OVOOAS8:]<6.NW4]OJ,<E[I$-K)HUS+)>,EX+-H(P8 9))YHL1PIN\]4#
MH)$"M4/AW]@SP5X7UU=4TV'5M-UA1 YOX6@24W$7E+]J 6+9O>.&)/+VB&-%
M(BBA,DA9OQ;_ &)=%\87$FLZ3#-#XHM=336[&6XNV%O'>)<S72MPIVD2SR%'
M*2HC>6S0SHC0R '27_Q7\(>,?"'PWU$0V^LZ/X^O;.?PW+<:<[1B9[.:_M;@
M(T1,+!(-RF3R]K8&X/@'ET^-WPQL?V:KSXP>%O#HUGPS)IT%S'%IOA]H;V]2
MWN&-NIA,:RCRII"Z[ES%EW 7DMUWPS_9XA\"_"CX9^%[RZFU:3X8VFGPVE\%
M%N+J:UL6LC*T8)PKH\C;,D*6')QBD^'W[+GAGX=? */X;:;:ZE'X9@@-ND<M
MYYDZJ7W_ .LQ_>SD^@Z4 <)K'[6?P=T/P?#X?\016^GMXBNI+"?PS_PCMU,U
M[?7 6XN+;[+]F!EDE^V1.=\8,AO86(!F3._X*^-WPH\8V^M:EH[:4UA\-[2U
MUNYUP:')!INGQW&EB:*>TNVB$4O_ !+63?Y#NT<,D:/L#JK8&G?\$W?AWIR:
M?+;Z?JT-]HVIS:QI5[]L5)-+NG6R"2QQA#%(\9TVQ*O/'*[-"YD:4S3&7OO"
M_P"RUX.\'?#/Q)X.T_1I1X9\56R6.H6$E[,RR6ZZ9;:6(4<OYBK]EM($SNW9
M#/G<Q- '->$?C%X-_:%^*=UH.F^%H]<AT_2HM:O=3U31FA%I*NHRP0V^R:'<
M;B.\TJ8NK;&A>UA(#D$Q\Q\"OV\OA[XI^'GA_6%T>Y\-_P#";"YU>&+2M*FU
M:SO6\JVFEG^UVD1B9W>]@@)<AI+OS8%WR(<^J?"7]G71?@UJ.HWVE_VA/J6L
MVB6VH7EY,&EO7%[?WS3,J!8UDDN=2O)&\M%7]ZJJJJBJ*=Y^RUX8G\*Z#I*6
M^K0P^&/#R>'-*F2\)FM($>TEC?)R&F22RMW#N&&8R""&8$ X3P'^UW\$/%;F
MYT.ZLXYKNYBL7E?P]<V\O^BWDME#(^^!=MO#>12P)*V(XY054@D V_$O[2/P
M[FTWPXUGHD>N/J1T>;2H+G19;.,VLNKV%JD\+SPA#]FN;FTGV)AD_=,,$HU9
M?P;_ ."</A?X9:+''<2ZG>:A:ZW=WEO<PWCQ%+%M9NM5M+)B,,T<4]P)6;(D
M:4, XBVQUO:/^P/X(T?QO#KD<&N&\L[9+:)I[_SFD"ZC::DSM(RM*-US9PMY
M2N(0NX+$I=R0"#XT_M"> ?@U\5IM*\3:#"&M] GO+_6!8BY:&WN+74+QX0JH
MTLB2P^'[MI N26@M0$D+ QZ7PO\ VBOA/XA\+^(O$WA/4-#@TOPYIT=]JE[;
MZ;):XL(%GCCE V*\D*"UNXE*A@K6TT8Y1EK5^+7[*'A?XT^)[K5-:MKZ2ZU#
M1WT6?RIO*1H6@O;=).A831PZGJ2)@A<7CEU=DB*9GPT_8;\"?"CX2^)/!&DZ
M7>?\(WXMM9K+4K.2ZQYD$T<J3*'558N[7%PYE8F0F7;O$<<,<8 O@_XE_##X
MI>*7\+:;HL=]=3>'8+N]2Y\+RK:VUA;WL]K#9W$TD0A2:*[BNU2TD82(T<S"
M,!6->G:+X"TK16CFL=/L+&3S+F;=!:)"VZYE\^X;Y0,-+-^\<XR[X9LL,U@_
M"/X!Z'\(M2OK[3UOI=1U.VBM[ZZNI0\EXRW5[>-,RJ @DDN-0NY&**JYEPJJ
MJJJ]T!@4 <U??"/P[JNI?;KK0=!N;Y;^'4TN9-.C>9+J&,Q0S[V!/FI&2BR#
M#*AV@@5=T_P)I>EZ^NIP:?IT-\D3VZW$=HB3+$[^8\8<#<$:3YRN<%N3S6Q1
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHEA$<ENWB+[/:&^37+K19X$G^SDF/S[.5XI61#(I7?' 2P0 ^L**\)_:0_;
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MW&GVS:C=6$-\]\CVUZZ6=M?0"W9E03K)9W E+1%T8JS6[W=NLES& ?0-%%%
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MQE>>*O$%G=Z+XN\56VE:7IVES27GV*X8ZKJKQWDL<(^R^>=7G;RY6(4LC+<
M7$%M" =9\']/^#_B']J?4/$7@W4+.?Q;:Z'>:,UGI]JL5K90"_C>^6-TA4O)
M]I%O))'YKB/[1%,L<?VXRW&;H?[0WPC^&&O>.+G0/!?]CZYX;O\ 5Y'@M?#4
M6FW7B>\AMI9K][9W6,.9/[/*>?(R),UHO[QU52*W[,_PO^!/P;U.;QQX/\5:
M'--=:;%I5WJU]?V?F7A%U]D>\>X9$F=KNYT\+N$GV>62VDDA0/)(\O1^/?V7
M?AS<:GJ'BK5O$5]I-LG]J+?W,FIV\-LAO5N87$C2(1&8C?7*QC<H#2@.)"J
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M "BBB@#D/CS_ ,DFUC_=C_\ 1J5:^#W_ "3+1_\ KA_4U5^//_))M8_W8_\
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MR]\=R>7;6ZNBA54)*+<6RSS;[7QU^!7QBC\+>'K/PG<>*M:N=%T&/4+66_\
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M_!+5O!5UX[^U?VE81:2;N#1Q"([</J\Y 0S,3*;C6;GYMV!''"NTMOD;&O\
MX:?M-7=EK<-O'XLM;K_A%KRV2Y?Q99S1WNJ/I6H)=26Z!E,!N-4?29K0L0+>
M&VN IL5E>UEP?AWX.^/VL'4)/"NJ>.-0\,Z7XEU71[235O$L%Q>SW=EXCNK:
M2]D:64L]DVCP-:) 2N+K$WV=7(O5 /3? '_!-[^R_BA-XF\1^([#Q!/J6MWV
MO:C8MI,\5E+)>RPM<P);M=O (66"W&YHY)20X:4H0BZ7[37_  3[A_::_9#^
M+GPGG\41:+9?%369=4-_::/&_P#9@DN[:X9-ADS<2,8&8R2/PTQ"A8ECB3A]
M0_9Y^,%G\?\ P*UU:^._$?@/PC;VFLS>9XKCEN+O4(I+<1Q%WO(6=HQ=:D&C
MEC=)88D:6[N6%M:V_;_#/X<_&[1_V2]>L/%>I:UKOCBZUZUGECM+J"RNYM.\
MVQ_M2"SN?M3[&N%74WMY/,M#%]JC2..Q6*)80#1E_8=\W]H.^\=+X@L2VH:O
MHFL+9SZ0)Y+>73[?[-)L=IMF)H8X0-T3-"?-=2T@@D@]5_9X^&%U\%?@_P"%
M?",U]#JD?A?3H=(@NHK8VWGVUN@A@:12[_O!$D88AL,^\A5&%'%_LE?#KXBZ
M"?$6J?$K4M8N]>U(:3;")K^.;3L1:+8"ZFMX8V"0E]1;4-Q"1L^ =NP1D^WJ
MG"DJ-P_2@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% '(?'G_DDVL?[L?_HU*M?![_DF6C_]</ZFJOQY_P"23:Q_NQ_^
MC4JU\'O^29:/_P!</ZF@#I:*** "BBB@ J&XMO-#$,ZMCC;CC^GYU-7+_%W^
MS#\-_$8UN'4+C13I=T+^.Q6X:ZEM_);S5B%O^^,ACW!1%^\W8V9;% 'QW\#/
M'_A_XR_%KPWXV\.QZ/X4\1+?VEMH'@Z:/PA,O]F3*)-8FL;^Q:XFNMAFOI9#
M;7B$21G=$P)6;Z4^#&1\7/&&Y55O/DSCO^^//0?_ %^O.<GQ"QN_&DK_  UF
M\>:U;V_@?4]<TAM*TVPU72I[F>\.V2RMYT@LHDE2.98IB;*;!2U=B?*5D;W#
MX,_\E;\7GA@T\A!!SG]\>_\ G\3DD ]7KA?VF_BC=?!']G#XA>,[%;%KSPCX
M:U+6K<7N?LQDMK629?-PRGR\H-V&4XSR.M=U6'\0/ ]A\2/!^K^']7LUOM'U
MZSFT^^MS(T?VB":,Q2(2I5@&1F&5((R".: /D'2O^"C7C?QU\9-%^'^CV/@[
M^U-:MKAK75IXITL[T6NH1VJWT4/VA9WM+^*>.:&2,2V\*KA;J^<R1P4?$_\
MP47\<_!W3[K3;Z3POXNUBUUK5M'OKB.T6Q_LF7^UK];>>6)KI8UAM=/MH[AX
MIYH3)#+'(]U H:5_N@\TBH%Z #C' [4 ?+_P^_;(\<>*-7M;S7/#_A?2=%OO
M$F@>&VTU9Y;K4=+N+[1K/4)\R0F1+K;-?1Q*8XT5$A>9SY.^6'Q[P!_P48\<
M?\* \.>*-4OO"<VK77AG2WN6OK/RXKJ]4:ZTI!22+,MY)IMM!$@(6*6XRJ2E
MA$?T"(S^/!K&\0^#K+Q/K&CW=[:K<3:#>_VAI[F1E-M.8);<R#!Y_=3RK@Y&
M'/?% 'SY^W7^VMK'[+WBKP-86,.B+;^+K+5VDGU&&5O[-GMEM##*W[Z&,Q*9
MWWK-)!&049[FVC1Y:\9_9C_X*U?$'X\_%/1]%D^'>D:?I>N>*6TNS(N#$6L!
M;:8[;99Y(_.FC^W7DF8(9"RZ1/&88PTEQ;?H"JA>@ ^@I: /D']HW]MCQY\"
M_BO\2-/\/Z;I?BRV\/:5I]]9:2ULXN+.:XEM;.%)'B8D+<SWOFIYBJ=NEW:
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MY-;1>++Q'N$MK>2<QAFT_"E@F,G@9S7NU>0_\%!F*_L$?&\@D$> ->(([?\
M$NGH [_X5^-&^)'PT\/^(&MELVUS3+;4/(67S1#YT*2;-V!NQNQG SC/>M^N
M&_9C&/V;_A__ -BWIO\ Z215W- !1110 4444 %%%% !1110 4444 %%%% !
M1110!POQR^)NM?#G3]#CT'2--U?5/$&LPZ3!'?7SV=O#OCED,CND4K8 B( "
M<EAR!FLO_A(?C%_T*OPS_P#"IOO_ )7T?M$HO_"0_#4[1G_A,;4YQ_TZWE>G
M4 >8_P#"0_&+_H5?AG_X5-]_\KZ/^$A^,7_0J_#/_P *F^_^5]>G44 >8_\
M"0_&+_H5?AG_ .%3??\ ROH_X2'XQ?\ 0J_#/_PJ;[_Y7UZ=10!YC_PD/QB_
MZ%7X9_\ A4WW_P KZ/\ A(?C%_T*OPS_ /"IOO\ Y7UZ=10!YC_PD/QB_P"A
M5^&?_A4WW_ROH_X2'XQ?]"K\,_\ PJ;[_P"5]>G44 >8_P#"0_&+_H5?AG_X
M5-]_\KZ/^$A^,7_0J_#/_P *F^_^5]>G44 >8_\ "0_&+_H5?AG_ .%3??\
MROH_X2'XQ?\ 0J_#/_PJ;[_Y7UZ=10!YC_PD/QB_Z%7X9_\ A4WW_P KZ/\
MA(?C%_T*OPS_ /"IOO\ Y7UZ=10!YC_PD/QB_P"A5^&?_A4WW_ROH_X2'XQ?
M]"K\,_\ PJ;[_P"5]>G44 >8_P#"0_&+_H5?AG_X5-]_\KZ/^$A^,7_0J_#/
M_P *F^_^5]>G44 >8_\ "0_&+_H5?AG_ .%3??\ ROH_X2'XQ?\ 0J_#/_PJ
M;[_Y7UZ=10!YC_PD/QB_Z%7X9_\ A4WW_P KZ/\ A(?C%_T*OPS_ /"IOO\
MY7UZ=10!YC_PD/QB_P"A5^&?_A4WW_ROH_X2'XQ?]"K\,_\ PJ;[_P"5U>G4
M4 >'_#GXR_%SXC:7?7=OX/\ AO;I9:OJ&D,DGBF]W%K2ZEMV;C3R,,8]P'8,
M.]=%_P )#\8O^A5^&?\ X5-]_P#*^C]E0?\ %$>(/^QR\2?^GBZKTZ@#S'_A
M(?C%_P!"K\,__"IOO_E?1_PD/QB_Z%7X9_\ A4WW_P KZ].HH \Q_P"$A^,7
M_0J_#/\ \*F^_P#E?1_PD/QB_P"A5^&?_A4WW_RNKTZB@#S/X3_%SQ1XA^+G
MB;P?XJT'0=+O-"TG3=8AN-)U66^ANHKV;4(@C>;!"49/[/). P/FCIM.?3*\
MI\'#_C-KX@GO_P (-X7_ /2_Q#7JU !1110 4444 %%%% !1110 4444 %%%
M% !1110!R'QY_P"23:Q_NQ_^C4JU\'O^29:/_P!</ZFJOQY_Y)-K'^['_P"C
M4JU\'O\ DF6C_P#7#^IH Z6BBB@ HHHH **** &R_P"K->5_!S_DL'C+_KYD
M_P#1QKU27_5FO*_@Y_R6#QE_U\R?^CC0!ZM1103@4 ?-/_!/K_DKW[5G_99)
M?_4:\/U]+5\S_P#!/I@?B_\ M68(;_B\DV<'./\ BFO#W!]Z^F* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^9/^"G__
M "(7PA_[+/X*_P#3S!7TW7S'_P %/6#> _A%_#CXS>"C\WR@_P#$Z@''O[4
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MFUC_ '8__1J5:^#W_),M'_ZX?U-5?CS_ ,DFUC_=C_\ 1J5:^#W_ "3+1_\
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M_G\M_P#OX*/[?L?^?RW_ ._@H N453_M^Q_Y_+?_ +^"C^W['_G\M_\ OX*
M+E%4_P"W['_G\M_^_@H_M^Q_Y_+?_OX* +E%4_[?L?\ G\M_^_@H_M^Q_P"?
MRW_[^"@#R/\ ;W_90\)_MB_LW:OX3\:>(/$WA?P_#+#J]SJ>@7,5M?6PM29<
MJ\D4H"D!@V$W%20"*_-/P#_P20^ /C/X9:MXLU#QM^U_X,TJQ2&XTY_$^O:-
MID?B.WN WV26SG>W^S[IBK 6\\L-U$0OGP0[TW?K_K6I6^I:-=V]OJD%G<7$
M+QQW"[)# Q4@.%;*M@G.&!!QSQ7S9X&_8XO]&\)_$BUOM:^'&E7OQ!\-P:-<
M1>%-!?2=-EO0UV]SJ4UN;B17EF>ZYP ^U,-)+\NT ^5/B#_P0@_9I^$^J6]C
MXH_:0^+_ (9O+S9]G@U?Q]H]C)/O=HTV)+9*QW,C*"!R00,X-,'_  0J_9D/
MAO5M;_X:4^+3:'H5T+'4M03X@Z,UMI]R5C=89I/L>V.1EEC8(QW$2(<?,*]J
M_:__ &4O%'[1/Q^OO#^@K8Z#X5UOQ7H_C'6O$.H:7;732-9Z:UKY-K/'>JZH
M/)ME\J:WW!I[EE<K(NW8\&_\$WKSX=>(M#U?3?''AR>[T#PEX1\,V\<FGR6[
M)+HEKJUK)=Q7$4XGMVN(M3*'R65Q&CQL\B2$  ^:;S_@BK^RYI?Q/U+P;>_M
M(?&2Q\1Z3ID6LW5G<^.M)A:.TDCN)A)\UD =L-M+,_\ <BV.Q"NI,FM_\$4_
MV4?#(5M3_:F^)FEJT%K=#[9\2-$@)@NHIYK:7#68^6:*UNI(VZ2);2LI(1B/
MJOX'_L'ZI\'/@9H/P[?Q_H^K:'-\-8OAYXDN7T]DNKC[/'>K;W=IF=DCYOY]
M\<RRA@D6&0J=^5\"O^"<]YX%^+F@^*O%WC'PAXD_X1^R\+6,-E!I#1Q2?V%I
MVN6D%Q^]FD"2F;5HIP0#Y;6G!)960 ^>]%_X(0_LU^)/%6DZ'IW[1_Q<O]:\
M0:;'K6EZ=;?$'1Y;S4;!]Q6\AB6R+20$(Y$J;D.QL'@UH?$K_@WL^"/PM;P_
M'??%G]IRZNO$^KPZ+IUO9ZY93R33NDDK$XT_"1QP0SS.[E5"0MR6*J?H/6O^
M";NCWW[<#?%N'Q-"UG<>(M.\22:3-J.I);VDUEI2Z=&(+6WO(;(N%BC(EG@F
M=5>=!D.NSU']I;P!_P )5\8_@QXYL;A[Y/ASXCN9KS3[>6,-<6]_I]SIS3?.
MRJ1 ]S',X+9\E)BH=PD;@'Q!XB_X("? GPEXT31]4^,G[16GK_8MSKTVH77B
MO2X;*UMH)88G,DC60*G,RG)&T!6RPP :D/\ P0E_9WU6^\$0:3\>/CGKG_"P
MFD.C2V'CO19([R!+:6X:YB_T0-/"!&$)@61@94)4('=/KKQI^S-XX^)NH0ZE
MXA\??#_4M4T%K)]#=O#;^1*UMK$.H[[Z/[4!)(5M;5%,(B$<T;S ?,L,?1?#
MS]F@^#;OPS>W'B71;B]TWQ]J?CN_CMK"*TM7DOK#4+5X($C(V[6OA(97W/*4
M=G)>5GH ^"_%/_!&S]E'PC\/_$GBBX_:8^+UQHOA+34U;5)K+Q_HUTUM!*CO
M;DJEF3F<12B(8_>-$P7-=-K7_! C]G_1OA1JGCC_ (7A^T)?^%-(T^XU6;4M
M.\3V%_#);0*[2O%Y.GN9"HC?Y4!)(P!7N7@'_@F!_P (7X.T_2A\1-)26U^&
M7C#X?27-MI9C+R:]J=O?I>!?/Z6_E.HC))8RDATY!^AOB;X#U+XQ?LU^)_!V
MK>)M*TWQ!XJ\/7VC7&JZ9!F"TFN;:2$7$4$SOD(75A&[L,K@G&: /S7^&7_!
M&W]F_P"(WBK7O#MU\9/VE/!_BKPU-:1W^A>)?%&E6&H11WLJQ6$RI]C8/'=2
M/&D15B?,;RF"3 Q#I/"'_!"W]F3XC:ZVE^&_VE?BQXCU14NY&L],^(>C7=P%
MM9A!<GRX[,MB&9ECD./W;L%;#8!^F?C)^P7KOQ\\1W/BS7/BAI^G>.+O1KCP
M^+O3]*3[!I]DUK*(1!$S^:95OVBNV>21E*JT00'9*G!:W_P1OTG6O@U>>!?^
M%B6]OH]SXJU/7%ECL$%TMI=^#)?# MBP?89 9!<O($VL5VA%)#@ \(NO^"/'
M[(.G^!K'Q1<?M:>/H?#.J&1;+5W^*&@K871B9$EV3FT$;;&EB!"L2#(H.,BN
MEC_X(%?L^W_B>7P_IOQZ^.&K^*%TQM7AT2S\=Z,VH75L%0B5(FLP?+)EB D.
M$_?1Y8!@:^E_V:/^">NE_ KQ99ZQ?:[H^M74'B5?$;R7MSJ>L7CS)HCZ5&YN
MM2OKF7S4620*\>P+"5A"\%ST>A?LO2>!/VH[[XD6FM>'+'2!=7>HR:/HUH\,
MFIAK!;<"6.>XDMDGR@9[BUCMI)EBMTD8I&0P!\N?#S_@W2^"7Q0\#:5XATGX
MQ?M(OI^L6R7,(E\0V,4T88<I(C6&Z.1#E71L,C*RD @BMG_B&5^$?_17OVC/
M_"ET_P#^0*^O_P!CKPQ=?#;]GGPW8Z\O]F:U<+<:M?V$VL'4CIMQ>W4UY+:B
M=L%UA:X,2[0$58U5%5%45ZG_ &_8_P#/Y;_]_!0!^=O_ !#*_"/_ **]^T9_
MX4NG_P#R!1_Q#*_"/_HKW[1G_A2Z?_\ (%?HE_;]C_S^6_\ W\%']OV/_/Y;
M_P#?P4 ?G;_Q#*_"/_HKW[1G_A2Z?_\ (%'_ !#*_"/_ **]^T9_X4NG_P#R
M!7Z)?V_8_P#/Y;_]_!1_;]C_ ,_EO_W\% 'YV_\ $,K\(_\ HKW[1G_A2Z?_
M /(%'_$,K\(_^BO?M&?^%+I__P @5^B7]OV/_/Y;_P#?P4?V_8_\_EO_ -_!
M0!^=O_$,K\(_^BO?M&?^%+I__P @4?\ $,K\(_\ HKW[1G_A2Z?_ /(%?HE_
M;]C_ ,_EO_W\%']OV/\ S^6__?P4 ?CG\2O^"1W[.GP;^/&M> ]5\??M<HGA
MW3=(UK5-?M=8TNXTG3O[7U">QLTEV6AN5EEGAF+$0&-47>S@9KK?'_\ P19_
M9:^&.FW%UK7[2?QBM8['6;3P_>*/'>DO)97US<+!'#*HLLHP8LS[L;$C=SA5
M8K]J_%']E/6?&W[2GB_Q?IGCS1M%\/>/]"\/^']<LUTT3ZF+72KK5+DI;3M+
MY49N#J(C9GA8QHCE,.RO'YOH7_!.#7O#?CO^W+'XA>%+.33M#T_2]+M8=(F7
M3DFL=<M-7BF:T6Z6*".1[9HV@M5C51,2I^4"@#P^R_X((?LYW_CC2?#,?[0W
MQF_X237+$:K8:5_PGFD&^OK-@Y6YAA%D7DB(C8AU&W"OS\I%=A_Q#*_"/_HK
MW[1G_A2Z?_\ (%>K:Y_P3>L_$7[:Z?&*Z\6PR7%]KFE>)-1TTZKJD=K#>V&F
M"P4V]M#>16K;@D;"6YAGD56F3YED"I]<6VM6D0;=>VS9_P!M?\_SH _/'_B&
M5^$?_17OVC/_  I=/_\ D"C_ (AE?A'_ -%>_:,_\*73_P#Y K]$O[?L?^?R
MW_[^"C^W['_G\M_^_@H ^;?V /\ @E5X/_X)U^)_$VJ>%?'7Q4\4-XJM;>TN
MK;Q3K$%[;Q"!G9'C6*WB_>9EDR[EB=Y]:^GJI_V_8_\ /Y;_ /?P4?V_8_\
M/Y;_ /?P4 7**I_V_8_\_EO_ -_!1_;]C_S^6_\ W\% %RBJ?]OV/_/Y;_\
M?P4?V_8_\_EO_P!_!0!<HJG_ &_8_P#/Y;_]_!1_;]C_ ,_EO_W\% %RBJ?]
MOV/_ #^6_P#W\%']OV/_ #^6_P#W\% %RBJ?]OV/_/Y;_P#?P4?V_8_\_EO_
M -_!0!<HJG_;]C_S^6__ '\%']OV/_/Y;_\ ?P4 7**I_P!OV/\ S^6__?P4
M?V_8_P#/Y;_]_!0!SGQY_P"23:Q_NQ_^C4JU\'O^29:/_P!</ZFLCX]>)+'_
M (5A?PK=0M+=-'%&JN"2=X8_@%4G/M6Q\'P5^&>C;E93]G'!&#U- '24444
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M10!Y+_PRMI?_ $%-0_[\C_"C_AE;2_\ H*:A_P!^1_A7K5% 'DO_  RMI?\
MT%-0_P"_(_PH_P"&5M+_ .@IJ'_?D?X5ZU10!Y+_ ,,K:7_T%-0_[\C_  H_
MX96TO_H*:A_WY'^%>M44 >2_\,K:7_T%-0_[\C_"C_AE;2_^@IJ'_?D?X5ZU
M10!Y+_PRMI?_ $%-0_[\C_"C_AE;2_\ H*:A_P!^1_A7K5% 'DO_  RMI?\
MT%-0_P"_(_PH_P"&5M+_ .@IJ'_?D?X5ZU10!Y+_ ,,K:7_T%-0_[\C_  H_
MX96TO_H*:A_WY'^%>M44 >2_\,K:7_T%-0_[\C_"C_AE;2_^@IJ'_?D?X5ZU
M10!Y+_PRMI?_ $%-0_[\C_"C_AE;2_\ H*:A_P!^1_A7K5% 'DO_  RMI?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>prxy02.jpg
<TEXT>
begin 644 prxy02.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_X0 B17AI9@  34T *@    @  0$2  ,
M   !  $       #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R
M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M            ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS:;%#_9L<FSS$M]H_=(^Q=RK@-M&>@H _.']GUM';_@U9\6?V+\0KSXC1_\
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M%S(^-S,Y!8Y[US/P\^*'PQ\#?"_PGJ7AG4/".G>#/'%U;1>&IM'2*'3]6FO
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M\D:O@-O9@.23AZO\-/A9X1\0VFC7&@_#^PU;Q4=1>UL'L+.&XU;S(HQ?E(B
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MPH &!Q0!^7OP*\9>._AOH?[ _C3Q7\6/'GQ&OOC!I&H>+==_X2.UL]06P8>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPXN/ .E^);.RL?&WCKQ! U_8ZS"+R6#4-4BM;V9XK2Z22YAMH8[:(20!XS+
M)!^XU% 'RK^T]X]O/A'^S+X!^+OPUD\4>*_#OPZ6SU6XTH7^H7EQXL\.3V?V
M:0W+2F6XN)8(YX-0\Z:.6X)L77EII-WSWX?^&7[3?BQ-5^%MUXU\9MXR^#>G
M7/C:+Q)%>R6,7C;6KZVMKG2;.5\A9M,34&\06TEL7:!(K&R61=A11]W?'/\
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MJ<A?[;U' /T^T5RT\^RU4W&7-S-6O&$8W=FKM>T>C7*W%67-!233O>O9RO\
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M510!\E:'_P %>_#NN:S9V2_ O]K6U:\N([<37/P:UN*&'>P7>[F'"HN<L3T
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MX4_\%3M#^+7Q)T7PS;_!?]I_0YM<NEM5U'7?A1JVFZ99EOX[BYEC"11CN['
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MWQ.C^'OQDT^ST<RA_#NH^";ZU\3W7EE!^XTUD\^4-O&TJ,$!O0U[110!\?\
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MX^S?:47SMGE'?MSL\R//WQ7CZ?\ !9+PZR GX _M@+D9P?@KK>1_Y"K[ HH
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M?LL_]'+?L_\ _AP](_\ DBC_ (>Q?LL_]'+?L_\ _AP](_\ DB@#Z HKY_\
M^'L7[+/_ $<M^S__ .'#TC_Y(H_X>Q?LL_\ 1RW[/_\ X</2/_DB@#Z HKY_
M_P"'L7[+/_1RW[/_ /X</2/_ )(H_P"'L7[+/_1RW[/_ /X</2/_ )(H ^@*
M*^?_ /A[%^RS_P!'+?L__P#AP](_^2*/^'L7[+/_ $<M^S__ .'#TC_Y(H ^
M@**^?_\ A[%^RS_T<M^S_P#^'#TC_P"2*/\ A[%^RS_T<M^S_P#^'#TC_P"2
M* /H"BOG_P#X>Q?LL_\ 1RW[/_\ X</2/_DBC_A[%^RS_P!'+?L__P#AP](_
M^2* /H"BOG__ (>Q?LL_]'+?L_\ _AP](_\ DBC_ (>Q?LL_]'+?L_\ _AP]
M(_\ DB@#Z HKY_\ ^'L7[+/_ $<M^S__ .'#TC_Y(H_X>Q?LL_\ 1RW[/_\
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M_P"2*/\ A[%^RS_T<M^S_P#^'#TC_P"2* /H"BOG_P#X>Q?LL_\ 1RW[/_\
MX</2/_DBC_A[%^RS_P!'+?L__P#AP](_^2* /H"BOG__ (>Q?LL_]'+?L_\
M_AP](_\ DBC_ (>Q?LL_]'+?L_\ _AP](_\ DB@#Z HKY_\ ^'L7[+/_ $<M
M^S__ .'#TC_Y(H_X>Q?LL_\ 1RW[/_\ X</2/_DB@#Z HKY__P"'L7[+/_1R
MW[/_ /X</2/_ )(H_P"'L7[+/_1RW[/_ /X</2/_ )(H ^@**^?_ /A[%^RS
M_P!'+?L__P#AP](_^2*/^'L7[+/_ $<M^S__ .'#TC_Y(H ^@**^?_\ A[%^
MRS_T<M^S_P#^'#TC_P"2*/\ A[%^RS_T<M^S_P#^'#TC_P"2* /H"BOG_P#X
M>Q?LL_\ 1RW[/_\ X</2/_DBC_A[%^RS_P!'+?L__P#AP](_^2* /H"BOG__
M (>Q?LL_]'+?L_\ _AP](_\ DBC_ (>Q?LL_]'+?L_\ _AP](_\ DB@#Z HK
MY_\ ^'L7[+/_ $<M^S__ .'#TC_Y(H_X>Q?LL_\ 1RW[/_\ X</2/_DB@#Z
MHKY__P"'L7[+/_1RW[/_ /X</2/_ )(H_P"'L7[+/_1RW[/_ /X</2/_ )(H
M ^@**^?_ /A[%^RS_P!'+?L__P#AP](_^2*/^'L7[+/_ $<M^S__ .'#TC_Y
M(H ^@**^?_\ A[%^RS_T<M^S_P#^'#TC_P"2*/\ A[%^RS_T<M^S_P#^'#TC
M_P"2* /H"BOG_P#X>Q?LL_\ 1RW[/_\ X</2/_DBC_A[%^RS_P!'+?L__P#A
MP](_^2* /H"BOG__ (>Q?LL_]'+?L_\ _AP](_\ DBC_ (>Q?LL_]'+?L_\
M_AP](_\ DB@#Z HKY_\ ^'L7[+/_ $<M^S__ .'#TC_Y(H_X>Q?LL_\ 1RW[
M/_\ X</2/_DB@#Z HKY__P"'L7[+/_1RW[/_ /X</2/_ )(H_P"'L7[+/_1R
MW[/_ /X</2/_ )(H ^@**^?_ /A[%^RS_P!'+?L__P#AP](_^2*/^'L7[+/_
M $<M^S__ .'#TC_Y(H ^@**^?_\ A[%^RS_T<M^S_P#^'#TC_P"2*/\ A[%^
MRS_T<M^S_P#^'#TC_P"2* /H"BOG_P#X>Q?LL_\ 1RW[/_\ X</2/_DBC_A[
M%^RS_P!'+?L__P#AP](_^2* /H"BOG__ (>Q?LL_]'+?L_\ _AP](_\ DBC_
M (>Q?LL_]'+?L_\ _AP](_\ DB@#Z HKY_\ ^'L7[+/_ $<M^S__ .'#TC_Y
M(H_X>Q?LL_\ 1RW[/_\ X</2/_DB@#Z HKY__P"'L7[+/_1RW[/_ /X</2/_
M )(H_P"'L7[+/_1RW[/_ /X</2/_ )(H ^@**^?_ /A[%^RS_P!'+?L__P#A
MP](_^2*/^'L7[+/_ $<M^S__ .'#TC_Y(H ^@**^?_\ A[%^RS_T<M^S_P#^
M'#TC_P"2*/\ A[%^RS_T<M^S_P#^'#TC_P"2* /H"BOG_P#X>Q?LL_\ 1RW[
M/_\ X</2/_DBC_A[%^RS_P!'+?L__P#AP](_^2* /H"BOG__ (>Q?LL_]'+?
ML_\ _AP](_\ DBC_ (>Q?LL_]'+?L_\ _AP](_\ DB@#Z HKQGX=?\%%/@'\
M9?'&G^&?!?QO^#OC#Q+JSNMGI.B^--.O[ZZV(TC^7!%,TCE41F(53A58G !-
M>S4 %%%% !1110 4444 %?SR_L^_LAZ+_P %T/\ @X"_:?A^/FL>(M<\)_ _
M5K[1M'\.VMZ]M;S6=GJDEE;VWF*1)!#MB>618"CR2S,_F*=_F?T-5^'O_!OC
M_P IZ_\ @H3_ -C5K?\ ZD5W0!]A_P#$+C^PG_T0W_R\_$'_ ,G4?\0N/["?
M_1#?_+S\0?\ R=7W_10!\ ?\0N/["?\ T0W_ ,O/Q!_\G4?\0N/["?\ T0W_
M ,O/Q!_\G5]_T4 ? '_$+C^PG_T0W_R\_$'_ ,G4?\0N/["?_1#?_+S\0?\
MR=7W_10!\ ?\0N/["?\ T0W_ ,O/Q!_\G4?\0N/["?\ T0W_ ,O/Q!_\G5]_
MT4 ? '_$+C^PG_T0W_R\_$'_ ,G4?\0N/["?_1#?_+S\0?\ R=7W_10!\ ?\
M0N/["?\ T0W_ ,O/Q!_\G4?\0N/["?\ T0W_ ,O/Q!_\G5]_T4 ? '_$+C^P
MG_T0W_R\_$'_ ,G4?\0N/["?_1#?_+S\0?\ R=7W_10!\ ?\0N/["?\ T0W_
M ,O/Q!_\G4?\0N/["?\ T0W_ ,O/Q!_\G5]_T4 ? '_$+C^PG_T0W_R\_$'_
M ,G4?\0N/["?_1#?_+S\0?\ R=7W_10!\ ?\0N/["?\ T0W_ ,O/Q!_\G4?\
M0N/["?\ T0W_ ,O/Q!_\G5]_T4 ? '_$+C^PG_T0W_R\_$'_ ,G4?\0N/["?
M_1#?_+S\0?\ R=7W_10!\ ?\0N/["?\ T0W_ ,O/Q!_\G4?\0N/["?\ T0W_
M ,O/Q!_\G5]_T4 ? '_$+C^PG_T0W_R\_$'_ ,G4?\0N/["?_1#?_+S\0?\
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M&C>4 'TU_P 0N/["?_1#?_+S\0?_ "=1_P 0N/["?_1#?_+S\0?_ "=7V;\
M/'D_Q2^#/A/Q-=PZ5!>>(=$L=3GCTO4(]1L8GF@61DM[F/Y+B$%CLE4;9%VN
MO##'YY_M]_\ !3CXK_L^_'#]KK0/#=]H=OI_P9^$VD>+_#?GZ8DTD=_<W&V5
MI23^\0KD!#\HX(&10!W_ /Q"X_L)_P#1#?\ R\_$'_R=1_Q"X_L)_P#1#?\
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M']A/_HAO_EY^(/\ Y.K[_HH ^ /^(7']A/\ Z(;_ .7GX@_^3J/^(7']A/\
MZ(;_ .7GX@_^3J^_Z* /@#_B%Q_83_Z(;_Y>?B#_ .3J/^(7']A/_HAO_EY^
M(/\ Y.K[_HH ^ /^(7']A/\ Z(;_ .7GX@_^3J/^(7']A/\ Z(;_ .7GX@_^
M3J^_Z* /@#_B%Q_83_Z(;_Y>?B#_ .3J/^(7']A/_HAO_EY^(/\ Y.K[_HH
M^ /^(7']A/\ Z(;_ .7GX@_^3J/^(7']A/\ Z(;_ .7GX@_^3J^_Z* /@#_B
M%Q_83_Z(;_Y>?B#_ .3J/^(7']A/_HAO_EY^(/\ Y.K[_HH ^ /^(7']A/\
MZ(;_ .7GX@_^3J/^(7']A/\ Z(;_ .7GX@_^3J^_Z* /@#_B%Q_83_Z(;_Y>
M?B#_ .3J/^(7']A/_HAO_EY^(/\ Y.K[_HH ^ /^(7']A/\ Z(;_ .7GX@_^
M3J/^(7']A/\ Z(;_ .7GX@_^3J^_Z* /@#_B%Q_83_Z(;_Y>?B#_ .3J/^(7
M']A/_HAO_EY^(/\ Y.K[_HH ^ /^(7']A/\ Z(;_ .7GX@_^3J/^(7']A/\
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M &:"SG%I<PK<2-"J"02*Z9CR,^8^?;_V?_\ @K7\&_VA$\1-;ZCX@\$KX<T
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MM?"?]M;0-2U3X5_$'PGX[L](D2*^_L?4%N);%GW;/.BX>+?LDVEU <(2,X.
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M$GBK3_C7X7\'_!B;P'X+L?%OB>UE\<1ZW?: UQ*8S#/'!;+'Y2_*5G25]Y<
M(.:T]3_X+7_LHZ/;:]-<?'[X7+'X:D@AO\:Y&S)+-NV)&H^:<_*VX0AS'M.\
M+@X /J2BO"_BY_P4O^ OP%\(^"_$'C+XM>!/#NA_$2);CPS?W>JHL&M0E4;S
MX6&0T(62,F4X0;URPR*]ML+]=0A62-HWC90RNC[E;/<'N/0]Z )Z*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ^/?\ @OW_ ,H;_P!H/_L5)?\ T;%1_P $!/\ E#?^SY_V*D7_
M *-EH_X+]_\ *&_]H/\ [%27_P!&Q4?\$!/^4-_[/G_8J1?^C9: /L*BBB@
MHHHH **** "OP]_X-\?^4]?_  4)_P"QJUO_ -2*[K]PJ_#W_@WQ_P"4]?\
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M^'?@^.#4K'X/0>'+D>)+'4X+_3?$46LV#WD3VSQ$J5C5"I;<P8\@XKTKQ_\
MM2_#GX4>/-"\+>*O'W@?PSXF\4,$T;2-6\06ME?ZL3)Y8%O!(ZR3?-A?D#'=
MQUH _*']M3_@EA\>/C)\.?\ @H-9^'/ACH=K<_'/3OA3!X(TO2/$-A_9]V^B
MQVJZG;V\DS6QCAM6C=$:XAMO-5%*1\A1Z9_P4"_X)4?%C]LS]I;]KK^PS%X3
M\/\ Q>^%_A[0/#7B2?4(EM[O4;"^CNI;*6..0W,<4JQ^2[M%MV2O@/C:WTEK
M7_!8#PC>_P#!2;3?V:/".BV_C#Q/'$LOB#4(?%6DV<>B$K-))!';33K<WMQ#
M'"TDT-O&SQ(06&,XS/VS?^"N.L?LS?MFV7P/\&_ ?Q]\9?%EUX)3QU(OAR]M
MHOLUBVH36)++*03MDC3)!/\ KEXZF@#;_8KUCXI>/_CGKFN?$']EWP/\#;#3
M?"NFZ'INM)X@TW5->U%HY6=[)/L"2*NFQ;MT:R31M&P#")_-8V]'_@I5^S%X
MZ^.O[5_[(_B;PIH+:MH?PQ^($VM^)KD7MM!_9EFUH8EEV32(\OSL!MB#M_L^
MM?X)?\%F/"_[0/P4\%^*-#\(:AH^M:O\4+;X3^*?#'BK7=.\.ZIX/U9MXN(V
M6[F07DL>T%+:VW7,P8A8@Z2(GN]G^W%\'=2\4>(-#M?BM\,;C7/",=[+K^G1
M>*[%[K0TLCB]:ZB60O ML2!,9 HBS\^V@#\_O^"AW_!.WXS?'/X^?ME:UX4\
M%G5M+^+/P?T?PKX5G_M>PMQJ>I6]P'F@VRSJT6U<G?*J(<$!B<9Z"X_X)N^.
M[O\ ;LMO%DWPZTJ7P?9_LA?\*N@D>;3VBA\2?:F_T!83)N4?97:/S@OD;&:/
MS.2M?>G@#]J_X:_%CX8:IXV\*_$#P)XF\&Z+Y_\ :.O:3XBL[S2[#R(A--YU
MS'(8H_+C(=]S#:K!C@'->,_M+?\ !9+X!_LX_L\VWQ(3X@^#?&^AZEK</AW3
MSX9\2:=?+=7LC1AAYHG$:QP+()9WW$Q1 N5/ (!^7OA+_@CQ^TI\'O"_@G5&
M\'_$S5FU3X+6WP[UW0/ GC[PSHNH:7<P7,YFL+R;4X[FVGL+E)EDWVKEE<LK
MQM@,?V'_ ."?_P #9OV9_P!C7X;^ ;B/6+>;PEX?M-,-MJFL)K%W9"-<+;O=
MI! DXA7$2LD*)MC4*-H!.KXP_;1^$OP_TSPG?:Y\3_AQHMCX]CCG\,W.H>)[
M*TB\1Q2!#')9-)(!<JXDC*F+<&#H02&&9/%O[8GPK\ _%6T\"ZY\2OAWHWC7
M4+FUL[7P_?\ B:SM=4N)[DD6T26LDBRL\Q!$:A29/X0>< 'I5%>7_#/]M7X1
M_&KQQ?\ ACP9\3OASXN\3:5YAO='T3Q/8ZAJ%H(WV2&2"&1I$"OA26 VD\XY
MKU"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /CW_@OW_RAO\ V@_^Q4E_]&Q4?\$!/^4-_P"SY_V*
MD7_HV6C_ (+]_P#*&_\ :#_[%27_ -&Q4?\ ! 3_ )0W_L^?]BI%_P"C9: /
ML*BBB@ HHHH **** "OP]_X-\?\ E/7_ ,%"?^QJUO\ ]2*[K]PJ_#W_ (-\
M?^4]?_!0G_L:M;_]2*[H _<*BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^7O\ @M'\*/$GQU_X)<_&
MKP?X/T6_\0^)O$/AR2UTW3K*/S)[R4RQD(B]R0"?H#7U#10!^='[8O[(WBKX
MT>(?V ;>3P%-XATCX<^([2[\7075I'<6^C11Z2B;[E'!4;9U !&[#H,$'!'S
M-^S]_P $Z/BE\-?VG_"LEE\+=5T+PCH/[9'C'QE;+;V26]E8>&I["UALKN-%
MPJ6K>64CV@ ;,  8K]L** /QE_X)Z?L:?$K]F_\ ;S\#^'_ WP+\::#\&="U
MG6+JXL?BGX9\,WB^ [.;SI4N-&\265U-?33N[1*ML1*JB>16F<1O<UZA_P %
MSKIM._X*I_L"W@^&DWQ@339_'E]+X3@^SM<:E%#IEA+(\"7!$4MQ B-<10NR
M^;) D8="X8?J57%^.OV>O!OQ)^+/@KQWK6@V-]XP^'(OQX:U60-]HT?[="L%
MWY6#C][$JJ<@\#C% 'X]_ 3_ ()B_%./4O@)J'B;X02:9X3U;]I7Q)\3G\&W
M(M]0A^'WAV^M8OL5M=1KNAB*20EQ&GW&=<A)-RKUG[;?["'C[2?BU^U]I*_L
MVM\?=6_:@TFTM/AYXRM&TM+/P<D5@MJMI?-=.KZ?]AD2&YADB#K=&*'YHW5O
M+_8RB@#\;/VZ_P#@GO\ &O\ :$\;_#Q;'P3'XON?V2_AUX?A\4ZIKDES:I^T
MC=13Z??SZ#"R;A)9HVGR3[[E9,7\L49A"EIZJ_\ !3SX/ZC\1/VVM!\&^&M+
MUWPU%_P4>\):%IOB?3+H)#K'AZ?P[?6-Y?75[&TWEH4T&>YMVBA<_O;5U&2^
M^OV=KS+PY^QU\-?"/[1?B+XO:;X.T&U^)_BRSBT_5O$XMMVHWEO'%%$D9D)^
M5=L$ (4 ,(ESG - 'S3_ ,%]?V9?$GQK_P""-'Q2^&OPQ\+WGB#Q!?V^AVFC
M:'ID6Z>2*UUG3Y2D:YY$<$3MUX"&OD[XG?L<?$GX7?\ !3G5+WX._ OQQ>>'
M_&?Q3C\5Z]IWQ!\,^&M?\#W[3N/M^O6FK_:7U'292%FGC@1))-RQ#RU,B6J?
MLI10!\5_\%K_ -E^S^/_ ,)O &N1^"_BYXJ\3?#SQ/'JVC7?P\CT>\U+1G>,
MQ/)+8ZI(MO>6[$QAXMK-P&)2,2$_'K_L8_'[XI?L(_"76OB+\&_#?B&/X6_&
M:;QQK7PYT[PWI7AO5?B5H0B*)JEYI\$KV"ZR&DGF>Q$OES+A"Y< /^RU% 'X
MA_%7_@G]\:OB?\+?CAXTT/X.:W\._#WQ7^-G@GQ-X8^&*-:->Z19Z<%CU#6I
MX+5V@MYKUBDLT0.]&@.YG 1VV(O^">?Q@M]'\?\ BN^^&^K^*-!\'_MG^(?B
M[=> Y%ABO/''AZ1+>."_L?.=89Y8LR2Q6\K(MQM=0P8*K_M)10!^2_QN_9W\
M6?M$_#3X%ZMX0_9/N/@C::?^UMX?\9:QHT?V-]2U#1[;[4MQK^I6]LHCM=V]
M0T1DE*XR&9&1W\3OO^";OQJM_P#@GOXL^%ND?"GQ9X:\2?#_ ./=MX^U]M/L
M=*GM_B)X:^VW\T=OIJ3S&WU1K4&&Y%G?HD198DV.QV5^ZE% 'X.:+_P3W^+T
M6O:3\4G^$_QR\>>']%^,F@^//$7@;Q1I/A7PY-KD-IIMU;3ZG8:1IUT+7[7&
MWE!X9$0W.R%UD8R7/E?;O_!#[]GSQA\&_C)^UEX@\1?"+6/@SHGQ$^(JZ[X=
MT74'M9&:T>%B9 ;:22$%F;>T<;LD;.R*S!<G]!J* /PN_:U_80^*GC76OV[O
M"]C^RSXB\=:U^T-XPL4\#^+UN]-M[:S2V$4OGSRW$R/;VZ?O)(Y(@XEDS#)Y
M?R,>N_X*7?LIZWX8_;1\._!G1]4O-2G_ &[O!^@^$?%VHP3EKP7?A2]L)=1U
MB8SRC,<FAO=1A0Q=G@8<ERP_:.O,O#G['7PU\(_M%^(OB]IO@[0;7XG^++.+
M3]6\3BVW:C>6\<4421F0GY5VP0 A0 PB7.< T ?,G_!<C]CS6OCI^P;H.A^
M/ \?C"^\"^+-!UFWT.TAMVO&TZRN4\^&T69E5W$&1Y9=2ZJRY.0I^.?VA_\
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M7?$^^3Q%::)H.@6'A#PU:7#SB(Z2MBKZE=6S[87N+J]EEC20 H^V1BN]9?\
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M+^"?A+2M6TZ\OOBQX4\,)KW@YRK^2NBZWI<QGU!+J98TE$D?EB&+(9PZE?V
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M) !OFGD;=)-*[]%XA\1V?A;3GO-0NK6QLX\>9<7,RPPQY(4;G8@#+, /4D4
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MSXP_8Z\%Z)\8O#LCZKI/ABUU/1-3\-SS"*RU*ZU"&-=)N)&)4!TU6"QM=Q9
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MLYMV"YA\P$A]A&\'!R.*UKWPW9W^MVNI26MHVH6<$MM!=- K3PQ2/$\D:O\
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M#;BKI^%7A]IK*1M%T5FTN]FU*R/]GQ?Z'=S,[RW,?'RS.\LK,XPS&1B2222
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M7[37A=;2PN+72)CH N/"NB21:C# EK'*TD*/]E@,[RV^VTA::&YD%PT_Z1?
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M]NWX^Z]X-_8DU'QKX%U2'PKJ%\='CCU_5M*-S%X2L-0U"SMKS5[FUD9%_P!
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MF'2;&[U+Q!J U"\U:YU[6A!-JM]>W;EKBX>2*...,LNV,)#''&D<<:(BJB@
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MQX\^)/[ &A^*O&6M^%]0\;3:7J)?7;.W:73-46VGN8;34?)MGV2)-!%!</\
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M/.Z -*VZ20[G).7<_P 1H ^7/VS_ -HFX\.?M2>&OAOJ7QFA_9]\,:AX2O\
MQ-%XH$&E1SZU=6MQ'"]E'<ZM!/9+'!#+]HEB6(SL'B8211I)YOE?_!,V^U[]
MJS]M[4_C5XFU_4X]6UCX,>#=0CTQ-#L;73I8+O4?%4*O )K9K^"WE^R_;8T%
MV6+7\BR23Q);I%]\?$'X7^'?BOI<%CXFT'1/$6GV\WVA+75+"*\A23:RAPD@
M*APK,-V,X9AW-:%EX;LK#6[K4H[6T74+R"*VGNE@59YHHGE>.-G^\RHTTI52
M< R2$<NV0#\Q?^"F6A3Z/^TO^TS<-\1M0ADOOA3X N+#PK>PZ:VFW0&OZ_$
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M\->'K323J)BW^69OL\:>84\V3:6SM\QL8W')\0OV5?AO\6_'FA>*?%GP_P#
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M7]J/]JC]J3X3_%;QOX5\)ZA:>(I_@WX2MO%&M:XOAWPYINE:S<W4]Y=;[_\
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M=K>:;NU2U6/>%N2) 2Y&]!^LG@;P#HWPT\.P:/X?TO3=%TBT!%O8V%I':VT
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M>?L[>";[X;Q^#9O"7A6;P?'(D@T&71[9]+RDXN4/V;9Y65G42@A>) &^\ 0
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MC!=B?/?B5^PK\%/C2R-XT^$'PM\8-'>7.I*=;\)6%_MN[D1"YN!YL38EF$$
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MEAU&QTJ_OH+6>(2KM;S4\Z"2"3RD)8OXQ#^UY\6-%_:PO/#_ (J\:?V%X/\
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MNOVVJ:+;7D6N"WP;?[4LB$7'E$*4\W?L*C;C% 'YY?%#]LOQ'X=^+MOKE_\
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MC?R(-RL88BGHGC?X5:'\1/$/A/5=6L_M6H>!]4DUK1)?.D3[%>26-U8-+A6
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M:]IGBF/6-0MKC1K"_P!1FCNK V\)CCN+/2M2D@DAEF8F"-)H[=I0%]?\0?\
M!-3X<:_XP-]]H\:Z?H-T]C)J7A.R\37L/AO6&L8+:"S\ZQ\PQJL4=I;*8X?+
MCF6)5G6920?//V/?^"4OAGX8?#'3;+XAI)XPU*"WUB&YT2[U:ZU7PM;OJDMR
M+V:VLKD*D<MQ:SM%*WE@;9[I451<3F4 \W\ _P#!=#6]<TC7X-4^";7'BB'1
MM-N]!TSPSXL&I6U[JM]JUEH\6C7UW=V=E'97(O=3L<RQBYMVB-S)'-(;<HW;
M?%[]JG]IK1_C#\&= E^$O@'PI_PD7Q%N= U"3_A89OM)\4Z?_P (OJ>HH+:?
M^R3=1>7-:S/(9+6!Q+86\:&:"[EE@]3TC_@FSX%C\*Z[H^OZY\1/'-OK5C%I
MMO-XG\57FI7>@V\4T=Q#]@G9Q);31W$-O.+I6-R9;6VD:9F@C*QV7_!-'P+9
MV-E<-K7CRY\76?B>'Q<?&$^NR2>(+F^BLI].C$D^-IMQ8W-S;"!46()/(X42
MNTI .(_;=_;/\>?LN?M5^'YX]'T74/@[HOPH\8^._%49U9H-6==(N=',TUO
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M\9:+KVE>-=1\;">V-A(ES)J$<<=[I\B36L@^QRI$B_)LN4 .RX4G- 'R!/\
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M-\-/ OAV3Q]^T3<>)?!OB_6KBRU*3P[H]Y/<V5[X<2VDDNH;6S@ABAAO+V)
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MXO%T)U6_L;R&ZM);G[.D:O:RR 3HP(EC8KL<84R(5E;G?'W_  36\.6'[/\
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MCXT\%QQ:!X/TIM/EFU'Q4_B"32#$+]6,'EQR07"/=+<O9F*W>:,S!HVD]_\
MV"/CWXT^.WB3XYKXVT6_\+W?@WQ];^'['0KN2UF?1X!X:T*[DC6>WRMQ$]U>
M74\<KGS&CN$#+'@11U?$?_!,OPKXNNK+4=4\:?$J_P#$VFZ+#IEGXAN-7BGU
M2UO(M2.IQZJDDD+*MTMTS8B"BR$+-;"U%L?(KT#]F/\ 97TO]EV#QFUCXB\7
M>*M2^(&OKXFUO4O$5['=75S?_P!G6-@[J8XXTCC=+")Q#&JQ1,[I"D4"Q0Q@
M$WQ;_:4T_P""WQC\#>&]<LS9:/XVM=69/$-Q<I!8Z?=V,$=V+64MCYI;-=0N
M V<*FG3$C&67YO\ $_\ P4SD\/6_A/Q5'X-^(%X_C+P9X<US3O!/VC3+<.^M
M^(K+2K0L\T:2QWP-]"662Y6!5#*P5P91]#_MC?L?^$?VY?@C=?#_ ,<#4O\
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MB#KVH6^LZ'KSRZ@^FQQRW6D+<Q6@6"VLX8+>'[/.D+06T<,6VUA9%CE:XDG
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MO! \?5_\,&^%_P#H,>(O^2<_\*O^_;_\@S_GM_JO^/K_ &_]7_TRH \7\?\
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M#UKP5>--K%A%;++;>*H8]+UFPL5E+'=#+:'7+YTECXD6>1)4DQ ]OY1\,?\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q[_P7[_Y0W_M!_\
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M[XC\-Z;8Z3X=UFWEO=6TG58K/SY3)J#AK22-9SL4HX9HOF(5E/N7Q+_X*_\
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M6B_LK_&W3?AV/AC\8?B3XNU?PU=>*[6P\#:'!JCO9VUU%;3!M]Q$4=6E5AN
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MU&:Y^QPQ0K%:O?W#6,<B1221K.ED;5)0DLJ"59,2RC]XP!\\Z)_P7B^"&O\
MA2QUB&#QDEO??";4/C#LEL;=9(=.LI9HIK!QY^!J)>UNPL()C;[)-^]&T9Y;
MQO\ \%6-?A\5S6OA_18;-XOBE\./!=]I/B/P]]FN]&M/$UM8W%RC3V^I31W%
MW''><.(XHH7!CV7*KYSX'B/_ (-TO _B&[\3NWC PP>(_BQ'X^2W3P] ([#0
MV^W?;/#*8D#&UN!JNJ L3Y:BZ7$!V$OZQ\4_^"4;_$KX]>-/&W_"?+8KXO\
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MA_:%U[5=+\3:WX-TQ=&\)PWJ>*]7TBX\J]M-.*W.92D237/F2".,0VTH9EE
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M?3O$NA7OC&\\$6VI6>OZ=K6LR:Q)')ICW"QPS0W1B9)8I5!*.'C9&6- #/\
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M5[*^N[K5X7FG8WK36L,96'RXD$3$1J9"L?T;^V'^Q=\7O$7[44/Q>^!/Q/\
M"O@/Q9K7@[_A ->B\3^'6UBT6Q2ZGN[74+,)+&5O;::YGVQR[X)1*-Z_NP'
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M^Q;R;2+>_P#$"^$=0CT?P[+JWDG3XK^>6)/LTDOVB#<C+NA,T8F$1= WR?\
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MA>.S\)IX1^)^E6EH]O:^-[:WMQ_9]XB1_NUN[6X,S+*Z%Y(;B2(N%"E?1_\
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M=?'#P=-\1OA'XH\.V\T-M<>(-%O=-CFESY<+30M&';'.U2P)QS0!\5?LS?\
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MPHWPGX/L(?#]O!9^'[/6M.\07&HWMIIUM=V]PMO#]GDV6L\\#".5H6*JR$*
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M1^$/A6S\-?"/7/"VJ:;\/+)M,T'3=5O?$%GJ"165K)\X0P1RF27@/,9&^42
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M)@CC\.7.MPQWQFF*B*W*YP+APRE8-WF,'0A2'4GD?V6O^"GG@W]L7]I[XA>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X]_P""_?\ RAO_ &@_^Q4E_P#1L5'_  0$_P"4
M-_[/G_8J1?\ HV6C_@OW_P H;_V@_P#L5)?_ $;%1_P0$_Y0W_L^?]BI%_Z-
MEH ^PJ*** "BBB@ HHHH *_#W_@WQ_Y3U_\ !0G_ +&K6_\ U(KNOW"K\/?^
M#?'_ )3U_P#!0G_L:M;_ /4BNZ /W"HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^/?\ @OW_
M ,H;_P!H/_L5)?\ T;%1_P $!/\ E#?^SY_V*D7_ *-EH_X+]_\ *&_]H/\
M[%27_P!&Q4?\$!/^4-_[/G_8J1?^C9: /L*BBB@ HHHH **** "OP]_X-\?^
M4]?_  4)_P"QJUO_ -2*[K]PJ_#W_@WQ_P"4]?\ P4)_[&K6_P#U(KN@#]PJ
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /CW_ (+]_P#*&_\ :#_[%27_ -&Q4?\ ! 3_ )0W
M_L^?]BI%_P"C9:/^"_?_ "AO_:#_ .Q4E_\ 1L5'_! 3_E#?^SY_V*D7_HV6
M@#["HHHH **** "BBB@ K\/?^#?'_E/7_P %"?\ L:M;_P#4BNZ_<*OP]_X-
M\?\ E/7_ ,%"?^QJUO\ ]2*[H _<*BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X]_P""_?\
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M;X_\IZ_^"A/_ &-6M_\ J17= '[A4444 %%%% !1110 4444 %%%% !1110
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M_P IZ_\ @H3_ -C5K?\ ZD5W0!^X5%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q[_P %^_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!\>_\%^_^4-_[0?\ V*DO_HV*C_@@)_RAO_9\_P"Q
M4B_]&RT?\%^_^4-_[0?_ &*DO_HV*C_@@)_RAO\ V?/^Q4B_]&RT ?85%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?'O_!?O
M_E#?^T'_ -BI+_Z-BH_X("?\H;_V?/\ L5(O_1LM'_!?O_E#?^T'_P!BI+_Z
M-BH_X("?\H;_ -GS_L5(O_1LM 'V%1110 4444 %%%% !7X>_P#!OC_RGK_X
M*$_]C5K?_J17=?N%7X>_\&^/_*>O_@H3_P!C5K?_ *D5W0!^X5%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?EO\0?@]-_P5>_X*\_'?X1_$KX@^//#GPY_9WTGPU-X8\(^$]=
M?0UU^?5;!KF[U*Z=,2SM"Y$"D$+&)0!M9W$OZD5\N?MS?\$>O@E_P4*\5Z3X
MD\>Z/K%GXNT>TETR+Q#X=U2;2-3N+&165[.>6(XF@)=B%D!V[F"E5>0. ?+G
MPW_:ZU[]ESP7\'?V=_@G\9M!_::^(GQ*\=>*O#VB^,_'4\E[:^$K#1E%[?6F
MIM:RFXO;NW@D18AOA$PE1P8X1"IS/$__  6O^,_@WPAX?\*S>!_AC_PN[1_V
MBM"^!_BJT>^U!O#FIV^H6T\T>H64W,UH9C$H!E6Z:$*S-'*6"#ZLOO\ @BQ^
MSW)^S'X-^$VF^$;WPWX;^'>K?\)!X7O=$UF\L-;T'5/F)OH=0CE%P9RSELN[
M+E8_EQ%$$MZ3_P $@/@OH7PK^'_A&STS6H;'X=_$6T^+%O>MJDL^IZWXFMRY
M.HZE=2EY+N65I"9"Y&0J*NU$50 ?G'^W+_P45_:>^(/[,WQ0\(WVK?#/PIXJ
M^%7QOT3P%K&K^%(=7L;?Q!8W;0R6Z*&N6FA0N-MTAD99H9#&I7;NE['X\?\
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M"K\'O^"(/Q5\-_!3_@XE_;>\,>+=<T[PWXA\=>*]:3P]8ZE*+9]9D.NSSK'
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M:?XU^W]% 'X@?\00WPM_Z+CX^_\ !/:?XT?\00WPM_Z+CX^_\$]I_C7[?T4
M?B!_Q!#?"W_HN/C[_P $]I_C1_Q!#?"W_HN/C[_P3VG^-?M_10!^('_$$-\+
M?^BX^/O_  3VG^-'_$$-\+?^BX^/O_!/:?XU^W]% 'X@?\00WPM_Z+CX^_\
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M\E5!!7<&_6S0-!M?#&DV]A8P6]K96<*6]O;P0K%%!&BA51%4 *H4  #@
M<5<HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>sig01.jpg
<TEXT>
begin 644 sig01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MF"02/?G)QVI<>P/U8G'N,C@^_6@@G^+&/;^?/^12?,?XNF#D#J".X/3GI@T
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M/RQIMA#>F^-R7,YG<(L8MQ"@B$?)+&:7?P-JX)/6;1[]3QDX.?7GK[__ *J
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(?\_G[T ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
